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1 Introduction 
1.1 The liver 
1.1.1 Anatomy and Physiology of the Liver 
The liver is an important organ within vertebrates that has a central role in 
metabolic homeostasis. It is responsible for the metabolism, synthesis, storage and 
redistribution of nutrients, carbohydrates, fats and vitamins. Additionally, it is the main 
detoxifying organ of the body metabolizing toxic substances and most medicinal 
products by metabolic conversion and biliary excretion. In mice and rats, the liver 
constitutes about 4.5 % of total animal weight; a human liver weighs about 2000 g 
which complies approximately 2.5 % of the body mass. 
Due to the extensive functions, the ultrastructure of the liver consists of 
various cell populations of complex organization. The main cell type carrying out 
these functions are the parenchymal cells, hepatocytes which represent about 80 % 
of hepatic cells. Depending on the hepatocytes location within the liver, its 
regenerative activity, metabolic load and age the cells vary in size and shape. About 
25 % of the cells contain two nuclei with one or more nucleoli the nuclear size 
correlating with its nuclear ploidy. Polyploidy has been noted frequently in the normal 
liver hepatocytes; approximately 15 % of hepatocytes are tetraploid (Gupta, 2000). 
The remaining 20 % of cells found in the liver comprise the non-parenchymal 
cells, which include endothelial cells, Kupffer cells, stellate cells, lymphocytes and 
oval cells. Endothelial cells line the hepatic vessels and are able to absorb nutrients 
with their large surface area. Kupffer cells are the resident macrophages in the liver 
and have the ability to migrate to sites of liver injury as well as to sectrete cytokines. 
Hepatic stellate cells represent ~2 % and their main function lies in storage of vitamin 
A. During liver injury they become activated myofibroblasts and produce extracellular 
matrix which ascribes them an important function in progression of fibrosis and liver 
disease. Lymphocytes are also part of the innate immune system and help resist 
infection. The origin of oval cells up to date is controversially discussed. However, 
their function seems to be as progenitor cells of hepatocytes and cholangiocytes, 
entering the liver tissue after severe injury in cases when hepatocytes are unable to 
replicate due to certain types of injury (Fausto, 2000). All these cell types are 
activated following hepatic injury (Taub, 2004). 
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1.2 Apoptosis 
Programmed cell death, also termed apoptosis, is a defined process which is 
actively regulated via distinct signals and signaling pathways. It plays an important 
role in the development of multicellular organisms and in the regulation and 
maintenance of the cell populations. Apoptosis is probably the most frequent form of 
programmed cell death, but there are also other non-apoptotic types of cell death of 
biological significance (Leist and Jaattela, 2001). 
 
1.2.1 The significance of apoptosis  
During morphogenesis of multicellular organisms many cells are produced in 
excess which eventually undergo programmed cell death and thereby contribute to 
sculpturing of organs and tissues. These events depend on a tightly regulated 
interplay between cells forming the organism (Meier et al., 2000). One example for 
the importance of programmed cell death is the formation of independent digits 
during embryonic development by massive apoptosis of the interdigital mesenchymal 
tissue (Zuzarte-Luis and Hurle, 2002). Also cells of adult organism undergo 
apoptosis. It is most often found during normal cell turnover and tissue homeostasis, 
induction and maintenance of immune tolerance, development of the nervous system 
and endocrine-dependent tissue atrophy (Rathmell and Thompson, 2002). 
Programmed cell death is also a widespread phenomenon in other mammals, 
insects, nematodes and cnidaria (Cikala et al., 1999; Liu and Hengartner, 1999; 
Richardson and Kumar, 2002) and might even play a role in plant biology and yeast 
(Frohlich and Madeo, 2000; Skulachev, 2002; Solomon et al., 1999).  
Taken together, apoptotic processes are of widespread biological significance, 
being involved in development, differentiation, proliferation/ homoeostasis, regulation 
and function of the immune system and in the removal of defect and therefore 
harmful cells.  
 
1.2.2 Morphological features of apoptosis 
Apoptosis is an event that occurs under normal physiological conditions and the 
cell is an active participant of its own “cellular suicide”. Cells undergoing apoptosis 
can be recognized by characteristic morphological and biochemical features (Kerr et 
al., 1972) also demonstrated in Fig. 1.1.  
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1. shrinking of cell and cytoplasm  
2. condensation of nucleus and chromatin aggregation 
3. membrane budding, but no loss of integrity 
4. cell fragmentation into compact membrane-enclosed 'apoptotic bodies' 
The cellular changes during apoptosis are microscopically visible (Sautin et al., 
2001) and are mediated by molecular and biochemical events like activation of 
members of the cysteine proteases family (see 1.4.1). In vivo, the apoptotic bodies 
are phagocytosed by macrophages or neighboring epithelial cells and removed from 
the tissue without causing an inflammatory response (Saraste and Pulkki, 2000). The 
lack of inflammation is one of the main differences between apoptosis and necrosis 
which is characterized as followed: 
1. swelling of cell and nucleus 
2. loss of cellular structure  
3. loss of membrane integrity  
During necrosis, the cellular contents are released uncontrolled into the cell's 
environment resulting in damage of surrounding cells and strong inflammatory 
response of the neighboring tissue (Leist and Jaattela, 2001). 
 
 
 
Figure 1.1: Hallmarks of the apoptotic and necrotic cell death process. Apoptosis includes 
cellular shrinking, chromatin condensation and margination at the nuclear periphery with the eventual 
formation of membrane-bound apoptotic bodies that contain organelles, cytosol and nuclear fragments 
and are phagocytized without triggering inflammatory processes. The necrotic cell swells, becomes 
leaky and finally is disrupted and releases its contents into the surrounding tissue resulting in 
inflammation. Modified from (Van Cruchten and Van Den Broeck, 2002) 
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1.2.3 Apoptotic signaling cascades 
The event of apoptosis can be activated by two distinct mechanisms, the 
extrinsic and the intrinsic signaling pathway, respectively Figure 1.2 reflects these 
pathways in a simplified form.  
The extrinsic signaling is activated by binding of death inducing ligands to cell 
surface receptors called death receptors. TNF-R1 (Tumor necrosis factor-receptor 1), 
Fas/ CD95, TRAIL-R1/ DR4 (TNF-related apoptosis-inducing ligand receptor 1/ 2)/ 
(death receptor 4/ 5) and TRAIL-R2/ DR5 are members of the TNF receptor family 
and are defined by the presence of a death domain (DD) in their cytoplasmic tail.  
Activation caused by binding of the respective ligands leads to a 
conformational change of the complex and binding of the adapter molecule Fas-
Associated protein with Death Domain (FADD). Then, via its death effector domain 
(DED) FADD recruits pro-Caspase-8 resulting in the formation of a death inducing 
signaling complex (DISC).  
Pro-Caspase-8 gets activated by proteolytical cleavage resulting in the 
initiation of the Caspase cascade (Ashkenazi and Dixit, 1998). This cascade follows 
two different pathways (Fig 1.2) (Scaffidi et al., 1998). In type I cells, Caspase-8 
directly cleaves Caspase-3 triggering apoptosis.  
In type II cells, such as hepatocytes the apoptotic signal of Caspase-8 requires 
further enhancement by the mitochondrial pathway. In this case, Caspase-8 
provokes cleavage of the cytosolic protein Bid (BH3-interacting domain death 
agonist) to its active form tBid. tBid translocates into the mitochondrial membrane 
causing release of cytochrome c. Eventually, cytochrome c initiates the formation of 
the apoptosome formed by apoptotic protease activating factor-1 (Apaf-1) and 
Caspase-9 which cleaves and activates pro-Caspase-3, completing the cycle of 
activation as the initiator Caspase-8. Additionally, more pro-Caspase-8 molecules are 
cleaved by Caspase-3 releasing a positive feedback loop. 
The intrinsic apoptotic pathway is initiated by cellular stress. This can arise 
from viral infection, chemicals or exposure to radiation or it might be a consequence 
of oxidative stress or lack growth factors. Initiation of apoptosis via intrinsic factors 
also generally involves mitochondria signaling (Fig. 1.2). 
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Figure 1.2: Apoptotic signaling pathways. Apoptosis is mediated either via the intrinsic 
(mitochondrial) pathway or the extrinsic (death receptor depending) pathway. Stimulation of death 
receptors of the tumor necrosis factor (TNF) receptor superfamily such as Fas- or TRAIL-receptors by 
CD95 ligand (CD95-L) or TRAIL results in receptor aggregation and recruitment of the adaptor 
molecule Fas-associated death domain (FADD) and Caspase-8. Upon recruitment, Caspase-8 
becomes activated and initiates apoptosis by direct cleavage of downstream effector Caspases. The 
mitochondrial pathway is initiated by stress signals through the release of apoptogenic factors such as 
cytochrome c from the mitochondrial intermembrane space. The release of cytochrome c into the 
cytosol triggers Caspase-3 activation through formation of the cytochrome c/Apaf-1/Caspase-9-
containing apoptosome complex. The receptor and the mitochondrial pathway can be interconnected 
at different levels, for example, by Bid, a BH3 domain-containing protein of the Bcl-2 family which 
assumes cytochrome-c-releasing activity upon cleavage by Caspase-8. Activation of Caspases is 
negatively regulated at the receptor level by FLIP, which blocks Caspase-8 activation, at the 
mitochondria by Bcl-2 family proteins and by inhibitor of apoptosis proteins (IAPs). Modified from 
Fulda and Debatin, (2006) 
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1.3 TNF- signaling pathways mediate inflammatory or apoptotic 
signals  
1.3.1 TNF-R1 and Tumor-Necrosis-Factor- (TNF) 
Tumor necrosis factor alpha (TNF-) is a pleiotropic cytokine which is able to 
mediate several biological functions by association to its respective receptors TNF-
receptor-1 (TNF-R1) and TNF-receptor-2 (TNF-R2) (Fig. 1.3). TNF-R1 and -R2 are 
integral membrane receptors located in the plasma membrane. However, most of the 
signaling pathways seem to be mediated by TNF-R1 as TNR-R2 does not possess 
an intracellular death domain. Studies in TNF-R1-deficient mice indicate that TNF-R1 
is essential for TNF-induced apoptosis of pathogen-infected cells (Zhao et al., 2000). 
TNF-R1 can be activated by its respective ligands, the membrane-bound TNF-
 (mTNF-), the soluble TNF- (sTNF-), and the soluble lymphocyte- derived 
cytokine (LT/TNF-) while it is secreted mostly by macrophages, monocytes and T-
cells. Upon stimulation and binding to the receptor, potentially three distinct pathways 
can be initiated (Fig 1.3); inflammation by activation of nuclear factor-kappa B (NF-
B), activation of JNK (c-Jun N-terminal kinases) via the MAPK (Mitogen-activated 
protein (MAP) kinases) pathways and induction of death signaling through activation 
of Caspase-8. Both, membrane-bound and soluble TNF- is biologically active, 
although the apoptosis-inducing capacity of the soluble form is significantly lower 
compared to their corresponding membrane-bound form. 
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Figure 1.3: Signaling pathway of TNF-R1. Upon binding of tumor necrosis factor- (TNF-), 
trimerisation of the TNF receptor TNF-R1 induces recruitment of several proteins to the cytoplasmic 
death domain (DD) of the receptor. On the one hand, association of RIP1 and TRAF2 to TRADD 
elicits the activation of two major transcription factors: nuclear factor NF-B and activator protein AP-1. 
When retained in the cytoplasm by the IB inhibitory protein, the NF-B dimer is inactive; in response 
to TNF-, IB becomes phosphorylated and degraded, allowing NF-B to translocate to the nucleus. 
AP-1-mediated gene induction results from activation of JNK via TRAF2. The transcriptional activity of 
NF-B and AP-1 results in suppression of apoptosis. On the other hand, recruitment of FADD to 
TRADD allows activation of initiator Caspase-8. The active heterodimeric Caspase-8 then activates 
executioner Caspases-3. Caspase-8 also cleaves the Bcl-2 family member Bid, the truncated form 
tBid translocates to mitochondria and activates the release of apoptotic mitochondrial factors such as 
cytochrome c. Together with ATP and apoptotic protease activating factor 1 (APAF1), cytochrome c 
promotes the activation of Caspase-9 (not shown, represented by dashed black lines), which in turn 
activates executioner Caspases. The Caspase cascade can be inhibited by the Bcl-2 or Bcl-XL 
proteins.  
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1.3.1.1 Signaling complexes for cell survival or apoptosis 
The interaction of TNF- with TNF-R1 leads to the formation of two distinct 
signaling complexes (Micheau and Tschopp, 2003). The initial complex-I regulates 
the expression of anti-apoptotic proteins that prevent cell death, whereas the second 
complex (complex-II) triggers cell death. In contrast to Fas, TNF-R1 acts 
predominantly anti-apoptotic but can induce apoptosis if protein synthesis is blocked. 
The rapidly formed plasma membrane-bound complex-I is composed of TNF-R1, 
RIP1 (receptor-interacting protein 1), TRAF2 (TNF-receptor-associated protein 2) 
and c-IAP-1 (cellular inhibitor of apoptosis 1) whereas the presence of TRADD (TNF-
R1-associated death domain protein) within this complex is controversially discussed 
(Micheau and Tschopp, 2003; Schneider-Brachert et al., 2004). Recruitment and 
activation of I-kappa B kinase (IKK) and JNK to the complex-I initiates inflammatory 
responses, thereby protecting cells from apoptosis (Fig. 1.3)  
TRADD, RIP1 and TRAF2 dissociate from TNF-R1. In the cytoplasm RIP1 and 
TRAF2 leave the complex and a second complex (complex-II) including TRADD, 
FADD (Fas-associating death domain protein) and pro-Caspase-8/ 10 is formed in 
the cytoplasm initiating the Caspase cascade (see 1.4.2).  
When NF-B is activated by complex-I, it initiates transcription of the Caspase-
8 inhibitor FLIPL (FLICE-inhibitory proteinlong) and the cell survives. Thus, TNF-R1-
mediated-signal transduction includes a checkpoint, resulting in cell death (via 
complex-II) in instances where the initial signal (via complex-I, NF-B and JNK) fails 
to be activated. 
 
1.3.1.1.1 NF-B in pro-survival signaling after TNF-induced stimulation 
The transcription factor NF-B regulates the expression of more than 300 
genes, and the expression of these genes is controlled by fine-tuned mechanisms 
that are regulated by the strength and duration of the NF-B activity (Hoffmann et al., 
2002).  
TNF-induced NF-B activation is mediated by the IKK complex. This complex 
consists of three associated proteins IKK, IKK and NEMO/ IKK (NF-kappaB 
essential modulator). IKK and IKK form the catalytical units of the complex while 
NEMO is the regulatory subunit. For IKK activation the presence of both RIP1 and 
TRAF2 proteins on complex-I is required. Upon TNF treatment TRAF2 recruits the 
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IKK complex to the TNF-R1 complex but activation of the subunit NEMO requires the 
presence of RIP1 (Devin et al., 2000).  
IKK in turn, phosphorylates the inhibitor of nuclear factor-B (IB), provoking 
its ubiquitination and subsequent degradation. The activated NF-B translocates into 
the nucleus were it triggers transcription of anti-apoptotic genes promoting cell 
survival and differentiation as well as immune and inflammatory responses. 
 
1.3.1.1.2 JNK mediated pathway in TNF-induced signaling 
 The second pathway originating from the TNF-receptor in complex-I leads to 
activation of JNK via the activation of MAP3K1 (Mitogen-activated protein kinase 
kinase kinase 1) and JNKK (JNK kinase). In the mammalian genome three genes are 
encoding for JNK. JNK1 and JNK2 are ubiquitously expressed, while JNK3 
expression is restricted to the brain, heart and testis.  
Despite their biochemical and structural similarities, JNK1 and JNK2 exert 
different effects on c-Jun turnover and activity, which correlates with their different 
effects on cell proliferation. JNK1 appears to be a positive regulator of cellular 
proliferation, being required for phosphorylation and active cell proliferation of c-Jun. 
On the contrary, JNK2 appears to primarily function as a negative regulator of c-Jun 
stability, correlating with its negative effect on cell proliferation (Sabapathy et al., 
2004). 
The exact activating mechanisms of JNK1 are still poorly understood. 
However, association of JNK1 with TRAF-2 at complex-I was shown to be essential 
for phosphorylation and activation of JNK1 (Blackwell et al., 2008). Subsequently, 
JNK1 mediates activation of c-Jun, a member of the transcription factor complex 
activator protein-1 (AP-1). Transcriptional activity of c-Jun is regulated by its 
phosphorylation status. 
 
1.4 Caspases 
1.4.1 Classification of Caspases  
Caspases (cysteinyl-aspartate specific protease) are an evolutionarily 
conserved family of cysteine proteases with central functions in apoptotic and 
inflammatory signaling pathways (Lamkanfi et al., 2007). To date, 11 genes were 
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found in the human genome to encode 11 human Caspases, Caspase-1 to Caspase-
10 and Caspase-14, while the mouse genome contains 10 genes encoding for 10 
murine Caspases (Caspase-1, -2, -3, -6, -7, -8, -9, -11, -12 and -14). The human 
Caspase-4 and -5 are functional orthologs of mouse Caspase-11 and -12, whereas 
Caspase-10 is absent in the mouse genome and Caspase-13 was found to be a 
bovine homolog of Caspase-4. Pro-Caspases are constitutively expressed as 
inactive zymogens containing a large and a small subunit as well as a prodomain 
(Fig. 1.4). Proteolytic cleavage removes the prodomain and separates the two 
subunits resulting into activation of Caspases (Li and Yuan, 2008). 
Caspases involved in apoptotic signaling are classified as either initiator 
(Caspase-2, -8, -9 and -10) or effector Caspases (Caspase-3, -6 and -7). This 
correlates with the order of activation during the signaling cascade. A subgroup, 
comprising Caspase-1, -4 and -5, predominantly plays a role in inflammation.  
Initiator Caspases have long prodomains with one out of two distinct protein-
protein interaction motifs. Caspase-8 and -10 contain the death effector domain 
(DED) while Caspase-2 and -9 have a Caspase recruitment domain (CARD) (Fig. 
1.4). With these interaction motifs they interrelate with upstream adapter molecules 
(Lamkanfi et al., 2007). Effector Caspases include short prodomains and are 
activated by proteolytic maturation by upstream Caspases. The final outcome of 
these proteolytic cascades is the specific cleavage of a wide variety of substrates 
that are implicated in apoptosis.  
However, during the past years Caspase activity and identification of Caspase 
substrates in the absence of apoptosis has triggered strong interest on their functions  
beyond apoptosis (Dohrman et al., 2005; Golks et al., 2006). 
 
 
Figure 1.4: The initiator and effector Caspases in mammals. Only Caspases with potential or 
demonstrated role in apoptosis are presented here. The small and large subunits and the protein–
protein interaction motifs (such as CARD and DED) are shown. The relative lengths of various 
domains and subunits are not drawn to size and only serve as a guide here to demonstrate the 
various types of apoptotic Caspases found in mammals (Kumar, 2007). 
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1.4.2 Activation and Regulation of Caspase-8 
Activation of the pro-Caspase-8 is one of the initiating steps towards 
apoptosis. Yet, the exact procedure is still unclear. During apoptosis the initiator pro-
Caspase-8 is recruited to the death receptor complex were it associates with the 
death effector domain (DED) of the adaptor protein FADD (Fas-associating death 
domain protein). One hypothesis, referred to as the induced proximity model 
suggests that local aggregation at the death receptor is sufficient to allow 
autoprocessing to produce active Caspase-8, which can subsequently activate 
downstream executioners, such as Caspase-3 (Salvesen and Dixit, 1999). A more 
recent model is the induced-conformational model, suggesting a conformational 
change and subsequent Caspase activation as a consequence of binding to the 
adapter protein complex (Chao et al., 2005). A third model involves the Caspase 
inhibitor FLIP and will be described in detail. 
Cleavage of pro-Caspase-8 precedes in three consecutive steps, which leads 
to the formation of active Caspase-8, consisting of a heterotetramer of two p10 and 
two p18 subunits. The prodomain of Caspase-8 remains at the death receptor 
complex, while active Caspase-8 dissociates to start the signaling apoptotic cascade 
(Krueger et al., 2001).  
Activation of the initiator Caspase-8 can be counteracted by the FLICE- 
Inhibitory protein (FLIP). Three human cellular isoforms have been identified, which 
are generated by differential splicing; c-FLIPlong, c-FLIPshort and c-FLIPRaji. In addition 
a viral protein named v-FLIP has been described by (Golks et al., 2005). 
Caspase-8, Caspase-10 and FLIP have probably evolved by gene duplication 
as their genes co-localize on human chromosome 2. However, the C-terminus of c-
FLIPL holds a catalytically inactive Caspase-like domain which is truncated in the 
short forms c-FLIPS and c-FLIPR. Previous studies could show that only one of the 
two short isoforms, c-FLIPR is evident in mice (Ueffing et al., 2008). 
Characteristically all FLIP proteins contain a tandem death effector domain 
(DED), which mediates their recruitment to the death receptor complex and binding 
to the adapter protein FADD. High concentration of FLIPL strongly prevents 
recruitment and activation of Caspase-8, thus blocking the induction of cell death by 
all known human death receptors (Irmler et al., 1997), while FLIPL expression 
mediates activation of NF-B. 
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Nevertheless, low concentrations of FLIPL have been demonstrated to 
enhance pro-Caspase-8 activation by forming heterodimeric chimeric complexes with 
Caspase-8. Indeed, in CD8+ T cells Caspase-8-mediated cleavage of c-FLIPL to 
p43FLIP has been shown to induce NF-B activation via a p43FLIP/ Caspase-8/ 
TRAF2 complex (Kataoka and Tschopp, 2004). Alternatively, Golks et al. (2006) 
discovered that Caspase-8 generates a shorter fragment of c-FLIPL, so called p22-
FLIP, corresponding to the prodomain region of c-FLIP. That is a key mediator of NF-
B activation in lymphocytes and dendritic cells by binding directly the IKK complex. 
However, the physiological and molecular contexts that control Caspase-8-mediated 
cleavage of c-FLIP to either p43FLIP or p22-FLIP require further investigation. 
 
1.5 Regulation of Liver Regeneration 
1.5.1 The Cell Cycle  
Regulation and precise control of the cell cycle is central to normal 
proliferation and differentiation. The cell cycle is a series of events that take place in 
a cell leading to its division and replication. In eukaryotic cells the cell cycle can be 
divided in two periods: interphase - during which the cell grows, accumulates 
nutrients needed for mitosis and duplicates its DNA - and the mitosis (M) phase. 
Interphase can be further devided into Gap-1-phase (G1-phase), synthesis-phase (S-
phase) and Gap2-phase (G2-phase) (Fig. 1.5). G1 and G2-phase are characterized 
by cellular growth while during S-phase DNA replication occurs. When this process is 
completed, all chromosomes have been replicated. Significant protein synthesis 
occurs during G2-phase preparing the cell to undergo mitosis.  
These processes are coordinated by Cyclins. Cyclins are regulatory subunits 
under the direction of Cyclin dependent kinases (CDKs). The process of DNA 
synthesis is initiated and regulated by four families of regulatory Cyclins (Cyclin D, E, 
A and B) combined with a limited number of CDKs (CDK4, CDK6, CDK2 and CDK1). 
The activities of Cyclin/ CDK complexes depend on the phosphorylation status of 
CDKs and the expression levels of Cyclins. Phase-specific Cyclin/ CDK complexes 
confer specificity and orderly progression through the cell cycle.  
Members of the Cyclin D family (D1, D2 and D3) are expressed during the 
early phase of G1. According to this model, in early G1 phase CDK4 and/ or CDK6 
are activated by D-type Cyclins and initiate phosphorylation of the retinoblastoma 
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protein (Rb) family (Rb, p107 and p130). This leads to the release of E2F 
transcription factors and results in the activation and transcription of E2F responsive 
genes required for cell-cycle progression (Satyanarayana and Kaldis, 2009). The 
expression of Cyclin D1 is the stage at which replication becomes growth factor-
independent and proceeds autonomous (Fausto, 2000). Transition through the G1 
and S phases is regulated by an increasing accumulation of Cyclin D/ CDK4/ 6 and 
Cyclin E/ CDK2/ 3 complexes and leads to overcoming of the restriction point 
initiating DNA replication.  
Cyclin A also binds to CDK2 and is important for progression through S-phase 
though they also bind CDK1 in the later S-phase and during G2-phase. The 
subsequent G2-M transition is regulated by Cyclin A/ CDK1/ 2 and Cyclin B/ CDK1 
complex with a crucial function in passing G2/ M-phase and mitotic spindle 
checkpoint. Replication of the DNA in each chromosome, followed by its separation is 
accomplished during M-phase (nuclear division) of the cell cycle. 
Under regular conditions, quiescent hepatocytes are in G0-stage of cell cycle 
which is a resting phase where the cell has left the cycle and has stopped dividing. 
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Figure 1.5: The cell cycle and its regulation by CDKs. Regulation and precise control of the cell 
cycle are essential for normal proliferation and differentiation. The activities of Cyclin/ CDK complexes 
depend on the phosphorylation status of CDKs and the expression level of Cyclins. Phase-specific 
Cyclin/ CDK complexes mediate specificity and orderly progression through the cell cycle.  
Source: (Chin and D'Mello, 2005) 
 
1.5.2 Liver regeneration after Partial Hepatectomy (PH) 
Despite its large metabolic load, the liver is a largely quiescent organ in terms 
of cell proliferation. Under normal and healthy conditions, hepatocytes are at the G0-
stage of the cell cycle. Only 0.0012 % to 0.01 % of hepatocytes in a healthy liver are 
undergoing mitosis at any given time (Koniaris et al., 2003). However, the liver has 
evolutionarily conserved its ability to proliferate in response to toxic injury and 
infection. This reaction is a logical adaptive response because the liver is the main 
detoxifying organ of the body and first in line to be injured by ingested toxins.  
Partial hepatectomy (PH), resulting in removal of 70 % of the liver, is a widely 
used method for studies of liver regeneration and was first described by Higgins and 
Anderson in 1931. In this model of partial hepatectomy there is no injury of the 
remnant liver cells and the remaining cells adapt almost instantly to the increased 
functional load per cell created by the reduction of liver mass. During this 
regenerative process cells maintain their major morphologic features, have an active 
urea cycle and continue to metabolize drugs and synthesize albumin (Taub, 2004). 
Involving different liver cell populations liver regeneration is sensitively regulated by 
1 Introduction 
 
15
the interplay between growth factors, cytokines, extracellular matrix components and 
other regulators (Michalopoulos and DeFrances, 1997). 
In contrast to other regenerating tissues (e.g. skin) liver regeneration is not 
depending on progenitor or stem cells. It is rather mediated by proliferation of 
surviving hepatocytes of the remnant liver. Restoration of its original size theoretically 
requires 1.66 proliferative cycles per residual hepatocyte. In fact, most hepatocytes in 
the remaining lobes participate in one or two cell cycles. This phenomenon is rather 
compensatory hyperplasia and not true regeneration because the removed liver 
lobes do not grow back unlike limbs of amphibians. The kinetics of cell proliferation 
slightly differs from species to species. Most of the increase in liver mass has 
occurred by day 3 after PH and complete restoration is achieved in approximately 7 
days. Once the original mass of the liver has been re-established regeneration stops 
(Fausto, 2000; Koniaris et al., 2003; Michalopoulos and DeFrances, 1997). 
 
1.6 Hepatocellular carcinoma (HCC) 
Liver cancer is one of the most important causes of mortality in the world, and 
primary hepatocellular carcinoma is the predominant histological subtype. The major 
cause for HCC development is chronic liver disease. It is believed that the incidence 
of HCC due to chronic hepatitis C infection will increase over the next few years 
(Ramadori and Meier, 2001). Although the exact molecular mechanism leading to 
HCC progression is still poorly understood, it is well accepted that chronic liver 
damage is associated with continuous cycles of apoptosis and/ or necrosis followed 
by compensatory proliferation of hepatocytes. This triggers liver fibrosis and cirrhosis 
but also results in the accumulation of mutations and transformed hepatocytes due to 
excessive DNA replication and increased mitosis during liver regeneration. 
Accordingly, a number of genes involved in cell cycle progression and apoptosis 
including E2F (Conner et al., 2000; Santoni-Rugiu et al., 1998), c-myc (Lee et al., 
2004) or the pro-apoptotic protease Caspase-8 (Liedtke et al., 2005) were shown to 
be deregulated in HCC and the number of identified genes affecting 
hepatocarcinogenesis is permanently increasing.  
To date the treatment options for patients with advanced HCC are very limited 
especially as hepatocellular carcinomas usually poorly respond to chemotherapy. In 
order to define new and better therapeutical targets, strong efforts have been made 
1 Introduction 
 
16
during the last years to better understand the molecular mechanisms of 
hepatocarcinogenesis. One promising approach is the analysis of transgenic – or 
knockout mice specifically targeting tumor promoters or tumor suppressors such as 
c-myc, p53, p21 and others. Indeed, earlier analysis of these animals gave a deep 
insight into the mechanisms of tumor development in the liver and other organs 
(Lechel et al., 2007; Pani et al., 2004; Sell, 2003; Sheahan et al., 2007; Teoh et al., 
2008). However, recent approaches to measure and compare the tumor incidence 
and tumor progression between different transgenic mouse lines are still problematic 
due to a lack of appropriate techniques and detection methods to monitor tumor 
initiation and tumor growth. Thus, current reports still rely on a huge amount of 
animals per group which have to be sacrificed at distinct time points for the 
measurement of tumor size. This is also a problem as many national animal welfare 
committees force researchers to reduce animal numbers in their experiments. 
Subsequently, methods for the continuous monitoring of liver tumor growth in 
individual transgenic mice need to be developed.  
 
1.7 Magnetic Resonance Imaging (MRI)  
The property of Nuclear Magnetic Resonance (NMR) was first described by 
Purcell and Bloch in 1946, work for which they received the Nobel prize in 1952. In 
1973, Lauterbur and Mansfield used the principles of NMR to describe a technique 
for determining physical structure. Since then, Magnetic Resonance Imaging (MRI) 
has been used in many clinical, biomedical, chemical and engineering applications.  
Magnetic Resonance Imaging (MRI) uses the magnetic properties of hydrogen 
and its interaction with both a large external magnetic field and radio waves to 
produce detailed images of the body. Hydrogen exists in many molecules. It is 
present in fat and most other tissues in the body. Water comprises up to 70 % of 
body weight. The varying molecular structures and the amount of hydrogen in 
various tissues effect how the protons behave in the external field, resulting in 
differential signal intensity and therefore creating a detailed image of different 
organs and tissues. Figure 1.6 depicts a simplified version of the mechanisms of 
MRI (Schild, 1990). 
The field strength of the magnets used for MR is measured in units of Tesla. 
One (1) Tesla is equal to 10,000 Gauss. The magnetic field of the earth is 
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approximately 0.5 Gauss. Given that relationship, a 1.0 T magnet has a magnetic 
field approximately 20,000 times stronger than that of the earth.  
In clinical practice, MRI is used to visualize the internal structure of organs and tissue 
of the body with a special focus on neurological (brain), cardiovascular and 
oncological imaging. MRI has been found to be an effective method for HCC in 
particular (Hecht et al., 2006). 
In comparison to ultrasound and CT, MRI has proven to be more reliable when 
focal liver lesions have to be detected and characterized (Braga et al., 2004; 
Semelka et al., 2001; Ward et al., 2005). This greater potential is based on a superior 
amount of diagnostic information by the assessment of T1- and T2-weighted 
sequences and the possibility of multiple sequences after injection of contrast media. 
Application of contrast media causes an intensification of the magnetic field and 
results in an image of higher resolution by shortening the T1 relaxation time. T1 
relaxation time describes a biological parameter that is used in MRI to distinguish 
between different tissue types or comparison of before vs. after contrast agent 
application. This tissue-specific time constant for protons is a measure of the 
time taken to realign 63 % of the protons within the external magnetic field after 
rearrangement by a strong radio frequency pulse  (Fig. 1.6 C) (Schild, 1990). 
 
 
 
Figure 1.6: (A) Due to their own magnetic moments, protons align with the direction of the magnetic 
field of the MRI. (B) A radio frequency electromagnetic field is then briefly turned on, causing the 
protons to alter their alignment relative to the field. (C) When this field is turned off the protons return 
to the original magnetization alignment. These alignment changes create a signal which can be 
detected by the scanner. T1 relaxation time describes the time point when 63 % of the protons have 
realigned to the external magnetic field. The frequency the protons resonate at depends on the 
strength of the magnetic field (Schild, 1990).  
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1.8 The Cre/ loxP technology for generating conditional knockout 
mice 
In 1989 Mario R. Capecchi, Martin Evans and Oliver Smithies created the first 
knockout mouse, for which they were awarded the Nobel Prize for Medicine in 2007. 
Since that time, mice are the most intensively studied laboratory mammalian species 
which are the most closely related to humans.  
Although knockout mice technology represents a valuable research tool, some 
important limitations exist. About 15 % of gene knockouts are embryonically lethal or 
mice die shortly after birth. In this case conditional knockout mice provide the 
opportunity of gene deletion on demand, allowing for cell- or tissue-specific gene 
targeting as well as inactivation in a particular stage of development (Gu et al., 1994).  
The most common used method for conditional knockout models is the Cre/ 
loxP recombinase system. The Cre (“causes recombination”) is an enzyme used by 
the bacteriophage P1 to excise itself from a host cell’s genome. Cre deletes the DNA 
fragment located between two recognition sites, e.g. the loxP sites (Hamilton and 
Abremski, 1984).  
Employment of definite promoters regulates the activation of the Cre 
recombinase resulting in controlled excision of the particular gene during a specific 
developmental stage, like when induced exogenous by interferon or pIpC (Poly-
Inosin-Poly-Cytidilin) injection (Mx promoter) (Kuhn et al., 1995) or tissue-specific in 
hepatocytes (AlfpCre promoter). To obtain hepatocyte-specific recombination of a 
DNA segment flanked with loxP sites, Kellendonk et al. (2000) generated transgenic 
mice that express the Cre-recombinase open reading frame (ORF) under the control 
of both the mouse albumin regulatory elements and the -fetoprotein enhancers 
(AlfpCre transgene). In mice, the albumin gene starts its expression during 
embryogenesis shortly after the appearance of the liver bud and Cre is active before 
day 10.5 pc but not before day 9.5 pc resulting in a knockout of the desired gene.  
 
1.8.1 Establishing of a conditional Caspase-8 knockout mouse 
Constitutive Caspase-8 knockout mice die in utero at day 12.5 due to impaired 
heart muscle development and congested accumulation of erythrocytes 
(Varfolomeev et al., 1998). Thus, a conditional Caspase-8 knockout was generated 
by creating a targeting vector with exon 3 and 4 of the Caspase-8 gene flanked by 
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two loxP sequences (Fig. 1.7, row 2) (unpublished data).  A deletion of these two 
exons resulted in a frameshift and a translational stop signal after 137 aminoacids 
preventing the generation of a functional protein. Floxed Caspase-8 mice (Casp8f/f) 
were then crossed with transgenic Cre-mice under the control of an albumin-
promoter resulting in a hepatocytes-specific knockout of Caspase-8 (Fig. 1.7, row 5) 
 
 
 
Figure 1.7: Knockout strategy of Caspase-8. Gene-targeting strategy. Exons and introns are 
represented by vertical bars and horizontal lines, respectively. A neomycin-resistance gene driven by 
a cmv promoter (NEO) was used as selection marker. A 50-bp difference between WT and 
recombinant clones represents the 34-bp loxP sequence flanked by SalI and XhoI restriction sites. 
Caspase-8 chimeric mice were generated by injection of embryonic stem cells with homologous 
integration of the targeting vector in the Caspase-8 locus and with both loxP sites (f) cointegrated into 
blastocysts that were retransplanted into pseudo-pregnant foster mice. Heterozygous and neo-deleted 
Caspase-8+/f animals were generated by backcrossing chimeras with transgenic mice containing the 
Flp-recombinase under the control of the ubiquitous human ACTB promoter (Rodriguez et al., 2000). 
For the hepatocyte-specific deletion, Casp8f/f mice were crossed with animals expressing a Cre 
transgene under control of the hepatocyte-specific albumin promoter (Kellendonk et al., 2000). The 
exons are labeled by roman numbers. B, BamHI; N, NotI; S, SalI; X, XhoI. 
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2 Aim of the present study 
The cytokine TNF- mediates pleiotropic effects by triggering at least three 
different pathways involving inflammation and cell proliferation via NF-B, apoptosis 
through Caspase-8, or activation of c-Jun N-terminal kinases (JNK).  In addition, TNF 
is crucial for the priming phase of liver regeneration following partial hepatectomy 
(PH) as it directly contributes to gene activation of Cyclin D via NF-B, c-Jun/ AP-1 
and E2F1 and subsequent cell cycle progression. Earlier findings indicated that 
genetic deletion of one TNF-signaling axis (e.g. NF-B) might over-activate the 
remaining TNF-dependent signals (e.g. apoptosis). However, regenerating livers are 
apoptosis-resistant, whereas only little is known about the role of apoptosis for the 
termination of liver regeneration. Thus, the first aim of this study was to investigate 
the consequences of a Caspase-8 inactivation for the initiation and termination of 
liver regeneration following partial hepatectomy of hepatocytes-specific Caspase-8 
knockout (Casp8hep) mice. In particular, it should be investigated whether Caspase-8 
inactivation might lead to over-activation of alternative TNF-related signals or 
hepatomegaly due to deficient apoptosis signaling. 
 Recent publications demonstrated that Caspase-8 is frequently silenced in 
different kinds of tumors like hepatocellular carcinomas or childhood neuroblastoma 
suggesting that Caspase-8 might act as tumor suppressor (Liedtke et al., 2005; 
Soung et al., 2005b). To proof this hypothesis, the second aim was to evaluate if a 
knockout of Caspase-8 in alb-myctg mice might lead to accelerated or enhanced 
hepatocarcinogenesis. In order to address this question with state-of-the-art 
techniques, in the third aim of this study a novel protocol for the non-invasive and 
reliable detection of murine HCC - induction and progression - should be developed 
using magnetic resonance imaging technique (MRI). This would allow the early 
detection of HCC and the subsequent continuous monitoring of liver tumorigenesis in 
transgenic mice thereby facilitating future investigations of transgenic mouse models 
in the liver.  
As specialized MR scanner for small rodents with higher magnetic field 
strength are expensive and not available in many clinical research centers, an 
additional requirement for this protocol was the applicability for regular clinical 1.5 
Tesla MR-scanning systems.  
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3 Material and Methods 
3.1 Material 
3.1.1 Chemicals 
product company 
Ammoniumpersulfate (APS) AppliChem 
Acetone  J.T.Baker 
Agarose Invitrogen 
Acetic acid (glacial) 100 %  AppliChem 
Ammoniumacetate  AppliChem 
Bromophenol Blue Serva 
BSA (Bovine Serum Albumin)  Sigma 
Calciumchloride (CaCl2) Sigma 
Chloroform Merck 
Cetyltrimethylammonium chloride  Sigma 
Collagen Type I from rat tail Sigma 
DAPI (4',6-diamidino-2-phenylindole) mounting medium Vectashield 
Diethylether  J.T.Baker 
DTT (Dithiotreitol) Sigma 
EDTA (N,N;N’,N’-Ethylendiamine- tetraacetate) Calbiochem 
EGTA (Ethylen glycol-bis (2-aminoethyl)- N,N;N’,N’- 
tetraacetate)  
Fluka 
Eosine  Sigma 
Ethanol, denaturated 100 %  J.T.Baker 
Ethidiumbromide (EtBr) (Stock 10 mg/ml) Sigma 
Formamide AppliChem 
Formaldehyde 37 %  Roth 
Glucose  Merck 
Glutaraldehyde AppliChem 
Glycerol (plant)  Serva 
Glycine AppliChem 
Haemosin Merck 
Hydrochloric acid (HCl) AppliChem 
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HEPES (2-[4-2-hydroxyethyl-1-piperazinyl]-ethansulfon acid)  Merck 
Sulfuric acid (H2SO4) Merck 
Magnesium chloride (MgCl2)  Sigma 
β-Mercaptoethanol  AppliChem 
Methanol  J.T.Baker 
MOPS (3-[N-Morpholino] propanesulfonic acid)  Sigma 
Nonidet P – 40  Sigma 
Paraformaldehyde  Merck 
Phenylmethyl sulfonyl fluoride (PMSF) Roth 
Ponceau Red  Sigma 
Potassium chloride (KCl) Merck 
2-Propanol Merck 
Salicylic acid  Sigma 
Sodium carbonate (Na2CO3) Merck 
Sodium hydrogencarbonate (NaHCO3) Merck 
Trichloracetic acid Merck 
Tri-sodium citrate 2-hydrate  Roth 
SDS (Dodecylsulfate)  Roth 
Sodium fluoride (NaF)  Roth 
di-sodiumhydrogenphosphate 2-hydrate (NaH2PO4)  Roth 
Sodium vanadate (Na3VO4)  Sigma 
Sulfosalicylic acid Merck 
TEMED (N,N,N’,N’-Tetramethylethylendiamine)  Sigma 
3,3-5,5-tetramethyl-benzidine Sigma 
Tris-(hydroxymethyl)-propane-1,3-diol AppliChem 
Triacetic acid  Merck 
Triton X-100 Sigma 
Trypan blue stain 0,4% Gibco 
TWEEN-20 Sigma 
Xylene J.T.Baker 
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3.1.1.1 Radiochemicals 
product company 
[32P]-γ-ATP (10mCi/ml)  Hartmann Analytic 
 
3.1.2 Instruments and equipment  
product company 
Analytical balance Sartorius 
-scintillation counter Wallac 
Blotting Trans-BlotTM Cell  BioRad 
Cell culture centrifuge Megafuge 1.0R  Heraeus 
Cell culture flow  Gelaire 
Cell culture Incubator Heraeus 
Centrifuge 5415D Eppendorf 
Cooling centrifuge 5417R Eppendorf 
Cryostat HM 550  Microm 
ELISA Reader μQuant +KC4 Software BIO-TEK 
Gel dryer  Biometra 
LAS mini 4000  Fuji 
Liquid scintillation counter 1219 Rack Beta  LKB Wallac 
Overhead shaker REAX 2 Heidolph 
Perfusion pump Ismatec 
pH Meter PB-11  Sartorius 
Powersupply PowerPac HC  BioRad 
7300 Real Time PCR System  
+ Sequence Detection Software Version 1.3.1. 
Applied 
Biosystems 
Roller Mixer SRT 9  Stuart 
Rotating incubator  Bachofer 
SDS PAGE electrophoresis system PerfectBlue Twin L  Peqlab 
Shaking incubator Unimax 1010  Heidolph 
Thermocycler T3000 and Tpersonal  Biometra 
Thermomixer 5436  Eppendorf 
Water bath Haake W13  Fisons 
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3.1.3 Consumables 
3.1.3.1. General material 
product company 
Hybond N membranes  Amersham 
Nitrocellulose membrane Protran®  Whatman 
Scintillation tubes Pony vialTM  Packard 
Scintillation fluid Ultima GoldTM XR  Packard 
Super Frost slides  Roth 
X ray films  Amersham 
 
3.1.3.2 Material for animal experiments 
product company 
Catheter with injection port (Biovalve® 22G; 1,0x25mm) Vygon 
Catheter with injection port (Biovalve® 20G; 1,0x32mm) Vygon 
Disposable Scalpels sterile No. 10, 11, 21 Feather 
Ethibond® Excel plated, laminated, not absorbable; 6/0 metric 
0,7 
Ethicon 
General chow for rodents Altromin 
Hematocrit capillary  Braun 
Heparine (Liquemin®) Roche 
Injection needles (Sterican®; Gr.17 24Gx25mm; 0,4x12mm) Braun 
Ketamine (Ketamin®) Albrecht 
Magnevist Gd-DTPA Bayer Schering 
Micro 47 coil for MRI Philips 
Micro tube (1,1 ml Z-Gel) Sarstedt 
MRT 1.5 T Achieva + software version 2.5.3 Philips 
Primovist Gd-EOB-DTPA Bayer Schering 
Sterile gossamer (Sterilkompresse®) Beese 
Surgical instruments Aesculap 
Syringe Omnican® Braun 
Vicryl®, absorbable 4-0 Ethicon 
Xylazin (Rompun®) Bayer 
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3.1.3.3 Material for cell culture  
product company 
Cell scrapers Costar 
Cell culture plates (6 well) Costar 
Cell strainer, 70 µm nylon mesh BD 
Collagen from rat tail Sigma 
DMEM  
+4500mg/L Glucose 
+GlutaMAX 
+Pyruvate 
Invitrogen 
 
 
 
EBSS positive Gibco 
EBSS negative Gibco 
Fetal Calf Serum (FCS) PAA 
10x PBS pH 7,4 Gibco 
1x PBS pH 7,4 Gibco 
Penicillin/Streptomycin (P/S) Gibco 
 
3.1.4 Antibodies 
3.1.4.1 Primary antibodies  
3.1.4.1.1 Primary antibodies 
product company 
c-Jun (N) Santa Cruz Biotechnology, Inc. 
Cyclin A (C-19) Santa Cruz Biotechnology, Inc. 
Cyclin D1 (72-13G) Santa Cruz Biotechnology, Inc. 
FADD (S-18) Santa Cruz Biotechnology, Inc. 
FLIPS/L (H-202) Santa Cruz Biotechnology, Inc. 
GAPDH Biogenesis 
IKKγ (FL-419) Santa Cruz Biotechnology, Inc. 
JNK1 (FL) Santa Cruz Biotechnology, Inc. 
PCNA Ab-1 dianova GmbH 
Phospho-c-Jun (Ser73)  Cell Signaling Technology 
Phospho-Histone H3 (Ser10) Cell Signaling Technology 
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Phospho-SAPK/JNK (Thr183/Tyr185) Cell Signaling Technology 
RIP1 BD Transduction LaboratoriesTM 
NF-B p65 (A) Santa Cruz Biotechnology, Inc. 
TRADD (H-278) Santa Cruz Biotechnology, Inc. 
TRAF2 Santa Cruz Biotechnology, Inc. 
 
3.1.4.1.2 Supershift antibodies 
product company 
c-Jun (D) x Santa Cruz Biotechnology, Inc. 
NF-B p65 (A) x  Santa Cruz Biotechnology, Inc. 
 
3.1.4.2 Secondary antibodies  
3.1.4.2.1 Secondary antibodies HRP-labeled 
product company 
chicken anti-mouse IgG-HRP Santa Cruz Biotechnology, Inc. 
chicken anti-rat IgG-HRP Santa Cruz Biotechnology, Inc. 
rabbit anti-goat IgG-HRP Santa Cruz Biotechnology, Inc. 
anti-rabbit IgG, HRP-linked Cell Signaling Technology 
 
3.1.4.2.2 Secondary antibodies for fluorescence microscopy 
product company 
Alexa 488 donkey anti-mouse Invitrogen 
Alexa 488 rabbit anti-rat Invitrogen 
Alexa 546 goat anti-rabbit Invitrogen 
Alexa 546 rabbit anti-goat Invitrogen 
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3.1.5 Enzymes 
product company 
Collagenase Type II Worthington 
Omniscript RT Qiagen 
Proteinase K AppliChem 
SYBR® GreenER qPCR SuperMix Invitrogen 
 
3.1.6 Analytical chemicals, reagents and kits 
product company 
Acrylamide Solution 30 % Biorad 
BioRad Protein Assay Biorad 
Block and Sample Promega 
Complete Mini® Roche 
Covering solution for cryo sections (Tissue-Tek®) Sakura 
Diaminobenzidine (DAB) Sigma-Aldrich 
Dako Pen Dako 
DNA marker 1kb plus Ladder® Invitrogen 
ECL-Western-Blot-analysis Solution® Pierce 
Ethidiumbromid Invitrogen 
Gluthathione Agarose Sigma 
Hot Star Taq Master Mix Kit Qiagen 
Nuclear Extraction Kit Imgenex 
Omniscript RT PCR Kit Qiagen 
Oligo dT primer Qiagen 
Paraformaldehyde Roth 
Poly(dI-dC)- Poly(dI-dC) Amersham 
Primer MWG 
Protein A agarose beads Roche 
Protran Membrane Whatman 
Red Taq Sigma 
Rotiblock Roth 
Rotiphorese 10x SDS Page Roth 
TAE Puffer 10x Roth 
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TAE Puffer 50x Applichem 
Trypsin Inhibitor Sigma 
TUNEL Kit Roche 
TUNEL Label Mix Roche 
Ultraspec II RNA Biotecx 
Vectashield Mounting Medium with Dapi Vector 
Laboratories 
  
3.2 Methods 
3.2.1 Animal experimental models 
3.2.1.1 Housing and breeding of mice 
All mouse strains were initially housed in a specific pathogen-free facility of the 
University Hospital Aachen in a temperature-controlled room with 12-h light/ dark 
cycles and free access to standard food and water.  
Upon approval by the local government (AZ 50.203.2.-Ac5a, 39/05), all 
experiments were performed in accordance with the German legislation on protection 
of animals and the National Institutes of Health ‘Guide for the Care and Use of 
Laboratory Animals’ (Institute of Laboratory Animal Resources, National Research 
Council; NIH publication 86-23 revised 1985).  
3.2.1.2 Used mouse strains 
3.2.1.2.1 Hepatocyte-specific conditional Caspase-8 knockout mice 
To study the role of Caspase-8 after partial hepatectomy we used male 
hepatocyte-specific conditional knockout mice for Caspase-8 (Casp8hep). Conditional 
hepatocyte-specific Caspase-8 knockout mice were generated by mating alb-cre-
transgenic mice (Kellendonk et al., 2000) with mice expressing loxP-flanked 
Caspase-8 alleles. Caspase-8 loxP/loxP mice lacking the Cre transgene derived from 
heterozygous breeding couple were viable and phenotypically normal, consistent with 
the expectation that the “floxed” Caspase-8 allele is functionally wildtype (Casp8f/f, 
WT).  
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3.2.1.2.2 Hepatocyte-specific conditional Caspase-8/NEMO double knockout mice 
Conditional hepatocyte-specific Caspase-8/NEMO double-knockout mice were 
generated by mating Casp8f/f (see 3.2.1.2.1) with mice expressing loxP-flanked 
NEMO alleles (NEMOf/f), which were generated in the Department of Medicine III, UK 
Aachen. The hepatocyte-specific knockout was achieved by expression of the Cre 
transgene and resulted in Casp8hepNEMOhep animals. Caspase-8f/fNEMOf/f mice 
lacking the Cre transgene derived from heterozygous breeding couple were viable 
and phenotypically normal and served as controls (Casp8f/fNEMOf/f, wildtype, WT).  
 
3.2.1.2.3 Caspase-8 c-myctg 
Analysis of tumor progression and development by MRI was performed on 
animals carrying a c-myc transgene under the control of the hepatocyte-specific 
albumin promoter (alb-myctg) of male gender as previously described (Thorgeirsson 
et al., 1997) and Casp8hepalb-myctg littermates. 
 
All strains were on a mixed C57BL6 X 129SvJ  background.  
 
3.2.1.3 Genotyping of genetically modified mice 
The correct genotypes were verified by PCR analysis from DNA isolated from 
mouse tail biopsies according to standard procedures (for primer see 3.2.2.1.2).  
 
3.2.1.4 Application techniques for drugs and other substances in mice  
3.2.1.4.1 Intraperitoneal (i.p.) injection 
For i.p. injection the mouse was fixed at the neck and tail with one hand. 
Injection was done in dorsal direction. 
3.2.1.4.2 Intravenious (i.v.) injection 
For i.v. injection the mouse was fixed in a plastic tube with free access to the 
tail. Warm water was used to make tail vein visible. The cannula was placed in 
cranial direction and was inserted into one of the lateral tail veins. For contrast 
medium application the mouse was anesthetized and the four limbs were fixed to a 
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clean plate. Application was performed using a catheter with injection port (Biovalve® 
22G; 1.0x25 mm). 
 
3.2.1.5 Blood and tissue sampling procedures 
3.2.1.5.1 Taking of blood samples 
Retro-orbital sampling was performed in mice under transient anesthesia 
using Isoflurane by penetrating the retro-orbital sinus with a glass capillary. Blood 
samples were collected in a serum tube and centrifuged at 12000 rpm for 5 minutes. 
Serum was transferred into a fresh tube and stored at -20°C. 
 
3.2.1.5.2 Extraction and sectioning of complete livers 
To remove the full liver mice were sacrificed by cervical dislocation. The 
abdominal cavity was cut open along the Linea alba. Two relaxation cuts were placed 
along the costal archs at the lateral abdominal walls. Removal of the liver was 
achieved by dissecting the ligaments.   
For paraffin embedding of the full organ of MRI-monitored animals, livers were 
perfused through the Vena cava for 15 minutes with 4 % formaldehyde. 
Subsequently the complete liver was extracted and fixed in 4 % formaldehyde/ PBS 
for 24-48 hours and then embedded in paraffin (Shandon Histoplast paraffin, Thermo 
Scientific, Egelsbach) according to its original three-dimensional composition. In 
order to perform tissue sections from formalin-fixed and paraffin-embedded liver 
which parallels MR images, the surface of the formalin-fixed liver was marked with 
different colors corresponding to topographical hallmarks. Afterwards the whole 
organ was embedded in paraffin and orientated as found in the MR images. From 
this primary total liver paraffin block two master blocks were created representing the 
upper or lower half of the liver. Using the master blocks serial whole organ 4 µm 
sections were performed and subsequently stained with HE or immunohistochemical 
stainings following routine protocols. 
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3.2.1.6 Partial Hepatectomy (PH) 
Male mice (7 - 9 weeks old) were anesthetized by i.p. (intraperitoneal) injection 
of 0.3 ml Ketamin/Xylacin per 20 g body weight and subjected to a 70 % PH. 
Surgeries consisted of midline laparotomy with separate ligation and removal of the 
right lateral as well as the left lateral and left anterior (median) lobes. Peritoneum and 
dermis were closed separately after surgery followed by post-operative treatment. At 
various times after liver resection, mice were sacrificed by cervical dislocation, and 
livers were harvested for analysis. BrdU (30 µg BrdU/ g body weight) was given by 
i.p. injection 2 h before sacrificing. 
 
Anesthesia  
Ketamin 450 µl 
Rompun 50 µl 
NaCl 0.9 % add 5 ml 
 
BrdU  
NaCl 0.9 % 100 ml 
BrdU 300 mg 
 
3.2.1.7 Experimental protocol for Magnetic Resonance Imaging (MRI) in 
mice 
All animal interventions including MRI analysis in mice were carried out under 
anesthesia by i.v. injection using 0.4 ml Ketamin/ Rompun. For contrast 
enhancement 0.025 mmol/kg body weight Gd-EOB-DTPA (Primovist®, Schering, 
Berlin, Germany) was administered by tail vein injection (see 3.2.1.4.2) using a 
catheter with injection port (Biovalve® 22G; 1.0x25mm).  
MR imaging was performed using an interventional closed-bore 1.5 T whole 
body MR scanner (Achieva, Philips) which was controlled by a 2.5.3 Philips software. 
A micro 47 coil (Philips) was used for signal reception. All data sets were then 
transferred to a postprocessing view forum workstation to assess the images. 
For each mouse, a standardized set of 5 sequences was applied which is 
shown in table 4.2.1 of the results. 
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All MRI measurements were carried out in the Department of Diagnostic 
Radiology (UK Aachen) under supervision of Prof. Dr. G. Krombach. 
 
3.2.1.8 Isolation of primary hepatocytes 
The connections and tubes of the peristaltic pump used for liver perfusion 
were disinfected with 70 % Ethanol and then rinsed with PBS. I.V. infusion catheter 
was attached to the tubes and rinsed with solution I (37°C) avoiding air-bubbles in 
the system at any time during the procedure.  
Mice were anesthetized as described above (3.2.1.6) and 300 µl of Heparin 
solution was administered i.p. to avoid blood coagulation. Then the mouse was 
immobilized with tape on all four limbs on a moist absorbing surface. The abdomen 
was opened and the intestine was moved aside with a sterile cotton applicator, 
thereby exposing the vessels.   
The Vena portae was then cannulated and fixed securely. Immediately after 
cutting the Vena cava caudalis the liver was rinsed with solution I. The peristaltic 
pump was set to a rate of 5 ml/minute. After approximately 3 minutes of perfusion 
with solution I the liver was perfused with solution II for another 2 minutes. 
Subsequently, the liver was perfused with solution III for 8 – 15 minutes. Afterwards, 
the liver was removed and transferred into a Petri dish with ice-cold medium without 
injuring the capsule. The liver capsule was then disrupted using a forceps and a 
scalpel and hepatocytes were washed out with a cell strainer.  The medium 
containing the hepatocytes was collected and filtered though nylon mesh into a 
sterile 50 ml tube. After 3 minutes centrifugation at 300 rpm (4°C) the cells were 
resuspended in 20 ml DMEM medium and washed twice using DMEM. Viability of 
cells was evaluated using a Neubauer counting chamber and trypan blue staining. 
Subsequently, hepatocytes were immediately cultured on collagene type I 
coated six-well plates at a density of 5  x 105 cells/ ml DMEM in a total volume of 1 
ml/well at 37°C in a humidified atmosphere of 95 % air/ 5 % CO2. Adhesion and 
survival of the cells was controlled after 3 hours and cells were washed in sterile 1x 
PBS (1 ml/ well) and culture medium was changed and kept over night at 37°C and 5 
% CO2. The next day cells were applied to experiments. 
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Heparin  
Heparin 100 µl 
NaCl 3 ml 
 
 
Buffers and media additives volume 
Solution I  
EBSS without Ca and Mg, 
EGTA 
50 ml 
100 mM 
Solution II  
EBSS with Ca and Mg, 
Hepes, pH 7.4 
30 ml 
10 mM 
Solution III  
EBSS with Ca and Mg, 
Hepes, pH 7.4 
Collagenase 
soybean trypsin inhibitor  
50 ml 
10 mM 
0.3 mg/ml 
0.04 mg/ml 
High Glucose DMEM 
Penicillin, Streptomycin, 
fetal calf serum (FCS) 
5 % 
10 % 
 
 
3.2.1.8.1 Stimulation of primary hepatocytes 
The stock solution of the murine TNF- (kindly provided by Dr. G. Tiegs) had a 
concentration of 1.2 µg/ µl. To trigger TNF- induced signaling pathways in primary 
hepatocytes, cells were stimulated with murine TNF- at a concentration of 30 ng/ 
ml. Cells were harvested at distinct time points. 
 
3.2.2 Biomolecular methods 
3.2.2.1 Isolation and analysis of genomic DNA 
3.2.2.1.1 DNA isolation from mouse tail biopsies 
Tail biopsies (approx. 0.5 cm) were taken from 4 week old mice. The tissue 
was lysed in 200 µl of NID-buffer and 1 µl Proteinase K at 56°C over night. Reaction 
was stopped at 95°C for 10 minutes. After mixing vigorously the lysate was 
centrifuged for 10 minutes at 12000 rpm. Supernatant containing the nucleic acid 
was removed and transferred to a new tube. For PCR 2 µl of DNA was used. 
3 Material and Methods 
 
34
 
NID buffer volume final concentration 
KCl 1 M 50 ml 0.05 M 
Tris 1 M 10 ml 0.01 M 
MgCl2 1 M 2 ml 2 mM 
Gelatine type3 10 mg/ ml 10 ml 0.1 mg/ ml 
NP-40 4.5 ml 0.45 % 
Tween 20 4.5 ml 0.45 % 
H2O add 1 l  
 
3.2.2.1.2 PCR-Polymerase chain reaction 
Since the original protocol for the polymerase chain reaction (PCR) was 
established in 1985 by Saiki et al., the procedure was subjected to continuous 
enhancement up to analyzing of the PCR product in real-time (see 3.2.2.2.3.1). 
Individual mice genetically modified at the Caspase-8 and/ or NEMO locus or 
transgenic for the Cre recombinase and/ or c-myc were genotyped using a PCR 
approach according to the following primers and cycling parameters: 
 
 
Sequences of primers (MWG Biotech) are listed in 5‘-3‘ orientation: 
 
target gene name (PCR) sequence in 5´-3´orientation 
Cre sense CCA CGA CCA AGT GACA GCA AT Cre 
transgene Cre antisense TTC GGA TCA TCA GCT ACA CCA 
Casp8 
sense 
CAT ACT GGT TGA GAA CAA GAC CTG G Caspase-8 
wildtype 
signal 
Casp8 
antisense 
GCA GAG GTG ACA AGA GGC CAC TG 
Flp sense CAC TGA TAT TGT AAG TAG TTT GC Deletion of 
Caspase-8 Flp antisense CTA GTG CGA AGT AGT GAT CAG G 
loxP sense AAC TTC GGC CGG CCA ATA ACT TCG Caspase-8 
flanked loxP 
sites 
loxP antisense AGC AGA AAA ACT TGA AGA AAC TTG G 
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c-myc transgene 
sense 
CTT CCT CGT CGC AGAT GAA 
c-myc 
transgene c-myc transgene 
antisense 
GGC AAA CAT ACG CAA GGG 
NEMO sense GCC TTG GTG CTC CCT AAC TCT Deletion of 
NEMO NEMO antisense TCA CAT CAC ATC GTT ATC CTT 
 
A standard PCR mastermix for genotyping of the mice was composed as followed: 
 
Mastermix volume/ reaction concentration 
DNA 1 µl 100 ng 
primer sense 1 µl 100 pmol 
primer antisense 1 µl 100 pmol 
Red Taq Mastermix (Sigma) 12.5 µl  
H2O add 25 µl  
 
Genotyping for the NEMO allele was performed using a HotStarTaq Mastermix 
(Qiagen) and an initial denaturing for 15 minutes.  
Annealing temperature was calculated individually for each primer set according to 
following formula: 
Tm = 4x (number of G + C) + 2x (number of T + A) – 2°C 
Elongation time was adjusted according to the length of the expected product: 0.5 
min/ 500 bp. 
PCR was carried out according to the following cycling programs: 
 
PCR program temperature time (h:min:sec) cycles 
initial denaturing 98°C 00:02:00  
denaturing 95°C 00:00:15 
annealing 56°C 00:00:30 
elongation 72°C 00:01:00 
x 34 
final elongation 72°C 00:05:00  
conservation 4°C 00:00:00  
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3.2.2.2 Isolation and analysis of RNA 
3.2.2.2.1 RNA isolation 
3.2.2.2.1.1 RNA isolation from liver tissue 
Samples were taken from frozen liver tissue and homogenized on ice in 1.6 ml 
Ultraspec II RNA (Biotecx) and incubated for 5 minutes. To extract the RNA 1/5 
volume Chloroform was added to the homogenate and incubated for 5 minutes on ice 
while shaking. Homogenate centrifuged for 15 minutes at 12.000 rpm and 4°C. 
Supernatants were transferred into fresh tubes. To precipitate the RNA, 1 volume of 
ice-cold isopropanol was added to each sample and incubated on ice for 10 minutes 
with shaking. After centrifugation (12000 rpm for 10 minutes at 4°C) the supernatant 
was discarded and the RNA-pellet was washed twice by adding 1 ml 70% ice-cold 
ethanol and centrifugation for 5 minutes at 10000 rpm (4°C). Pellet air-dried for 5-15 
minutes and was then resuspended in 100 µl dH2O and stored at -80°C.  
 
3.2.2.2.2 Determination of RNA concentration 
To determine RNA concentrations each sample was diluted 1:50 in dH2O and 
measured at an optical density of 260 nm.  dH2O was used as blank. Concentration 
was calculated as followed: 1 OD260 = 40 μg RNA/ml.  Purity of the sample was 
determined by the ratio of E260/E280. Results between 1.9 and 2.1 accounts for pure 
RNA. 
 
3.2.2.2.3 RNA analysis 
3.2.2.2.3.1 Reverse transcription PCR (RT PCR) 
Reverse transcription (RT) is a process in which single-stranded RNA is 
reverse transcribed into complementary DNA (cDNA). The reaction is carried out 
using total cellular RNA, the enzyme reverse transcriptase, random primers, dNTPs 
and an RNase inhibitor. The number of reverse transcribed cDNA molecules for a 
defined gene transcript is directly proportional to the gene expression levels and can 
be quantitatively analyzed by real time PCR analysis. 
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For the assembling of RT PCR reactions an Omniscript RT Kit (Qiagen) was 
used according to manufacturer’s recommendations. A typical RT PCR reaction in 
this study was composed as followed: 
 
Component volume/ reaction 
10x Buffer RT 2 µl 
dNTP mix (5 mM each dNTP) 2 µl 
Oligo-dT primer 10 µM 2 µl 
Omniscript Reverse Transcriptase 1 µl 
template RNA (1 µg/µl) 2 µl 
dH2O add 20 µl 
 
PCR program temperature 
60 minutes 37°C 
5 minutes 95°C 
 
cDNA was diluted in dH2O at a ratio of 1:200 and stored at -20°C. 
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3.2.2.2.3.2 Real-Time PCR (RT-PCR) 
Real-Time PCR combines the possibility of DNA amplification analysis and 
quantification of the PCR product in real time. Addition of a fluorescent dye like SYBR 
Green I to the PCR reaction enables monitoring of PCR reactions in real time. This 
dye intercalates into double-stranded (ds-) DNA and produces a fluorescent signal, 
whose intensity is proportional to the amount of dsDNA. Under optimal PCR 
conditions, the template DNA is amplified in a logarithmic scale, which can be 
monitored by a direct proportional increase of the fluorescence intensity. 
 
For the assembling of real time PCR reactions SYBR® GreenER qPCR 
SuperMix (Invitrogen) was used according to manufacturer’s recommendations. Real 
time PCR reactions in this study were composed as followed: 
 
Mastermix volume/ reaction concentration 
cDNA 5 µl  
primer sense 0.5 µl 5 pmol 
primer antisense 0.5 µl 5 pmol 
Sybr green 12.5 µl  
dH2O add 25 µl  
 
For all Real-time PCR reactions the expression of the housekeeping gene 
GAPDH was measured in parallel and used as an internal standard. Data from Real-
time PCR experiments can be analyzed by two different methods: In quantitative 
analyses the number of the initial cDNA target- and GAPDH molecules per sample is 
calculated by comparison with respective standard curves for both molecules. In 
relative analyses the target gene/ GAPDH ratio is calculated and compared to the 
target gene/ GAPDH expression of an untreated control.  
For the present study, the relative gene expression was calculated according 
to the 2-Ct method (Livak and Schmittgen, 2001). 
Real-time PCR reactions were performed in a 7300 Real-Time PCR System 
(Applied Biosystems). Ct values were calculated using SDS software version 
1.3.1(Applied Biosystems) and the Ct values were calculated according to the 
formula: 
 Ct = Ct (sample) - Ct (untreated control) 
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 Ct (sample) is the Ct value for any sample normalized to endogenous 
GAPDH housekeeping gene expression and  
 Ct (untreated control) is the Ct value for the calibrator also normalized to 
GAPDH.  
 From these parameters, the 2-Ct values of all samples were calculated and 
interpreted as fold induction compared to untreated controls. 
 
Real-time PCR was carried out according to the following cycling program: 
PCR program temperature  time (h:min:sec) cycle 
activation 50°C 00:02:00  
denaturation 95°C 00:10:00  
denaturation 98°C 00:00:15 
annealing Tm 58°C 00:00:30 
elongation 60°C 00:00:30 
40x 
conservation 4°C 00:00:00  
 
The specificity of PCR products was confirmed by melting curves and 
electrophoresis. 
 
Following primers (MWG) were used for RT-PCR analysis: 
gene name sequence in 5´-3´orientation 
sense CGA GCT GAT CAG AAC CAT CA 
Bax 
antisense GGT CCC GAA GTA GGA GAG GA 
sense GTC AGA ACG GTC AAC TTT GGG 
CCR5 
antisense GTG TGG AAA ATG AGG ACT GCA T 
sense AAG CAT GCA CAG ACC TTT GTG G 
Cyclin D1 
antisense TTC AGG CCT TGC ATC GCA GC 
sense ACA GCA GGT CTT CGT GCA GAT CG 
Cyclin E1 
antisense CAG CGA GGA CAC CAT AAG GAA ATT C 
sense TGA TGC TTG TCA AAT GCT CAG C 
Cyclin A2 
antisense AGG TCC TCC TGT ACT GCT CAT 
sense CTG CAC TTC CTC CGT AGA GC 
Cyclin B1 
antisense AAA ATG CAC CAT GTC GTA GTC C 
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sense GAG GCT GTG AAC GGG ATC C 
DR5 
antisense GTC GTT TCC GTT TAC CGG AAC C 
sense AGA GTG AGC AGC AGC TGG AT 
E2F1 
antisense GGT CCT GGC AGG TCA CAT AG 
sense TTC TAC CTC CTT TGA GCC CAT C 
E2F4 
antisense ACA TCA GTT CTT CCA GCA GCT C 
sense CTT TGG CTA TGG GCT TCC ATC 
F4/80 
antisense GCA AGG AGG ACA GAG TTT ATC GTG 
sense TGT TGA AGT CAC AGG AGA CAA CCT 
GAPDH 
antisense AAC CTG CCA AGT ATG ATG ACA TCA 
sense CCA AGT ACC CGG ATA CAG CA 
IB- 
antisense CTG GCC TCC AAA CAC ACA GT 
sense CCT CTT CTC ATT CCT GCT TGT GG 
TNF 
antisense GAG AAG ATG ATC TGA GTG TGA GG 
sense CCA ACG AGA TGA AGC AGC 
TRAIL 
antisense CCA TCA GTG GAG TCC CAG 
 
3.2.2.3 Protein extraction and analysis 
3.2.2.3.1 Protein isolation 
3.2.2.3.1.1 Isolation of whole cell protein from liver tissue 
For protein extractions, approximately 1 mg of frozen liver tissue was 
homogenized on ice in 500 µl NP40 buffer. The homogenate was centrifuged for 10 
minutes at 12.000 rpm and 4°C. Supernatant was transferred into fresh tube and 
concentration was determined using a Bradford assay (compare 3.2.2.4.1). The 
samples were snap frozen in liquid nitrogen and stored at -80°C.  
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NP40-Buffer volume final concentration 
Tris HCl 7.5 pH (1 M) 25 ml 50 mM 
NaCl (5 M) 15 ml 150 mM 
Nonidet P-40 2.5 ml 0,5 % 
Sodium Fluoride 1.05 g 50 mM 
H20 add 500 ml  
freshly added: 
Sodium Vanadate (100 mM) 100 µl 1 mM 
DTT (1 M) 10 µl 1 mM 
PMSF (100 mM) 100 µl 1 mM 
Complete Mini® (Roche) 1 tablet  
H2O add 10 ml  
 
3.2.2.3.1.2 Isolation of whole cell protein for Casapse-8 assay with AFC-lysis buffer  
For protein extractions, approximately 1 mg of frozen liver tissue was 
homogenized on ice in 500 µl AFC lysis buffer. Homogenate was centrifuged for 10 
minutes at 12.000 rpm and 4°C. Supernatant was transferred into new tube and 
concentration was determined. Samples were shock frozen in liquid nitrogen and 
stored at -80°C. 
 
AFC-Lysis Buffer volume final concentration 
Hepes 1 M pH 7.4 100 µl 10 mM 
Chaps 10 % 100 µl 0.1 % 
EDTA 0.5 mM pH 8 40 µl 2 mM 
DTT 1 M 50 µl 5 mM 
Pefa Block 0.1 M 100 µl 1 mM 
Complete Mini® 1 tablet  
dH2O add 10 ml  
 
3.2.2.3.1.3 Isolation of nuclear protein from cell culture 
Primary hepatocytes cultured in 6-well petri dishes were washed twice in PBS, 
scraped off in 500 µl PBS and transferred into fresh tube. After 5 minutes 
centrifugation at 4000 rpm and 4°C supernatant was removed and pellet was 
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resuspended in 200 µl NPBT buffer and incubated on ice for 10 minutes. Cell 
suspension was then carefully loaded on top of a 50 % sucrose layer (200 µl) and 
centrifuged at 14000 rpm and 4°C for 10 minutes. Supernatant and sucrose layer 
were removed and the pellet containing cell nuclei was resuspended in 50 µl Dignam 
C followed by 30 minutes rotating incubation at 4°C. After 10 minutes centrifugation 
at 14000 rpm and 4°C supernatant was transferred into new tube and concentration 
was determined. Samples were shock frozen in liquid nitrogen and stored at -80°C. 
 
NPB volume final concentration 
Tris/ HCL 10 mM, pH 7.4 100 µl 10 mM 
MgCl2 1 M 20 µl 2 mM 
NaCl 5 M 280 µl 140 mM 
Na3VO4 1 M 100 µl 1 mM 
DTT 1 M 50 µl 5 mM 
Complete mini® 1 tablet  
dH2O add 10 ml  
 
NPBT 
NPB + 0.5 % Triton x-100 
 
NPB/ 50 % Sucrose 
100 ml NPB + 50 g Sucrose 
 
Dignam C volume final concentration 
Hepes 1 M,  pH 7.9 200 µl 20 mM 
Glycerol 2.5 ml 25 % 
NaCl 5 M 840 µl 420 mM 
EDTA 0.5 M, pH 8.0 4 µl 0.2 mM 
DTT 1M 50 µl 5 mM 
Complete mini® 1 tablet  
dH2O add 10 ml  
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3.2.2.4 Protein concentration 
3.2.2.4.1 Measurement of protein concentration 
Concentration of whole cell protein was determined by Bradford assay as 
previously described (Bradford, 1976). Protein concentration was adjusted to 2 µg/ µl 
and 1 volume of loading buffer was added to the sample for a final concentration of 1 
µg/ µl. Samples were snap frozen in liquid nitrogen and stored at -20°C. 
 
2x Loading Buffer volume final concentration 
Tris 0.5 M pH 8 2 ml 500 mM 
Glycerol 6 ml 60 % 
SDS 20 % 1.25 ml 25 % 
Bromophenolblue  100 µl 1 % 
DTT 10 M 200 µl 200 mM 
dH2O add 10 ml  
 
3.2.2.4.1 Protein concentration of nuclear extracts 
Samples of nuclear extracts were diluted 1:50 (dilution factor = DF) and 
measured at a wavelength of OD230 and OD260. Protein lysis buffer served as blank. 
Concentration was determined by ratio of D230/260 using following formula: 
 
187 x DF x ODcorr230 – 81.7 x DF x ODcorr260     = protein concentration [µg/µl]    
                              1000 
 
 
3.2.2.5 Protein analysis 
3.2.2.5.1 Western Blot 
Samples containing 40 – 55 µg of protein and loading buffer (see 3.2.2.4.1) 
were boiled for 5 minutes at 95°C and loaded on a 10 % SDS/ polyacrylamide gel (8-
15 %, depending on molecular weight of investigated proteins) . Electrophoretic 
separation was performed at 80 V in 1x running buffer over night. After 
electrophoresis, proteins were transferred to a Nitrocellulose Membrane 
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(PROTRAN©, Whatman) using a wet western blotting system (BioRad) for 2 hours at 
385 mA and 4°C. 
After blotting, equal loading of proteins and efficiency of protein transfer was 
verified by Ponceau S staining of the membrane. Subsequently, the membrane was 
incubated in Rotiblock (Roth) for one hour at room temperature for blocking of non-
specific binding activities. After blocking, the membrane was incubated at 4°C over 
night under gentle agitation in primary antibody solution at a dilution according to 
manufacturer’s recommendations. To remove unbound primary antibody the 
membrane was washed three times for 10 minutes in TBS-Tween and then exposed 
to a secondary horseradish peroxidase (HRP)-conjugated antibody for one hour at 
room temperature under gentle agitation. Then, the secondary antibody was removed 
and the membrane was washed three times for 10 minutes with TBS-Tween. 
The membranes were subjected to enhanced chemiluminescent (ECL) 
substrate for 5 minutes and then exposed to a LAS mini 4000 developing machine 
(Fuji) until specific signals were detectable.  
 
Ponceau S  
For a 10x stock solution, a solution of 2 % Ponceau S, 30 % Trichloracetic 
acid and 30 % Sulfosalicylic acid in H2O was generated. The solution was stable at 
room temperature for over one year. 1x Ponceau S working solution was diluted in 1 
% acetic acid. 
 
10x Running Buffer volume  final concentration 
Tris 15.1 g 25 mM 
glycine 72 g 192 mM 
SDS 5 g 0,5 % 
dH2O add 1 l  
 
10x Transfer Buffer volume final concentration 
Tris 24.4 g  
glycine 112.6 g  
dH2O add 1 l  
for 1x Transfer Buffer: 
10x Transfer Buffer 100 ml 10 % 
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Methanol 200 ml 20 % 
dH2O add 1 l  
 
Buffer A volume Buffer B volume 
Tris 91.0 g Tris 30.3 g 
SDS 2 g SDS 2 g 
dH2O add 500 ml H2O add 500 ml 
adjust to 8.8 pH (6 M HCl)                            adjust to 6.8 pH (6 M HCl) 
 
separating gel 8 % 10 % 12,5 % 15 % 
dH2O 21.84 ml 18.5 ml 14.32 ml 10.145 ml 
Buffer A 14.8 ml 14.8 ml 14.8 ml 14.8 ml 
Acrylamide 13.36 ml 16.7 ml 20.87 ml 25.045 ml 
APS 10 % 300 µl 300 µl 300 µl 300 µl 
TEMED 30 µl 30 µl 30 µl 30 µl 
 
stacking gel volume 
dH2O 18 ml 
Buffer B 7.5 ml 
Acrylamide 4.5 ml 
APS 10 % 225 µl 
TEMED 15 µl 
 
3.2.2.5.2 Analysis of protein-protein interactions by co-immunoprecipitation (IP) 
Protein-protein interactions were identified in co-immunoprecipitation 
experiments using protein A/G PLUS agarose beads (Santa Cruz). Per sample 50 µl 
of A/G PLUS agarose slurry was washed twice with 200 µl PBS and spun down at 
2500 rpm at 4°C for 1 minute. The agarose-pellet was resuspended in 25 µl NP40 
buffer, and added to 500 µg total protein in 500 µl NP40 buffer. The reaction rotated 
for 1 hour at 4°C followed by a centrifugation step at 2500 rpm, 4°C for 3 minutes. 
The pellet was discarded and supernatant was transferred into a fresh tube. The 
proteins were then incubated with 2 µl of antibody at 4°C with rotation over night and 
then precipitated with 50 µl of A/G PLUS agarose suspension for another hour under 
rotation at 4°C. The agarose beads were spun down for 3 minutes at 2500 rpm and 
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4°C. The pellet was washed twice with 1 ml of cold NP40 buffer and centrifuged 
again for 3 minutes at 2500 rpm and 4°C. Protein/ antibody complexes were 
dissolved from A/G agarose beads by denaturation in 30 µl 1x SDS loading buffer 
with β-mercaptoethanol and boiling at 95°C for 10 minutes. Agarose beads were 
spun down at 14000 rpm and the supernatant containing precipitated proteins was 
transferred into a new tube. Proteins were stored at -20°C or immediately loaded on 
SDS PAGE gels. 
 
5x Loading Buffer volume final concentration 
Tris/ HCl 0.5 M, pH 6.8 7.5 ml 125 mM 
SDS 3 g 5 % 
Glycerol 15 ml 50 % 
Bromophenolblue 1 % 100 µl  
-Mercaptoethanol 1.5 ml  
dH2O add 30 ml  
 
3.2.2.5.3 Electrophoretic Mobility Shift Assay (EMSA) 
Electrophoretic Mobility Shift Assay (EMSA; alternate designation Gel Shift, or 
Band Shift Assay) is a technique used for studying gene regulation and determining 
protein-DNA or protein-RNA interactions. The assay is based on the fact that 
complexes of protein and DNA migrate through a non-denaturing polyacrylamide gel 
more slowly than free DNA fragments or double-stranded oligonucleotides. The gel 
shift assay is carried out by first incubating a protein(s), such as nuclear or cellular 
extract, with a [32P] end-labeled DNA fragment containing the putative protein binding 
site. The reaction products are then analyzed on a non-denaturing polyacrylamide 
gel. The specificity of the DNA-binding protein for the putative binding site is 
established by super-shift-assay, a competition experiments using a specific antibody 
containing a binding site for the protein of interest or other unrelated DNA 
sequences. This leads to an altered migration of the complex within the 
polyacrylamide gel. Bound to the DNA-binding domain the antibody inhibits the 
specific complex between oligonucleotide and DNA. 
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3.2.2.5.3.1 Establishing of the double-strand DNA probe 
Same amounts of complementary DNA single strands (each 50 µg) were 
added to 26 µl 10x annealing buffer and H2O to a final volume of 260 µl. After heating 
the probe for 5 minutes at 95°C the two single strands annealed over night while 
slowly cooling down to room temperature. DNA double-strands were stored at 4°C. 
 
10x Annealing buffer volume final concentration 
Tris/ HCl 1 M, 7.6 pH 200 µl 200 mM 
MgCl2, 1 M 100 µl 100 mM 
NaCl, 5 M 100 µl 500 mM 
dH2O add 1 ml  
 
3.2.2.5.3.2 Radioactive end-labeling of double-strand DNA probe 
Using the bacteriophage T4 polynucleotide kinase, the double-stranded DNA 
probe was labeled with [32P]- γ-ATP at its 5´-hydroxylgroup. After 60 minutes of 
incubation at 37°C the labeled oligonucleotide was centrifuged in a Nick-spin-column 
for 2 minutes at 3000 rpm in order to remove non-bound [32P]- γ-ATP. Efficiency of 
the labeling and the radioactivity was determined by β-counter using 1 µl of probe in 
5 ml of scintillation solution. 
 
Reaction mix volume 
oligonucleotide (125 ng) 3.3 µl 
10x T4-kinase buffer 2.0 µl 
dH2O 9.7 µl 
T4-kinase 1.0 µl 
γ-ATP (0.1 mCi/ l) 4 µl  
 
3.2.2.5.3.3 Gelshift analysis 
For the reaction 1-5 µg of nuclear protein extract was mixed with 4 µl 5x 
binding buffer, 2 µl 10x proteinase inhibitor cocktail, 1 µl Poly dI:dC (1 µg/ µl), 1 µl 
BSA (10 µg/ µl in dH2O) and P32-labeled oligonucleotide (30000 cpm per reaction) 
and filled up to 20 µl with H2O. As control a reaction mix without protein was applied. 
The samples were incubated 30 minutes on ice. For super-shift-assays 1 µl of 
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specific antibody was added to a sample and incubated for another 30 minutes on 
ice. The reaction was stopped with 2 µl loading buffer containing 20 % Ficoll. 
Samples were loaded on a non-denaturating 5 % polyacrylamide gel (5 %) and 
separated at 300 volt and 4°C for approximately 3 hours. The gel was fixed for 30 
minutes in 20 % methanol/10 % acetic acid, transferred to a whatman filter, dried 
under vacuum and exposed at -80°C on x-ray film. 
 
EMSA Gel 5 % 6 % 
5x TBE 2.5 ml 2.5 ml 
Acrylamide 30 % 8.3 ml 10 ml 
dH2O 39.2 ml 37.5 ml 
APS 10 % 350 µl 350 µl 
TEMED 50 µl 50 µl 
dH2O add 50 ml 50 ml 
 
10x Proteinase Inhibitor Cocktail volume final concentration 
DTT 1 M 20 µl 20 mM 
Pefabloc 0.1 M 50 µl 50 mM 
Aprotinin solution 200 µl  
dH2O add 1 ml  
 
5x Binding buffer volume final concentration 
HEPES 1 M, pH 7.6 125 µl 125 mM 
MgCl2 0.5 M 50 µl 25 mM 
KCl 1M 170 µl 170 mM 
dH2O add 1 ml  
 
5x TBE volume final concentration 
Tris-base 54 g 0.045 M 
Boracid 27,5 g 0.44 M 
EDTA 0.5 M, pH 8.0 2 ml 1 mM 
dH2O add 1 l  
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0.25x Running buffer volume gel fixation  
5x TBE 75 ml acetic acid 10 % 
dH2O 1425 ml methanol 20 % 
 
Olignucleotide consensus sequences used for EMSA: 
name orientation Sequence 
sense CGC TTG ATG ACT CAG CCG GAA 
AP-1 consensus 
antisense TTC CGG CTG AGT CAT CAA GCG 
sense AGT TGA GGG GAC TTT CCC AGG C 
NF-B consensus 
antisense GCC TGG GAA AGT CCC CTC AAC T 
 
3.2.2.5.4 Caspase Assay 
Caspases-8 is a key enzyme for induction of the apoptotic cascade. This 
assay works with a Caspase-8 specific substrate IETD and a fluorochrome AFC. 
Active Caspase specifically cleaves the substrate IETD between D and AFC, thus 
releasing the fluorogenic AFC which can be quantified by U.V. spectrofluorometry. 
These tetrapeptide substrates are used to identify and quantify Caspase-8 activity in 
apoptotic protein lysates 
AC-IETD-AFC-substrate: Caspase-8 substrate 
Per reaction tube 487.5 µl mastermix and 12.5 µl protein were mixed. 
Following 200 µl in duplicate were pipetted into a 96-well-cellstar plate and incubated 
at 37°C. Mastermix with lysis buffer was taken as blank. AFC-release was measured 
in 4 minute intervals and stopped after 2 h. 
 
Extinction-wavelength: 390 nm                                       Emission-wavelength: 510 nm 
Extinctions-slit: 0.0 nm                                                    Emissions-slit: 2.5 nm 
Integration-time: 1 sec                                                    Emission-filter: open 
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AFC-release was determined as followed: 
Mastermix   volume/ reaction 
25x Reaction Buffer 20 µl 
dH2O 465 µl 
substrate 2.5 µl 
Protein sample 12.5 µl 
 
25x Reaction buffer volume final concentration 
Pipes 1 M pH 7.4 2.5 ml 250 mM 
EDTA 0.5 M pH 8 1 ml 50 mM 
Caps 10 % 2.5 ml 2.5 % 
DTT 1 M 1.25 ml 125 mM 
dH2O add 10 ml  
 
3.2.3 Histological analysis 
3.2.3.1 Immunohistochemistry 
PCNA (Proliferating Cell Nuclear Antigen) immunohistochemistry was 
performed on 5 µm paraffin embedded sections. For deparaffinization and 
rehydration sections were placed in Xylol 3x each for 5 minutes, 100 % Ethanol (2x, 
10 minutes) 95 % Ethanol (2x 10 minutes), 70 % Ethanol (2x 10 minutes) and 5 
minutes in dH2O twice. The antigen unmasking was done in sodium citrate pH 6.0 at 
95°C for 30 minutes followed by 30 minutes of cooling down to room temperature. 
Sections were then washed 5 minutes in dH2O and fixed 10 minutes in 3 % H2O2/ 
Methanol. Washing was repeated twice in dH2O and 5 minutes in TBS. To prevent 
unspecific bindings blocking solution was applied for one hour to the sections at room 
temperature. Using an anti-PCNA antibody at a dilution of 1:200 the sections 
incubated over night at 4°C. A secondary goat anti-mouse-HRP antibody was used at 
a dilution of 1:100 for one hour at room temperature. Final staining was performed 
with DAB solution (Sigma) and counterstaining with hematoxylin.  
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Blocking solution volume concentration 
Triton X-100 30 µl 0.3 % 
Serum (from same species 
 as secondary antibody) 
500 µl 5 % 
PBS add 10 ml  
 
3.2.3.2 Immunofluorescence 
Frozen liver sections were fixed immediately in 4 % formaldehyde at room 
temperature. After 15 minutes formaldehyde was removed and the slides were 
washed three times in PBS for 5 minutes each. All subsequent steps were carried out 
at room temperature unless otherwise indicated in a humid light-tight box to prevent 
drying and fading of the fluorochrome. The specimen was then blocked for 1 h to 
avoid unspecific binding of the antibody. Blocking solution (compare 3.2.3.1) was 
aspirated and primary antibody was added at a dilution according to manufacturer’s 
recommendation (1:50 – 1:500) in blocking solution. Slides were incubated with the 
antibody over night at 4°C. Sections were then washed three times in PBS and 
incubated with a secondary antibody for 1 h at room temperature in the dark. 
Remaining unbound secondary antibody was removed by rinsing the slides three 
times in PBS for 5 minutes. DAPI mounting medium was applied to the sections for 
counterstaining of the nuclei. Then slides were covered by coverslips and specimens 
were immediately examined under a fluorescence microscope by using appropriate 
excitation wavelengths depending on the fluorochrome used. 
 
3.2.4 Serological analysis  
Transaminases like alanine-aminotransferase (ALT) and aspartate-
aminotransferase (AST) are enzymes catalyzing the reversible conversion of -keton 
acids to amino acids. These enzymes are qualified as specific markers for liver 
damage. In this study, aminotransferases were analyzed from murine blood. After 
spinning down blood samples at 1200 rpm, plasma was recovered and stored at -
20°C until used for determination of aminotransferase activities. Measurement was 
performed in the clinical routine laboratories of the Institute of Clinical Chemistry and 
Pathobiochemistry, UK Aachen. 
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4 Results 
4.1 The role of the pro-apoptotic mediator Caspase-8 for liver 
regeneration following partial hepatectomy  
4.1.1 Hepatocyte-specific deletion of Caspase-8 accelerates the onset of 
liver regeneration in mice after partial hepatectomy  
The cytokine TNF plays a critical role early in liver regeneration following 
partial hepatectomy (PH). TNF mediates signals via at least three different pathways 
involving protective effects via NF-B, apoptosis signaling through Caspase-8 
activation and activation of c-Jun N-terminal kinases (JNK).  
The focus of the present study was the Caspase-8 signaling pathway in 
hepatocytes in order to understand the relevance during liver regeneration after PH. 
For this approach, hepatocyte-specific Caspase-8 KO mice (Casp8hep) and WT 
littermates (Casp8f/f) were subjected to 2/3 partial hepatectomy and sacrificed at 
different time points after surgery to evaluate the contribution of Caspase-8 to tissue 
recovery from injury. Harvested liver samples were analyzed for molecular marker of 
cell cycle initiation and progression but also for termination of liver regeneration. 
Cyclin D1 is critical for driving quiescent hepatocytes from G0 into the G1-
phase of cell cycle and is predominantly regulated by growth factors and immediate 
early genes. Therefore, at first the expression of Cyclin D1 was analyzed after PH. 
WT controls showed a beginning of Cyclin D1 expression after 40 hours (Fig. 4.1 A). 
In contrast, Casp8hep mice showed a strong upregulation of Cyclin D1 protein 
already 30 h after surgery (Fig. 4.1.1 A). To determine whether these effects were 
due to a transcriptionally regulated mechanism of the Cyclin D promoter, Cyclin D1 
gene expression levels were investigated by quantitative Real-time PCR (qRT-PCR). 
Differential Cyclin D1 expression patterns were found between both groups 
correlating with protein analysis (Fig. 4.1.1 B). Control animals showed a peak of 
Cyclin D expression 40 hours after PH indicating entry in G1 phase whereas 
Caspase-8 deleted animals showed maximal Cyclin D mRNA levels already 36 hours 
post surgery although with the same amplitude. At 60 h post surgery both Casp8f/f 
and Casp8hep showed an identical second peak of Cyclin D gene expression 
indicating the initiation of a second round of cell cycle following PH, which is 
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consistent with earlier findings. However, 72 h post surgery the Cyclin D mRNA 
levels in both groups returned back to baseline levels. 
 
 
Figure 4.1.1: Accelerated G0/ G1 cell cycle transition in Casp8hep mice. Casp8f/f and Casp8hep 
mice were subjected to PH and sacrificed at the time points indicated. (A) Western Blot for Cyclin D1 
demonstrated earlier onset of Cyclin D protein expression and G0-G1 transition in Casp8hep mice 
GAPDH (lower panel) was used as internal loading control. (B) Relative Real-time PCR for Cyclin D1 
mRNA expression in Casp8hep and Casp8f/f mice demonstrated significant earlier onset of cell cycle in 
KO mice. The Cyclin D/ GAPDH expression ratio was determined and calculated as fold induction in 
comparison to untreated controls. Each value represents the mean of 4 animals.  Solid black lines 
represent Casp8hep; dashed grey lines represent Casp8f/f animals 
 
The G1/ S-Phase transition is mediated by the E-type Cyclins E1 and E2. In 
Casp8f/f animals, the Cyclin E1 mRNA peaked 40 h after hepatectomy showing a 26 
fold up-regulation in comparison to untreated controls (Fig. 4.1.2). On the contrary, 
Casp8hep littermates revealed a significantly increased transcription as early as 24 h 
after surgery, with an expression maximum after 36 h post PH and a 36 fold up-
regulation compared to baseline levels. However, beginning 40 h after PH, no further 
significant differences between both groups could be observed.  
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Figure 4.1.2: Accelerated and amplified induction of Cyclin E1 gene expression in Casp8hep 
mice. Relative Real-time PCR for Cyclin E1 of Casp8hep mice and Casp8f/f controls after PH. The 
Cyclin E1/ GAPDH expression ratio was determined and calculated as fold induction in comparison to 
untreated controls. Each value represents the mean of 4 animals. Solid black lines represent 
Casp8hep mice; dashed grey lines represent Casp8f/f animals.  
 
 
The E2F family of transcription factors plays a pivotal role in the regulation of 
cellular proliferation and differentiation. In fact, binding sites for E2F factors have 
been identified in a large number of genes that control cell cycle and DNA synthesis, 
including Cyclin D, E, A and the Proliferating Cell Nuclear Antigen (PCNA). In more 
detail, E2F1-E2F3 bind to cell cycle regulated gene promoters and activate 
transcription of these genes, while E2F4 usually functions as a repressor (Dimova 
and Dyson, 2005).  
In Casp8hep mice expression of E2F1 was amplified at any time point between 
24h – 36h post PH compared to Casp8f/f animals (Fig. 4.1.3 A). On the contrary, the 
transcriptional repressor E2F4 showed significantly reduced basal expression levels 
in Casp8hep animals compared to WT littermates (Fig 4.1.3 B), indicating, that the 
accelerated cell cycle onset in Casp8hep animals might be mediated via an E2F-
dependent mechanism. 
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Figure 4.1.3: Modified expression profiles of transcription factor E2F1 and antagonistic E2F4 in 
Casp8hep mice after hepatectomy. Relative Real-time PCR for (A) E2F1 and (B) E2F4 mRNA 
expression in Casp8hep and Casp8f/f mice. E2F1 mRNA is significantly upregulated after PH in 
Casp8hep mice while basal E2F4 mRNA expression in the liver is strongly reduced compared to WT 
littermates. The E2F/ GAPDH expression ratio was determined and calculated as fold induction in 
comparison to untreated controls. Each value represents the mean of 4 animals.  Solid black lines 
represent Casp8hep; dashed grey lines represent Casp8f/f animals. 
 
Next, it was analyzed if the accelerated S-phase initiation after PH as found in 
Casp8hep mice might also result in modified kinetics of S-phase progression. For this 
approach, the DNA synthesis in liver cells following PH was monitored by 
measurement of BrdU incorporation and the expression profile of Cyclin A2, which 
serves as a marker for S-phase, but also for transition into mitosis. Casp8f/f control 
animals displayed strong BrdU incorporation between 36 and 48 hours after 
hepatectomy (Fig. 4.1.4), whereas Casp8hep mice revealed a different kinetic 
showing prolonged and also amplified BrdU incorporation in a time frame between 30 
and 48 hours after PH (Fig. 4.1.4). 
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Figure 4.1.4: Accelerated and prolonged S-phase progression in Casp8hep mice. Casp8f/f and 
Casp8hep mice were subjected to PH and sacrificed at the time points indicated. Two hours before 
sacrificing, animals were injected with the nucleotide analogue BrdU. (A) BrdU immunofluorescence 
staining of frozen liver sections from Casp8hep mice and control animals at representative time points 
after PH. Green: BrdU-positive nuclei; blue: co-staining total nuclei with DAPI. (B) Quantification of 
BrdU-positive cells relative to total nuclei (DAPI) per 200x power field. The amount of BrdU positive 
nuclei was determined by counting 4 representative high power fields/ mouse after microscopic 
examination. Each time point represents a minimum of 4-5 animals. Solid black lines represent 
Casp8hep; dashed grey lines represent WT animals.  
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In agreement with these findings, the induction of Cyclin A gene and protein 
expression appeared significantly earlier in Casp8hep mice compared to controls 
(Fig. 4.1.5). In addition, the Cyclin A2 expression levels in Casp8hep mice were also 
strongly increased between 24 and 48 hours post PH clearly demonstrating that 
ablation of Caspase-8 results in an accelerated and prolonged S-phase progression 
during liver regeneration.    
 
 
Figure 4.1.5: Accelerated S-phase progression after PH correlates with modulated Cyclin A 
expression in Casp8hep mice. (A) Determination of Cyclin A mRNA expression by Real-time PCR. 
The Cyclin A2/ GAPDH expression ratio was determined for each time point and calculated as fold 
induction in comparison to untreated controls. Each value represents the mean of 4 animals. Solid 
black lines represent Casp8hep; dashed grey lines represent Casp8f/f animals. (B) Cyclin A protein 
expression in Casp8hep mice and control animals after PH was detected by western blot analysis. 
GAPDH was used for equal loading control 
 
The finding, that Caspase-8 ablation results in accelerated - and potentially 
also increased DNA synthesis, raised the question whether this might be directly 
correlated to increased mitosis and subsequent hepatocyte proliferation. As a marker 
for mitosis, Cyclin B1 mRNA expression was studied in Casp8hep mice and Casp8f/f 
controls. In Casp8f/f mice, Cyclin B mRNA revealed a biphasic expression pattern 
with two distinct peaks 36 h and 48 h after hepatectomy (Fig. 4.1.6) as previously 
described (Trembley et al., 1996). In sharp contrast, Casp8hep animals showed an 
overall lower, but prolonged Cyclin B expression with almost constant expression 
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levels between 36 -60 hours post PH (Fig. 4.1.6).  This aberrant Cyclin B expression 
in Casp8hep suggests that mitosis in these animals is not necessarily increased but 
rather delayed despite an augmented DNA synthesis. 
 
 
Figure 4.1.6: Aberrant Cyclin B1 gene expression indicates retarded M-phase. At different time 
points after PH the Cyclin B1 mRNA expression in Casp8hep and Casp8f/f mice was determined by 
relative Real-time PCR. The Cyclin B1/ GAPDH expression ratio was determined for each time point 
and calculated as fold induction in comparison to untreated controls. Each value represents the mean 
of 4 animals. Solid black lines represent Casp8hep; dashed grey lines represent Casp8f/f animals. 
 
4.1.3 Progression and termination of hepatic regeneration after PH is 
independent of Caspase-8 function 
Following partial liver resection, liver regeneration is eventually terminated 
after a phase of hepatic growth, restructuring, and liver mass restoration. In Casp8f/f 
mice, DNA synthesis is mostly completed after 72 hours, followed by changes in liver 
histology (Martinez-Hernandez and Amenta, 1995) and the original liver mass is 
restored within 12-15 days (Fausto, 2000). However, the mechanisms leading to 
proper termination of liver regeneration are poorly understood and Caspase-8 
induced apoptosis could potentially contribute to this process. Therefore this study 
addressed the question whether Caspase-8, which is a key player for the initiation of 
receptor-mediated apoptosis, might also play a role for termination of liver 
regeneration. 
To investigate the physiologic relevance of earlier S-phase onset, enhanced 
DNA synthesis and inhibition of apoptosis in Casp8hep mice after PH, the liver/ body 
weight ratio at different time points after liver resection was determined and 
compared to Casp8f/f controls. The liver/ body weight ratio revealed no significant 
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differences at any analyzed time point between both groups (Fig. 4.1.7 A). The ratio 
of untreated control animals was 5.3 % in Casp8f/f controls and slightly increased (6.1 
%) in Casp8hep animals. However, seven days after 2/3 liver resection Casp8f/f and 
Casp8hep animals had restored their liver mass to the same extend (Casp8f/f: 4.6 %; 
Casp8hep: 4.7 %). Macroscopic appearance of livers from untreated Casp8hep and 
Casp8f/f littermates did not differ in size, weight, color and texture (Fig 4.1.7 B, left 
panel). Livers of both genotypes had an even surface, soft texture and displayed a 
dark red color. Also one week after liver resection macroscopically no discrepancy 
could be detected concerning size, weight, color or texture between both genotypes 
(Fig 4.1.7 B, right panel). 
These data indicate that the aberrant cell cycle progression in Casp8hep mice 
does not result in unphysiological liver mass restoration. Moreover these experiments 
clearly show that termination of the regeneration process does not depend on the 
presence of Caspase-8.  
 
 
Figure 4.1.7: Similar liver mass restoration in Casp8hep and Casp-8f/f mice after PH. (A) Liver/ 
body weight ratio of Casp8hep and Casp8f/f animals of distinct time points between 24 h and 1 week 
after PH did not display any significant differences. Solid black lines represent Casp8hep; dashed grey 
lines represent Casp8f/f animals. (B, C) Surgical situs. (B) Normal macroscopic appearance of 
representative livers from 8 week old Casp8f/f and Casp8hep mice in comparison to (C) regenerated 
Casp8f/f and Casp8hep livers one week after PH. 
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To further evaluate a potential function of Caspase-8 activity for termination of 
the regenerating process after liver resection, a Caspase-8 assay was applied to 
measure enzymatic Caspase-8 activity from liver protein extracts of Casp8f/f and 
Casp8hep mice at different time points after PH. In both groups, activity of Caspase-8 
did not exceed basal levels at all investigated time points between 72 h and 7 days 
post surgery (Fig. 4.1.8). In contrast, strong Caspase-8 activity was detected in a 
positive control from an apoptotic liver proving the functionality of this assay.  
  
 
Figure 4.1.8: Caspase-8 is not activated during late liver regeneration in Casp8f/f or Casp8hep 
mice after 2/3 liver resection. Casp8f/f and Casp8hep mice were subjected to PH and sacrificed at 
the time points indicated. Native protein extracts were isolated from harvested livers and analyzed in 
Caspase-8 assays for Caspase-8 substrate turnover. The specific Caspase-8 activity was determined 
and calculated as fold induction in comparison to untreated control animals. As positive controls 
(yellow bar) murine WT livers with excessive apoptosis due to Fas-induced liver injury were used. 
Each bar represents the mean of at least 4 animals per group.     
 
Together, these results further suggest that Caspase-8 function is dispensable 
for the termination of liver regeneration. 
 
4.1.4 Ablation of Caspase-8 affects the priming phase of liver 
regeneration and TNF-mediated signal transduction  
To further investigate the functional link between Caspase-8 inactivation and 
earlier induction of cell cycle progression, Casp-8f/f and Casp-8hep animals were 
analyzed at early time points (0-6 hours after liver resection) for TNF-related signals.  
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During this priming phase of liver regeneration, Kupffer cells are activated and 
secrete pro-inflammatory cytokines such as TNF- which in turn promotes 
stimulation of the acute phase and the inflammatory response in hepatocytes (Fausto 
et al., 2006).  
In Casp8f/f control animals, expression of TNF- mRNA was already induced 
0.5 h after PH and showed an expression peak (8 fold induction) 1 h post surgery. At 
later time points beginning 2 h post PH, TNF expression dropped to almost 
background levels (Fig. 4.1.9). Interestingly, Casp8hep mice displayed already a 5 
fold increased basal TNF- expression compared to control littermates, which was 
further induced 30 minutes after hepatectomy (Fig. 4.1.9). 
 
 
Figure 4.1.9: Significantly enhanced TNF- mRNA expression in mice lacking Caspase-8. Real-
time PCR for TNF- in Casp8hep and Casp8f/f animals demonstrates significant basal mRNA 
expression in Casp8hep livers. The TNF/ GAPDH expression ratio was determined for each time point 
and calculated as fold induction in comparison to untreated controls. Each time point represents the 
mean of 3-4 animals. Solid lines represent Casp8hep; dashed lines represent Casp8f/f animals. 
 
To further investigate these unexpected findings, the expression of additional 
factors relevant for the inflammatory response was analyzed in Casp8hep mice and 
control littermates. The chemokine receptor CCR5 is predominantly expressed on T 
cells, macrophages and dendritic cells and it is believed that CCR5 plays a role in 
inflammatory responses. Accordingly, Casp8f/f mice showed an immediate 10 fold up-
regulation of CCR5 following PH and an elevated gene expression for at least 6 
hours post PH (Fig. 4.1.10 A). In contrast, Casp8hep mice displayed an even 
amplified but transient CCR5 expression compared to controls, which was restricted 
to 0.5-1 hours after surgery.  
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One important source for TNF expression in the liver are the resident liver 
macrophages referred to as Kupffer cells, which can be characterized by the 
expression of the cell surface antigen F4/80. In this line of evidence, the overall F4/80 
mRNA expression in Casp8hep mice was significantly upregulated compared to 
control littermates (Fig. 4.1.10 B) with a peak expression 1-2 hours post PH. 
These data strongly indicate that Casp8hep mice comprise characteristics of 
spontaneous liver inflammation such as elevated TNF level and are per se triggered 
for a strong TNF-mediated response. 
 
 
 
Figure 4.1.10: Different expression profiles of chemokine receptor CCR5 and Kupffer cell 
marker F4/80 in Casp8hep and Casp8f/f mice following PH. (A) Real-time PCR for mRNA 
expression of CCR5 in Casp8hep and Casp8f/f animals before and after PH. Strong up-regulation is 
detectable between 0.5 and 1 h post surgery in animals without Caspase-8 expression. (B) 
Significantly elevated mRNA expression of Kupffer cell surface marker F4/80 in Casp8hep and Casp8f/f 
animals was observed 1 and 2 h after 2/3 liver resection. The CCR5 and F4/80/ GAPDH expression 
ratio was determined for each time point and calculated as fold induction in comparison to untreated 
controls. Each time point represents the mean of 3-4 animals. Solid lines represent Casp8hep; dashed 
lines represent Casp8f/f animals. 
 
Further indications for basal inflammation were obtained from histological 
analyses of Casp8hep livers. Untreated Casp8f/f and Casp8hep paraffin embedded 
liver sections were subjected to Hematoxylin/Eosin (HE) staining and the microscopic 
tissue structure was investigated. Severe differences in liver histologies were 
depicted in the untreated Casp8f/f and Casp8hep mice (see Figure 4.1.11). In the 
healthy liver the hepatic parenchyma is organized in units called hepatic lobule, 
which is the structural unit of the liver. It consists of a roughly hexagonal arrangement 
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of plates of hepatocytes radiating outward from a central vein in the center. At the 
vertices of the lobule are regularly distributed portal triads, containing a bile duct and 
a terminal branch of the hepatic artery and portal vein. In liver histologies of 
Casp8hep mice strong accumulations of infiltrating mononuclear cells were observed. 
Moreover, a number of bile ducts were enlarged in Casp8hep mice compared to 
Casp8f/f controls. 
 
 
Figure 4.1.11: Hematoxylin/ Eosin staining of liver sections from untreated Casp8f/f and 
Casp8hep animals. Representative Hematoxylin/ Eosin (H/E)-stained liver sections showing normal 
histological architecture in livers of 8 week old control mice (left panel) or Casp8hep animals (right 
panel). Black arrows pointing to structural characteristics of the liver: central vein (CV), bile duct (BD), 
portal vein (PV). In Casp8hep mice a strong accumulation of infiltrating mononuclear cells (IC) is 
visible in the liver tissue (200x magnification). 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 Results 
 
64
The response to the liver injury induced by partial hepatectomy was further 
monitored by determination of the serum transaminases AST and ALT. Both Casp8f/f 
and Casp8hep animals showed an increase of transaminases after partial 
hepatectomy. However, 6 hours after PH Casp8hep mice had clearly reduced AST 
and ALT levels compared to control littermates (Fig. 4.1.12) indicating that ablation of 
Caspase-8 might activate additional protective signals after partial liver resection. 
 
 
Figure 4.1.12: Reduced serum transaminases in Casp8hep mice after partial hepatectomy. 
Levels of AST (A) and ALT (B) in Casp8hep mice (black bars) and Casp8f/f animals (grey bars) 
between 0.5 and 6 h after surgery compared to untreated control animals (Ctrl) of both genotypes. 
Results are expressed as mean of at least 5 animals per group; error bars indicate SD. 
 
4.1.5 Earlier onset of cell cycle entry in Casp8hep mice after PH is 
preceded by an accelerated activation of NF-B  
The experiments described so far demonstrated that ablation of Caspase-8 
results in an accelerated induction of Cyclin D gene- and protein expression and 
subsequent cell cycle progression. Based on these results, the molecular basis for 
the differential cell cycle entry of Casp8f/f and Casp8hep animals after PH should be 
elucidated. Cyclin D is the first Cyclin in a cascade of G1 Cyclins predominantly 
regulated by growth factors and transcriptional regulators such as NF-B and c-
Jun/AP-1. Previous studies have shown that the ability of NF-B to control cellular 
proliferation and differentiation are processes tightly coupled to its transcriptional 
regulation of Cyclin D1 (Gupta et al., 2000). Thus, in further experiments it was aimed 
to investigate if modified kinetics of NF-B activation in Casp8hep mice could 
contribute to the phenotype observed in these animals after PH. 
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Electrophoretic Mobility Shift Assay (EMSA) of nuclear extracts from primary 
hepatocytes were isolated from Casp8f/f and Casp8hep livers and stimulated with 
murine TNF-. Demonstrated in Fig. 4.1.13, cells isolated from a Casp8f/f mouse had 
a short transient activation of NF-B 0.5 h after TNF- stimulation. Interestingly, 
hepatocytes lacking Caspase-8 displayed prolonged NF-B activation until 6 h after 
stimulation. Specificity of the signal was provided by supershift experiment for the 
NF-B subunit p65 demonstrated in the last panel of figure 4.1.13. 
 
 
Figure 4.1.13: Primary hepatocytes from Casp8f/f and Casp8hep mice after stimulation with 
murine TNF- Primary hepatocytes from the indicated mouse lines were stimulated with murine 
recombinant TNF (30 ng/ml) for the indicated time points. In the first lane the free probe without any 
protein was loaded as control. In the remaining lanes, 5 µg protein per sample were used for 
electrophoretic mobility shift assay. In the last lane (0.5 h + p65) a protein extract of Casp8hep cells 
(0.5 hour after TNF stimulation) was incubated with 1 µl p65 antibody (Santa Cruz). Supershift of the 
respective slow migrating complex indicates specificity for p65 binding to the probe. Unspecific 
DNA/protein slow migrating complex formation is highlighted and was used as loading control. 
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P65-immunofluorescence staining from frozen liver sections of Caspase-8 
deficient mice and respective WT controls demonstrated a differential course of 
activation and nuclear translocation of NF-B after liver resection (Fig. 4.1.14). In 
Casp-8f/f mice NF-B activation and nuclear translocation was transient and clearly 
detectable only 1 hour post surgery with little residual activity at later time points. 
Interestingly, Casp8hep livers showed accelerated and persistent nuclear 
translocation of NF-B starting already 0.5 hours after surgery up to 2 hours post PH 
(Fig. 4.1.14).  
 
 
Figure 4.1.14: Hepatocyte-specific Caspase-8 deletion enhances NF-B activation after PH. 
Merged pictures of representative p65 immunofluorescence staining and DAPI of Casp8hep and 
Casp8f/f frozen liver sections at different time points after operation as indicated. Nuclei with 
translocation of p65 are stained in red; total nuclei were visualized by DAPI and stained in blue. 
 
The NF-B inhibitor subunit IB- is one the first genes activated by NF-B 
after TNF- signaling (Taub, 1996) leading to auto-regulation of NF-B by a negative 
feedback-loop responsible for the mostly transient activation of NF-B. In Casp8f/f 
control animals, IB-mRNA expression was induced 2 h after liver resection and 
peaked 2 h later (Fig. 4.1.15 A). Surprisingly, IB-mRNA expression was 
completely abolished in Casp8hep mice, potentially explaining the persistent NF-B 
activation in these animals. 
IKK is a subunit of the IKK complex which is essential for the activation of 
NF-B. The expression profile of IKK protein was significantly different in control 
animals compared to Casp8hep mice. WT animals revealed a regulated expression 
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profile with maximal protein levels 2 - 6 h after liver resection while Casp8hep mice 
showed strong basal IKK expression lasting up to 4 h after surgery (Fig. 4.1.15 B). 
Micheau et al., 2001 demonstrated that FLIPL is one of the first target genes of 
NF-B. Interestingly, Casp8hep mice showed a continuous FLIPL protein expression 
between 0 and 6 h post PH, while FLIPL expression in control animals was regulated 
with enhanced protein levels restricted to 1 - 2 hours after partial hepatectomy (Fig. 
4.1.15 B).  
 
 
Figure 4.1.15: Ablation of Caspase-8 modulates upstream- and downstream targets of NF-B 
after partial hepatectomy. (A) Relative RT-PCR analysis of IB- liver mRNA expression from 
Casp8f/f and Casp8hep mice after 2/3 liver resection. Solid black lines represent Casp8hep; dashed 
grey lines represent Casp8f/f animals. Results are expressed as mean of at least 4 animals per time 
point; error bars indicate SD. (B) Immunoblot analysis of liver protein extracts from 8 weeks old 
Casp8f/f and Casp8hep mice after PH using antibodies specific for IKK- and FLIP. Expression of 
GAPDH was determined as loading control. 
 
In summary these experiments provide strong evidence that ablation of 
Caspase-8 enhances the activation of NF-B after 2/3 hepatectomy, which is 
correlated with an atypical constitutive expression of IKK and FLIPL. 
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4.1.6 Caspase-8 deficiency in hepatocytes leads to stronger JNK 
activation after PH 
The second approach to explain the accelerated induction of Cyclin D 
expression and cell cycle progression in Casp8hep mice was focused on the JNK/ c-
Jun/ AP-1 axis of the TNF-induced signaling cascades as the Cyclin D promoter also 
contains functional c-Jun/AP-1 binding sites. Previous studies have demonstrated an 
important role especially for JNK1 in phosphorylating c-Jun (Wang et al., 2006) and 
promoting G0 exit and cell cycle progression in hepatocytes after PH while JNK 
inhibition in primary hepatocytes resulted in diminished proliferative response  
(Schwabe et al., 2003). Therefore it was investigated if the absence of Caspase-8 
might have an effect on JNK1 signaling after PH. To address this question, JNK 
phosphorylation was analyzed in Casp8hep and Casp8f/f mice. JNK1 activation in 
Casp8f/f control animals was first detected 2 hours after surgery, whereas 
phosphorylation of JNK1 in Caspase-8 deficient mice occurred already 0.5 hours post 
PH as demonstrated by western blot analysis (Fig. 4.1.16). 
 
 
Figure 4.1.16: Ablation of Caspase-8 in hepatocytes leads to accelerated and prolonged JNK1 
phosphorylation. Whole liver protein extracts from Casp8f/f and Casp8hep mice before and at short 
time points after PH were subjected to western blot analysis for JNK phosphorylation. The JNK 
antibody used detects both JNK1 (46 kD) and JNK2 (54 kD) as indicated. The expression of total JNK 
(medium panel) and GAPDH (lower panel) was used as loading control. 
 
JNK1 is the major c-Jun activating kinase and it was demonstrated before that 
phosphorylation of c-Jun is required for proper hepatocyte proliferation after PH 
(Behrens et al., 2002; Sabapathy et al., 2004). As shown in Fig. 4.1.17 A, activation 
and nuclear translocation of c-Jun in Casp8f/f controls started about 2 h after surgery 
consistent with the time point of JNK1 phosphorylation. However, in Caspase-8 
deficient mice nuclear c-Jun translocation and phosphorylation was already evident 
0.5 h after surgery (Fig. 4.1.17 A-B) thereby suggesting that an earlier induction of 
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the JNK1/ c-Jun signaling pathway might contribute to an accelerated liver 
regeneration in these animals. 
 
Figure 4.1.17: Earlier phosphorylation and nuclear translocation of c-Jun in Casp8hep mice. (A) 
Immunofluorescence staining of phosphorylated c-Jun before and at distinct time points after PH. 
Phosphorylated c-Jun is stained in red; for determination of cellular c-Jun localization, the sections 
were counter stained with DAPI (blue). (B) Quantification of phosphorylated c-Jun positive cells 
relative to total amount of nuclei (DAPI) per 200x power field. Solid black lines represent Casp8hep; 
dashed grey lines represent Casp8f/f animals. Each time point represents the mean of 3-5 animals. 
   
As part of the transcription factor AP-1, c-Jun contributes to the gene 
regulation of Cyclin D1 leading to cell cycle entry and proliferation (Shen et al., 2008).  
To gain insight into the time dependent contribution of the c-Jun/ AP-1 transcription 
complex, primary hepatocytes of Casp8f/f control mice and Casp8hep animals were 
isolated and stimulated with recombinant murine TNF- for different time points. A 
mobility shift assay was performed using an AP-1 consensus binding site as a probe. 
In nuclear extracts derived from Casp8f/f hepatocytes, two slow migrating complexes 
were formed 2 h after TNF stimulation, which persisted at least until 6 h post 
treatment and could be super-shifted by using a c-Jun specific antibody (Fig. 4.1.18, 
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right lane). However, the same slow mobility complexes were evident in nuclear 
extracts from Casp8hep hepatocytes at all time points investigated including 
untreated samples, which suggests that in these cells c-Jun is,  at least at latent 
levels, constitutively activated.   
 
 
Figure 4.1.18: Accelerated and prolonged c-Jun/ AP-1 activation in TNF-stimulated primary 
hepatocytes lacking Caspase-8. Primary hepatocytes from the indicated mouse lines were 
stimulated with murine recombinant TNF (30 ng/ml) for the indicated time points. In the first lane the 
free probe without any protein was loaded as control. In the remaining lanes, 5 µg protein per sample 
were used for electrophoretic mobility shift assay. In the last lane (1 h + c-Jun) a protein extract of 
Casp8hep cells (1 hour after TNF stimulation) was incubated with 1 µl c-Jun antibody (Santa Cruz). 
Supershift of the respective slow migrating complex indicates specificity for c-Jun binding to the probe. 
Unspecific DNA/ Protein slow migrating complex formation is highlighted and was used as loading 
control.  
 
These findings suggest that activation of JNK and subsequent c-Jun 
phosphorylation exerts an important role in promoting G0 exit in hepatocyte-specific 
Caspase-8 KO mice after 2/3 surgery. 
 
4.1.7 Earlier complex-I formation after PH in mice lacking Caspase-8 
Next, the upstream mechanisms leading to accelerated JNK1- and c-Jun 
activation in Casp8hep mice were investigated in more detail with a focus on the 
analysis of complex-I composition. It is generally accepted that TNF- binding to its 
receptor TNF-R1 after PH mediates the formation of complex-I consisting of the 
adaptor protein TRADD, the adaptor kinase RIP1 and the receptor associated factor 
TRAF2.  RIP1 and TRAF2 were shown to be crucial for recruitment and activation of 
NF-B and JNK to complex-I. Thus, in the first instance the expression profile of 
RIP1, TRADD, TRAF2 and FADD in Casp8hep mice shortly after PH was evaluated 
and compared to Casp8f/f controls. 
4 Results 
 
71
Deletion of Caspase-8 resulted in constitutive expression of RIP1 at basal 
level with further up-regulation immediately after PH (0.5 h and 1 h post surgery, Fig. 
4.1.19). In contrast, RIP1 was not expressed in untreated control mice but displayed 
a pronounced expression peak 2 h post PH. TRAF2 expression in Caspase-8 deleted 
mice occurred already in untreated animals at significant levels and further increased 
until 1.5 h after liver resection while control littermates had their expression maximum 
at later time points (2-4 h after surgery, Fig. 4.1.19). However, the protein expression 
of the adapter molecule TRADD did not differ between both groups. In agreement, 
the adaptor molecule FADD, which is essential for formation of complex-II, was also 
expressed at constitutive levels in Casp8hep and Casp8f/f mice.  
 
 
Figure 4.1.19: Hepatocyte-specific Caspase-8 deletion results in enforced expression of 
complex-I components in the liver after PH. Immunoblot analysis of liver protein extracts from 8 
weeks old Casp8hep mice and Casp8f/f controls after PH using antibodies specific for RIP1, TRAF2, 
TRADD and FADD. GAPDH expression was determined as loading control.  
 
To investigate if the modulated expression profile of complex-I components in 
Casp8hep mice might also result in a modified complex-I formation, eventually 
culminating in earlier cell cycle entry, interactions of related proteins in co-
immunoprecipitation experiments were analyzed (Fig. 4.1.20). Interestingly, a slight 
association of JNK with TRAF2 was already detectable at basal levels in Casp8hep 
animals further increasing 0.5 – 4 h after surgery, whereas in controls significant 
association of JNK to TRAF2 was first evident 1 h after PH. Of notice, the overall 
amount of JNK protein bound to TRAF2 was higher in Casp8hep compared to 
controls for all time points investigated. 
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Analysis of TRADD - JNK interactions demonstrated significant differences 
among the two groups. In Casp8f/f controls, maximal but transient JNK1 recruitment 
to TRADD occurred between 2h and 6h after PH. Surprisingly, Casp8hep mice 
revealed constitutive and strong complex formation throughout all time points 
analyzed (0 - 6 h after liver resection, Fig. 4.1.20). Nevertheless, this approach could 
not distinguish between a direct or indirect (adaptor-mediated) JNK – TRADD 
interaction. In addition, the potential association of TRAF2 with the Caspase-8 – 
antagonist cFLIP was analyzed. In Casp8f/f control mice, a physical interaction 
between cFLIP and TRAF2 was first evident 4 - 6 h after surgery whereas in 
Casp8hep mice cFLIP – TRAF2 complexes were detectable immediately after PH 
(0.5 – 2 h post PH, Fig. 4.1.20). Moreover, it could be demonstrated that FADD and 
TRADD constitutively associated in both groups.    
 
 
 
Figure 4.1.20: Deletion of Caspase-8 leads to earlier assembly of complex-I components after 
surgery. Immunoprecipitation experiment of liver protein extracts from 8 weeks old Casp8hep and 
Casp8f/f mice with antibodies against TRAF2, TRADD, or FLIP was performed to investigate 
differential complex formation in the two genotypes. This was followed by immunoblot analysis using 
antibodies against JNK, TRAF2 and FADD  
 
           These data provides evidence that apart from its pro-apoptotic function, 
Caspase-8 might also serve as a signaling molecule responsible for the regulation- 
and formation of complex-I. Thus, ablation of Caspase-8 before PH results in 
accelerated RIP1 expression, constitutive or enhanced recruitment of JNK1 and 
cFLIP to complex-I and consequently a faster activation of NF-B and c-Jun. These 
transcription factors might then – alone or in a synergistic manner, drive accelerated 
induction of the Cyclin D promoter.  
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4.1.8 Simultaneous ablation of IKK/ NEMO in Casp8hep mice restores 
normal onset of hepatocyte proliferation after PH 
It had recently been shown that TNF- dependent NF-B activation in the liver 
is dependent on functional IKK/ NEMO. Ablation of NEMO in NEMOhep mice 
completely abolished NF-B activation in vivo or in primary hepatocytes after TNF- 
stimulation resulting in a serious spontaneous phenotype including massive liver 
apoptosis and hepatocarcinogenesis (Beraza et al., 2009; Luedde et al., 2005)  
The previous data leaded to the working hypothesis that a knockout of 
Caspase-8 results in a modulated TNF- mediated signaling with enhanced or 
accelerated NF-B and/ or JNK activation and corresponding Cyclin D induction. To 
further verify this idea, Caspase-8hep mice were crossed with NEMOhep animals with 
the aim to investigate respective Casp8hepNEMOhep double knockout mice during 
liver regeneration after PH. 
It has to be noted that Casp8hepNEMOhep mice revealed a novel phenotype 
involving liver cholestasis which was not observed in either single knockout strain (C. 
Liedtke, J. Freimuth et al., unpublished data). However, the molecular 
characterization of this phenomenon was beyond the scope of this study and will be 
described elsewhere.  
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Analogous to the earlier experiments Casp8hepNEMOhep mice and respective 
Casp8f/fNEMOf/f control littermates were subjected to PH and analyzed for G0-G1 cell 
cycle initiation, progression and liver regeneration. Interestingly, expression of Cyclin 
D1 mRNA during the time course of liver regeneration did not show any difference 
between both groups at time points between 24 h and 6 weeks after hepatectomy 
(Figure 4.1.21) indicating that simultaneous ablation of Caspase-8 and NEMO might 
convert the phenotype observed in Casp8hep single knockout animals. 
 
 
Figure 4.1.21: Additional ablation of NEMO abrogates the aberrant Cyclin D expression profile 
in Casp8hep mice after PH. Casp8f/fNEMOf/f control animals and Casp8hepNEMOhep double 
knockout mice were subjected to PH and sacrificed at the time points indicated. The Cyclin D 
expression was determined by real-time PCR. The Cyclin D1/  GAPDH expression ratio was 
determined for each time point and calculated as fold induction in comparison to untreated controls.  
Solid black lines represent Casp8hepNEMOhep; dashed grey lines represent Casp8f/fNEMOf/f animals. 
Results are expressed as mean of at least 4 animals per group; error bars indicate SD. 
 
Onset of DNA synthesis was further determined by measurement of BrdU 
incorporation in Casp8f/fNemof/f and Casp8hepNEMOhep mice between 24 h and 2 
weeks after liver resection (Fig. 4.1.22). 
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Ablation of both Caspase-8 and NEMO abrogated the earlier onset of DNA 
synthesis as observed in Casp8hep mice, but resulted in a reduced DNA synthesis at 
the expression peak. Casp8f/fNemof/f controls had a single pronounced maximum of 
DNA-synthesis 40 hours after surgery with 40 % of BrdU-positive hepatocytes. 
Although the maximum of proliferation in Casp8hepNEMOhep mice was also evident 
40 h after PH, in this group only 20 % of hepatocytes were in S-phase.  
 
 
Figure 4.1.22: DNA synthesis in hepatocytes after PH is blunted in Casp8hepNEMOhep mice. 
BrdU staining of liver sections from Casp8hepNEMOhep and control animals after PH. green: 
Immunofluorescence labeled nuclei for BrdU, blue: co-staining for nuclei with DAPI. Quantification of 
BrdU-positive cells relative to total number of nuclei (DAPI) per 200x power field. Solid black lines 
represent Casp8hepNEMOhep; dashed grey lines represent Casp8f/fNemof/f animals. Results are 
expressed as mean of at least 4-5 animals per group; error bars indicate SD. 
 
Interestingly, the Cyclin A expression profile of Casp8hepNEMOhep mice was 
remarkably different from controls or Casp8hep animals showing increased basal 
expression levels, delayed onset of Cyclin A induction as well as an unexpected 
prolonged Cyclin A expression up to 2 weeks after PH (Fig. 4.1.23) However, it 
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needs to be mentioned that Cyclin A is not only a marker for S-phase but is also 
necessary for G2-M phase transition.  
 
Figure 4.1.23: Shifted expression of S-phase marker Cyclin A in Casp8hepNEMOhepmice after 
PH. Significant delay was observed in Cyclin A mRNA expression in double KO mice compared to WT 
animals, while after 2 weeks mRNA levels were still high. Solid black lines represent 
Casp8hepNEMOhep; dashed grey lines represent Casp8f/fNEMOf/f animals. Results are expressed as 
mean of at least 4 animals per group; error bars indicate SD. 
 
Determination of liver/ body weight ratio displayed a significant increase in 
Casp8hepNEMOhep mice compared to Casp8f/fNemof/f controls 6 weeks after PH. 
However, at earlier time points between 24 h and 2 weeks no differences were 
detectable between the two groups (Fig. 4.2.24). 
  
 
Figure 4.2.24: Increased liver/ body weight ratio in Casp8hepNEMOhep 6 weeks after partial 
hepatectomy. Comparison of liver/ body weight ratio between Casp8f/fNEMOf/f and 
Casp8hepNEMOhep mice displayed a significant difference 6 weeks after PH.  Solid black lines 
represent Casp8hepNEMOhep; dashed grey lines represent Casp8f/fNEMOf/f animals. 
 
 
These findings indicate that an earlier induction of S-phase in Casp8hep mice 
might be at least in part due to over-activation of NF-B dependent signals.
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4.2 Application of Magnetic Resonance Imaging in mice 
4.2.1 Rationale for the study 
The previous experiments clearly indicated that depletion of Caspase-8 in the 
liver results in accelerated onset of S-phase initiation and cell cycle progression due 
to enhanced and prolonged NF-B and c-Jun/AP-1 activation. These findings raised 
the question whether Caspase-8 inactivation in hepatocytes might also result in 
increased hepatocarcinogenesis induced by a second stimulus such as over-
expression of the proto-oncogene c-myc. This idea was supported by earlier findings 
showing that hepatocellular carcinomas (HCC) are frequently silenced for Caspase-8 
gene expression (Liedtke et al., 2005). Therefore, as part of this study, the tumor 
incidence of Casp8hepalb-myctg double transgenic mice should be evaluated and 
compared to single c-myctg animals in order to investigate, if Caspase-8 inactivation 
per se might have a tumor-promoting potential. 
However, recent approaches to measure and compare the tumor incidence 
and tumor progression between different transgenic mouse lines are problematic due 
to a lack of appropriate techniques and detection methods to monitor tumor initiation 
and tumor growth. Thus, recent reports rely on a huge amount of animals per group 
which have to be sacrificed at distinct time points for the measurement of tumor size. 
Subsequently, methods for the continuous monitoring of liver tumor growth in 
individual transgenic mice need to be developed.  
As requested properties an appropriate method has to be (i) non-invasive, (ii) 
highly sensitive to detect even small tumor nodes in mice and (iii) accessible to the 
investigator. These properties theoretically applied to Magnetic Resonance Imaging 
(MRI) techniques, which were available at the Department of Diagnostic Radiology 
(University Hospital Aachen). Therefore, at first a MRI protocol should be established 
to allow the monitoring of HCC in alb-myctg animals serving as a well defined tumor 
model with the ultimate aim to compare tumor development in alb-myctg – versus 
Casp8hepalb-myctg double transgenic mice.  
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4.2.2 Establishment of a standard protocol for the analysis of transgenic 
mice 
In clinical practice, MRI is used to visualize the internal structure of organs and 
tissue of the body with a special focus on neurological (brain), cardiovascular and 
oncological imaging. MRI has been found to be an effective method for detection of 
HCC in particular (Lauenstein et al., 2007). In comparison to ultrasound and 
computer aided tomography, MRI has proven to be more reliable when focal liver 
lesions have to be detected and characterized (Braga et al., 2004). This greater 
potential is based on a superior amount of diagnostic information by the assessment 
of T1- and T2-weighted sequences and the possibility of acquiring multiple 
sequences after injection of contrast media. 
However, in initial experiments and by optimizing several parameters, the 
application of a clinical MRI scanner to the monitoring of tumor initiation and 
development in the murine liver had to be intensively established. For evaluation of 
the initial settings and display of liver anatomy, wildtype mice at the age of 35 weeks 
were used. 
After the correct positioning of the mouse in the MRI scanner in the supine 
position (Fig. 4.2.1 A) a short localizer sequence (Tab. 4.2.1 no.1) was performed in 
order to plan the following sequences effectively. Based upon these images axial T1-
weighted and T2-weighted scans were planned (Tab. 4.2.1 no. 2 and 3). For better 
diagnostic purposes a sagittal FI2 3D true FISP (fast imaging in steady state 
precession) sequence and an axial Look Locker sequence (Tab. 4.2.1 no. 4 and 5) 
were added to the protocol. The later was performed in order to assess successful 
administration of contrast medium. The acquisition of all pre-contrast scans lasted 13 
minutes. After all pre-contrast scans had been performed the contrast medium was 
administered by tail vein catheter (Fig 4.2.1 B and C) for optimized lesion detection 
and the Look-Locker sequence as well as the T1-weighted sequence were repeated 
for analysis. The scan parameters have been optimized, so that structural elements 
of the liver, such as the vessels and the gall bladder could clearly be distinguished. 
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Figure 4.2.1: Positioning of a mouse in the 1.5 T MRI scanner and correct application of a tail 
vein catheter. (A) Correct positioning of the mouse inside the 1.5 T MRI indicated by the green arrow. 
(B) Demonstration of a representative anesthetized mouse fixed with all four limbs to a clean board. 
Tail vein catheter is applied before the first scans for proper contrast agent administration. (C) Close-
up view of tail-vein catheter. 
 
 
No 
Sequence 
type 
Plane TR/TE 
Thickness 
(mm) 
FOV 
(mm) 
Flip 
angle (°) 
Time 
1 FI2 MST 
axial,sagittal, 
parallel 
9.40/ 4.20 3.00 110.0 30 1:28.5
2 T2TSE axial 
1800.00/ 
110.00 
2.00 60.0 90 2:34.8
3 T1WFFE axial 253/ 6.7 2.00 45.0 80 4:58.3
4 Look-Locker axial 9.7/ 4.5 3.00 70.0 15 2:48.0
5 FI2 3D sagittal 9.40/ 4.20 1.50 80.0 30 1:03.2
 
Table 4.2.1: Settings for MRI sequences. Explanation of abbreviation are found in table 4.2.2. 
 
 
 
4 Results 
 
80
Flip the angle by which the magnetization vector is rotated around to 
an axis perpendicular to the main magnetic field during the RF 
excitation pulse 
 can be adjusted for an optimum contrast and/ or signal-to-
noise ratio 
FOV Field of view; specifies the area to be imaged 
RFOV rectangular FOV enables operator to define a non-square FOV, 
with the fold-over direction having the smaller dimension 
repetition time (TR) this parameter determines the user defined repetition time in spin 
echo sequences 
time to echo (TE) this parameter determines the excitation pulse (90°) of the same 
slice 
 
Table 4.2.2: Explanation of abbreviation in MRI settings 
 
One representative example for MRI aided imaging of a healthy murine liver 
after parameter optimization is demonstrated in Fig. 4.2.2. In T1-weighted images the 
liver has a higher signal intensity compared to T2-weighted scans. However, signal 
intensity from the entire liver parenchyma is homogeneous on both sequences 
indicating healthy liver tissue. In T1-weighted sequences fat and fat containing tissue 
(e.g. bone marrow) appear bright (hyperintense) and the structure of organs is clearly 
detectable. Therefore, in clinical use, T1-scans serve to demonstrate anatomical 
organ structure in humans. After optimization of scanning parameters the anatomical 
organ structure of mice could also be displayed in T1-weighted scans (Fig. 4.2.2 D). 
Images show clearly defined structure of right kidney (red arrow), the liver (middle 
panel) and beginning section of the murine heart (green arrow).  
The optimized standard protocol for MRI in mice included the use of contrast 
enhancing procedures. Therefore, a T1-weighted scan was collected before and after 
administration of contrast agent allowing better determination of pathological 
alterations within the tissue. Fig. 4.2.2 B shows a T1-scan of an un-enhanced murine 
liver.  The same liver after up-take of contrast agent is given in Fig. 4.2.2 D (middle 
panel) showing that up-take of i.v. injected contrast agent leaded to an evenly 
distributed marked signal enhancement in hepatic tissue resulting in a brighter 
appearance. 
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In T2-weighted sequences water- and fluid-containing tissues such as cysts or 
vessels are strongly demarcated from the surrounding tissue and have a bright 
appearance. Fig. 4.2.2 E clearly demonstrates the dark healthy liver parenchyma 
crossed by a hyperintense mesh-work of connective blood vessels (blue arrow).  
 
 
Figure 4.2.2: MR images of a healthy liver from a 35 weeks old WT mouse using a 1.5 Tesla MRI 
scanner. (A) Healthy liver from 35 weeks old mouse after resection. (B) T1-weighted fast field echo 
image of a healthy mouse liver (C) Sagittal Fast Imaging with Steady state Precession (FISP) images 
of respective liver. (D) Distinct images of T1-weighted sequence after application of contrast agent. 
Clearly defined structure of different organs (red arrow: right kidney; green arrow: heart) are visible (E) 
Distinct images of healthy mouse liver using T2-weighted sequence, specifically sensitive to water 
content. Blue arrow pointing to mesh-work of blood vessels. Orientation labeling: R: right; L: left; H: 
head; A: anterior; P: posterior; F: foot 
 
4.2.3 Application of MRI on tumor susceptible alb-myc transgenic mice 
Hepatocyte-specific, c-myc transgenic mice (alb-myctg) are a well established 
animal model for hepatocarcinogenesis. These animals develop slow growing liver 
tumors similar to a group of human HCCs with better prognosis and survival (Lee et 
al., 2004). As a starting point of this study, the age-dependent tumor incidence of alb-
myctg mice was determined showing less than 40 % of HCCs in 45 weeks old 
animals, whereas 80 % of the 65 weeks old mice had a minimum of one liver tumor 
or more (Fig. 4.2.3) which is comparable to earlier findings (Thorgeirsson et al., 
1997). 
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Figure 4.2.3: Tumor incidence of hepatocyte-specific c-myc transgenic mice at the age of 45 – 
65 weeks. Tumor incidence in alb-myctg mice used in this study. A subset of animals was sacrificed at 
the age of 45 weeks (alb-myctg: n= 20), 55 weeks (alb-myctg: n= 10) and 65 weeks (alb-myctg: n= 16), 
respectively. The extracted livers were analyzed for macroscopically visible tumor nodes. Tumor-
positive mice were defined as animals with a minimum of one tumor node with a diameter ≥1 mm. 
 
Therefore, to proof whether the previously optimized MRI parameters (Tab 
4.2.1) are sufficient to detect HCCs, an initial set of experiments was performed with 
a group of n= 24 alb-myctg mice at the age of 65 weeks and a predicted tumor 
probability of 80 %. Following contrast enhanced T1-weighted imaging and 
comparison with respective T2-weighted scans in 15 out of 18 animals pathologically 
conspicuous areas were detected in sections which could clearly be allocated to the 
liver. A representative example is shown in Fig.4.2.4.  
The T1-weighted contrast-enhanced sequence (Fig. 4.2.4 A) indicates 
extensive tumor invasion throughout the entire left hepatic parenchyma. The 
hypervascular nature and the inhomogeneous internal structure of the tumor stroma 
are important criteria in the differential diagnosis of this liver compared to the even 
texture of a healthy animal (compare Fig. 4.2.2). Furthermore, sagittal FI2 3D true 
FISP sequence displays a strong malformation of the liver (Fig. 4.2.2 B) in 
comparison to the healthy liver described in chapter 4.2.2. A representative slide of 
the T2-weighted sequence shows the dark liver parenchyma together with the 
isointense tumor node of the left hepatic lobe (Fig. 4.2.4 C).  Final confirmation of the 
diagnosed HCC was obtained upon surgical removal and macroscopical analysis of 
the liver as depicted in Fig. 4.2.4 D. These initial findings indicate clearly that the 
developed MRI protocol is applicable to display tumor formation in the murine liver. 
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Figure 4.2.4: Detection of advanced HCC in Mice (A) After i.v. injection of the extracellular contrast 
agent Primovist®, irregular structure of tumor becomes obvious in T1-weighted scan. The carcinoma 
is visible as hypointense foci spread over the organ, due to lack of accumulation of the contrast 
medium. The surrounding hepatocytes have taken up the agent, which is then present in the 
intracellular space and causes reduction of T1 relaxation time. (B) Sagittal FI2 3D true FISP clearly 
shows strong malformation of the liver and (C) T2-weighted scan demonstrates the same tumor as an 
isointense area covering the left hepatic lobe. Red dashed line indicates large tumor (A – C). (D) 
Macroscopic appearance of the respective liver after surgical removal confirms large HCC covering 
the left part of the liver of an alb-myctg mouse at 65 weeks of age. White dashed line indicates large 
tumor. Orientation labeling: R: right; L: left; H: head; A: anterior; P: posterior; F: foot 
 
4 Results 
 
84
4.2.4 Comparison of a non-specific with a hepatocyte-specific contrast 
agent 
The need for more accurate characterization of all histological types of liver 
lesions and for detection of the full extent of malignant liver lesions have been major 
reasons for the use of intravenous contrast agents. 
Currently there are several contrast media used in clinical practice. For 
optimized murine liver imaging the use of two distinct contrast agents was tested and 
compared. In 1988 Magnevist® had been approved as the first contrast agent for 
MRI and it is still applied for diagnostics of focal liver lesions, inflammatory diseases 
and angiographic studies. Magnevist® is an extracellular non-specific contrast agent 
with a rapid distribution throughout the vascular system and the extracellular space. 
In contrast, Primovist® is a novel contrast agent highly selective for hepatocytes. As 
a starting point of this study, both contrast agents should be tested in mice and 
evaluated for their benefits in imaging of murine HCCs. For this approach alb-myctg 
mice at the age of 65 weeks with high tumor incidence (Fig. 4.2.3 -Tumor incidence) 
underwent MRI analysis by using both contrast agents, which were applied by i.v. 
injection of the tail vain using a catheter with injection port.  During this approach, 
animals were first scanned using Primovist® and two weeks later the same mice 
were subjected again to MRI using Magnevist®. Each time a pre-contrast T-1 
weighted scan was performed first to ensure optimal contrast up-take. Figure 4.2.5 
shows images of a representative mouse with HCC investigated under the three 
different conditions without contrast-enhancement, with Primovist®-enhancement 
and with Magnevist®-enhancement two weeks later. The unenhanced T1-weighted 
image (Fig. 4.2.5 A) has a slightly hyperintense appearance compared to surrounding 
tissue (white dashed line). Inside the tumor stroma a hypointense, round lesion is 
visible. After up-take of Primovist® a hyperintense signal emitted by the entire left 
liver lobe could be monitored. In addition to the hypointense signal of the pre-contrast 
scan, a second hypointense area became obvious with strong indication for a liver 
cyst (Fig. 4.2.5 B, green arrow).  
T1-weighted Magnevist®-enhanced scans (Fig. 4.2.5 C) displayed an 
isointense tumor tissue compared to the healthy liver. Contrast-enhancement was 
overall weaker compared to Primovist® application and signals predicting a potential 
liver cyst could not be detected at all. 
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In order to validate the imaging results obtained with the two contrast agents, 
analogue T2-weighted and sagittal FI2 3D true FISP sequences were analyzed. 
Additionally, these animals were sacrificed after the second MRI analysis and the 
liver was macroscopically investigated. With MRI hepatic cysts appear hypointense 
on T1-weighted images without up-take of contrast agent and homogeneously 
hyperintense on T2-weighted scans (compare Fig. 4.2.5 B and D). Compared to 
hypointense tumors in sagittal FI2 3D true FISP sequences cysts present a clearly 
delineated, rounded structure which was also evident in Fig. 4.2.5 E.  In summary, it 
was proven that the representative mouse liver analyzed in Fig. 4.2.5 A-F comprised 
a large HCC invading the entire left hepatic lobe as well as a liver cyst embedded 
inside the tumor stroma (Fig. 4.2.5 F). 
These initial experiments demonstrated that the use of Primovist® mediated 
contrast enhancement might be more suitable for the monitoring of murine 
hepatocarcinogenesis by MRI compared to Magnevist® and was thus exclusively 
used for further studies. 
 
 
Figure 4.2.5: Comparison of contrast agents in murine livers. (A-F) Alb-myctg mice at the age of 
65 weeks with high tumor incidence were first investigated in a T1-weighted MRI scan followed by 
immediate application of Primovist® (i.v.) and a subsequent second MRI scan. Two weeks later, the 
same animals were treated with Magnevist® and again subjected to MRI. For each figure, the same 
section plane is shown. A representative mouse from a set of experiments is depicted. The left panel 
shows the murine liver of an un-enhanced T1-weighted scan. (A) A lesion invading the entire left lobe 
appears slightly hyper- to isointense (dashed white line) with a dark area inside. (B) T1-weighted scan 
was taken the same day, contrast enhanced with hepatocytes-specific Primovist®. The lesion appears 
clearly hyperintense compared to surrounding tissue with a well-defined hypointense liver cyst inside 
the lesion (green arrow). (C) T1-weighted scan of the same mouse using Magnevist®-mediated 
contrast enhancement. The contrast between lesion and healthy parenchyma appears weak. In 
addition, dark hypointense signals indicating a liver cyst (compare with B, green arrow) is barely 
visible. D) T2TSE image of the liver clearly demonstrates hyperintense cyst (green arrow) inside an 
HCC which invades the entire left side of the hepatic lobe (E) FI2 3D true FISP demonstrates 
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malformation of the liver in sagittal axis. Hyperintense area pointed out by the green arrow represents 
the cyst inside the tumor stroma (F) Macroscopic image of the left hepatic lobe confirms existence of 
the HCC (dashed white line, A+F) and the cyst indicated by green arrow (B, D-F). Orientation labeling: 
R: right; L: left; H: head; A: anterior; P: posterior; F: foot 
 
4.2.5 Hypointense MR signals in livers of alb-myc transgenic mice 
corresponds to highly tumorigenic tissue section with strong 
proliferation capacity  
In the next step it should be demonstrated that signal abnormalities in murine 
livers following MRI indeed corresponded to carcinogenic lesions by correlating the 
imaging results with histological and molecular findings. Of notice, this approach is 
usually not possible with human patients but restricted to animal models. 
65 weeks old animals showing MR signals related to HCC (Fig. 4.2.6 A) were 
sacrificed and their livers immediately perfused with 4 % formaldehyde for in situ 
fixation of the organ. Remarkably, 100 % of animals with radiological indication for 
liver tumors showed also macroscopically clear signs of strong HCC development 
(Fig. 4.2.6 B). Before liver sampling, the orientation of all liver lobes relative to the 
longitudinal, transversal and sagittal axis of the animals were marked and the 
respective, complete liver was embedded in paraffin and used in routine diagnostic 
procedures. Through this approach the liver could be fixed in a three-dimensional 
orientation which was absolutely identical to the in vivo orientation before. These 
samples were then sectioned in the axial orientation, thus completely comparable to 
the MR plane of the T1- and T2 sequences. Interestingly, these crude paraffin 
sections already showed strong similarity with the MR imaging results as hypointense 
signals were completely congruent with striking tissue abnormalities in the paraffin 
slides (compare Fig. 4.2.6 A and C). Hematoxylin/ Eosin staining of whole liver 
sections confirmed that hypointense MR signals corresponded to a pathological liver 
architecture (Fig. 4.2.6 D-F). Direct comparison of MR images and histologies 
revealed that the MRI was able to detect internal liver tumor nodes with diameters of 
2 mm. A detailed histological analysis of the tumor-transformed liver tissue was 
performed by Prof. N. Gaßler (Institute of Pathology, UK Aachen)  and revealed 
characteristics of hepatocellular neoplasia with some features of hepatocellular 
carcinoma (Fig. 4.2.6 F). Histomorphological stigmata for neoplastic growth of 
hepatocytes were nodular arrangement of cells variable in size and nuclear 
configuration, a macrotrabecular pattern of tumor cells, increased mitotic activity, 
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atypical mitosis, destruction of both portal areas and liver lobules, and, occasionally, 
starting of vascular infiltration with thinning of the vascular vessel wall.  
Proliferating Cell Nuclear Antigen (PCNA) is an essential factor for initiating 
DNA synthesis and thus an established marker for proliferating cells. In order to 
definitely prove that positive signals identified by MRI correspond to 
hyperproliferative, tumorigenic nodules, whole liver sections were stained for nuclear 
PCNA expression (Fig. 4.2.5, G-H). Strong accumulation of PCNA-positive cells was 
evident exclusively in areas corresponding to liver regions with hypointense signals in 
MRI analysis (compare Fig. 4.2.5, A, G and H).  
In summary, these experiments demonstrated that MRI of the murine liver can 
specifically detect dysplastic nodules with strong hepatocyte proliferation. 
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Figure 4.2.6: Hypointense MR signals in livers of alb-myc transgenic mice correspond to highly 
tumorigenic tissue sections with strong proliferation capacity. (A) T1-weighted liver MR image of 
a 65 weeks old male alb-myctg mouse after i.v. application of Primovist®. Sharply demarcated multiple 
hypointense foci become obvious within hepatic lobes due to contrast up-take of surrounding hepatic 
tissue (indicated by arrows); one lesion (white circle) was followed up in subsequent analyses. (B) 
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Macroscopic appearance of explanted liver showing multifocal and sometimes multinodular tumor 
growth characterized by enhanced vascularization, discoloration, and destruction of liver segments. 
(C) Paraffin-embedded section of the complete mouse liver shown in B. Please note that these serial 
sections were performed in the same transversal orientation as performed for the MR imaging shown 
in A. White circle: macroscopically visible tissue abnormality corresponding to hypointense signal as 
highlighted in A. (D) HE staining of the liver section shown in C. White circle highlights one selected 
neoplastic lesion surrounded by normal liver tissue. Scale bar indicates diameter of the lesion (mm). 
(E) enlarged view of mouse liver with lesions in HE staining (G) PCNA (Proliferation Cell Nuclear 
Antigen; brown nuclei) staining of liver tissue as a marker for cell proliferation demonstrates DNA 
synthesis only in areas identified as HCC and (H) close-up view (200x magnification) of tumorous 
areas in PCNA staining. black arrows indicate PCNA positive nuclei; dashed black line separates 
healthy liver tissue from HCC; Orientation labeling: R: right; L: left 
 
4.2.6 Monitoring of HCC progression 
A further prerequisite for the application of MRI in murine tumor studies of the 
liver was the option to monitor the tumor growth of HCCs in mice and the respective 
comparison of tumor size in different animals. Therefore a periodical MR imaging was 
performed in a cohort of alb-myctg animals starting at the age around 45 weeks. The 
animals were monitored every 5 weeks and the tumor growth of detected HCCs was 
analyzed by measuring liver and tumor volume using View Forum software (Philips). 
Tumor measurement was performed on the basis of T1-weighted contrast-enhanced 
scans. Figure 4.2.7 A is a representative example of a T1-weighted contrast-
enhanced (left panel) and a T2-weighted sequence (right panel) of a 47 weeks old 
mouse with three distinct tumor nodes. Measurement of the median nodule 
demonstrated a volume of 0.4 cm3. Time-dependent monitoring revealed that the size 
of this nodule increased only slightly up to 58 weeks of age followed by a duplication 
of tumor size between 58-63 weeks of age (Fig. 4.2.7 B) which corresponded to the 
increase of total liver volume (Fig. 4.2.7 C). These findings demonstrate that alb-myc 
transgenic HCCs are slow progressing tumors as strong tumor progression is 
restricted to old animals which is in good agreement with earlier reports (Lee et al., 
2004). 
 
In summary it could be demonstrated that the protocol established in this study 
in combination with the available technical equipment allows the measurement and 
comparison of tumor progression among diverse types of transgenic mice (compare 
chapter 4.3). 
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Figure 4.2.7: Monitoring of HCC progression in c-myc transgenic mice. (A) Periodical 
measurement of tumor growth in a mouse liver at 47, 52, 58 and 63 weeks of age in T1-weighted 
contrast enhanced and T2-weighted sequences. Red circle: tumor node measured for volumetric 
statistics. (B) Chronological progression of tumor growth within 15 weeks demonstrated on one 
representative tumor node. (C) Measurement of increasing mouse total liver volume within 15 weeks. 
Median of three independent measurements is shown. Orientation labeling: R: right; L: left 
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4.2.7 Limitations for the detection of small liver tumors in transgenic 
mice 
The previous data showed that MRI is a potent method to monitor HCC 
progression even in small rodents. However, for the comparison of different 
transgenic mouse strains with respect to hepatocarcinogenesis, the method of choice 
should also be applicable for the monitoring of tumor initiation. Therefore the final aim 
of this study was to determine the smallest size of nodules in murine livers, which are 
already detectable on 1.5 T MRI scans. To meet this approach, 33 animals in the age 
between 45 – 57 weeks (tumor incidence of approximately 50 %) were scanned by 
MRI and checked for hypointense signals in contrast-enhanced T1-weighted images. 
Immediately after MRI the animals were sacrificed and the respective livers were 
macroscopically and histologically analyzed for HCCs. The size and location of the 
macroscopic tumor nodes was measured and correlated to the MRI findings. Overall 
22 out of 33 animals with evidence of hypointense signals in contrast-enhanced T1-
weighted images displayed tumor nodes with a size between 2 and 10 mm of 
diameter. 
The data for one representative animal is shown in Fig 4.2.8. Liver lesions 
could be identified only dimly on T1-weighted scan before contrast-enhancement 
(Fig. 4.2.8 A) while on the sagittal FI2 3D un-enhanced scan (Fig. 4.2.8 D) two 
hyperintense areas are already visible. However, after application of contrast agent 
(Fig. 4.2.8 B) multiple hypointense signals patterns appeared in the scan of the right 
hepatic lobe. Direct comparison of the T1 contrast-enhanced signals with the T2-
weigthed sequence (Fig. 4.2.8 C) demonstrated 100 % accordance of the signals. 
Following resection and macroscopic analysis of the respective liver lobes, the size of 
macroscopic tumor nodules was measured and correlated to the size of hypointense 
MRI signals as determined by View Forum software (Philips) (compare Fig. 4.2.8 B 
and E) revealing that murine tumor nodes in the liver could be identified by MRI 
beginning with a diameter of 2 mm. 
Of note, out of all MRI monitored animals between 45 and 65 weeks of age we 
could detect 100 % of tumors with a size bigger than 4 mm of diameter. While on the 
other hand nodules with a size of 4 mm of diameter or smaller 71 % were detectable 
by MRI. 
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Figure 4.2.8: Detection of a nodule with 2 mm diameter in an alb-myc transgenic mouse. (A) In 
the unenhanced T1-weighted fast field echo image of a murine liver the lesions can be identified only 
faintly. (B) Sagittal Fast Imaging with Steady state Precession (FISP) image demonstrates slightly 
hyperintense lesion signals indicated by green arrows. In the contrast enhanced T1 scan (C) of the 
right hepatic lobes it appears multiple slightly hypointense lesions (green arrow) These lesions cannot 
be seen with certainty on the pre-contrast scan (A). (D) In the T2-weighted scan hyperintense space-
occupying lesions can be seen in a murine liver indicated by green arrows. (E) Surgical situs. View of 
two hepatic lobes. Visualization of four nodules (green arrows) with 2 mm of diameter within normal 
liver tissue. Of note, corresponding signals were made visible by FI2 3D (see B) T1-weighted contrast 
enhanced, (see C) and T2-weighted (see D) MR images but not in unenhanced T1-weighted image 
(see A). Labeling of orientation: R: right; L: left; H: head; A: anterior; P: posterior; F: foot 
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4.3 The role of Caspase-8 for hepatocarcinogenesis and tumor 
progression in the liver 
4.3.1 Delayed onset but accelerated tumor progression in Casp8hepalb-
myctg mice 
Caspase-8 transcription and expression is frequently repressed in murine 
hepatocellular carcinomas (HCC) derived from several transgenic mouse strains 
including c-myc transgenic mice (Liedtke et al., 2005; Soung et al., 2005b), 
supporting the hypothesis that inhibition of apoptosis may trigger 
hepatocarcinogenesis. Nevertheless, it is still unclear whether a lack of Caspase-8 
per se contributes to the initiation or to progression of HCC.  Hence, to address this 
question, Casp8hep mice were crossed with hepatocyte-specific c-myc transgenic 
animals (alb-myctg) and monitored for changes in liver volume and HCC progression 
by applying MRI technique. In the previous chapter of this work (compare 4.2.3) it 
was demonstrated that the tumor incidence of c-myctg animals at the age of 45 weeks 
was around 40 %. Analysis of 55 weeks old alb-myctg mice displayed an age-
depending increase of 60 %, whereas by the age of 65 weeks 75 % of the animals 
had developed a minimum of one liver tumor (Fig. 4.2.3).  
In the present paragraph the previous findings in c-myctg animals should be 
compared with Casp8hepalb-myctg mice to definitely evaluate the effect of Caspase-8 
ablation for hepatocarcinogenesis.   
In general, the tumor incidence in Casp8hepalb-myctg mice was below the 
value for alb-myctg animals for all time points investigated (Fig. 4.3.1 A). Forty-five 
week old Casp8hepalb-myctg mice displayed only approximately 50 % of the tumor 
incidence seen in alb-myctg animals (20 % compared to 40 % in alb-myctg mice; Fig. 
4.3.1 A), whereas 55 weeks old Casp8hepalb-myctg animals already had 2/3 of the 
tumor incidence seen in the alb-myctg reference group. However, 65 week old 
animals of both groups showed a similar frequency of tumor development (68 % in 
the Casp8hepalb-myctg group compared to 75 % in c-myctg animals; Fig. 4.3.1 A), 
indicating that between 55 and 65 weeks of age Casp8hepalb-myctg animals are 
characterized by accelerated hepatocarcinogenesis. 
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However, comparison of the tumor size between both groups indicated an 
interesting feature of Casp8hepalb-myctg tumors. Between the age of 45 and 55 
weeks the average tumor size of Casp8hepalb-myctg mice increased only from 2.5 
mm to 3.9 mm in diameter and was significantly smaller in comparison to nodules 
detected in the alb-myctg group. Surprisingly, between 55 - 65 weeks of age the size 
of the nodules had more than doubled (8.3 mm) in animals lacking Caspase-8, 
whereas  alb-myctg animals did not display any further increase in tumor growth in the 
same time frame (Fig. 4.3.1 B).  
Fig. 4.3.1 C demonstrates the median number of tumor nodules found in all 
mice at the age of 45, 55 and 65 weeks, respectively, including those without any 
signs of carcinogenesis. Comparison of alb-myc transgenic mice with Casp8hepalb-
myctg animals displayed an age-depending increase in tumor numbers/per mouse. 
Nevertheless, differences between the two genotypes were not significant.  
Between the age of 45 and 55 weeks the average tumor size in Casp8hepalb-
myctg mice increased only from 2.5 mm to 3.9 mm in diameter and was significantly 
smaller in comparison to nodules detected in the alb-myctg group. Surprisingly, 
between 55 - 65 weeks of age the size of the nodules had more than doubled (8.3 
mm) in animals lacking Caspase-8, whereas  alb-myctg animals did not display any 
further increase in tumor growth in the same time frame (Fig. 4.3.1 B).  
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Figure 4.3.1: Comparison of tumor incidence, tumor size and number of Casp8hepalb-myctg and 
alb-myctg mice at the age of 45, 55 and 65 weeks. (A) Tumor incidence in alb-myctg and 
Casp8hepalb-myctg mice were used in this study. A subset of animals was sacrificed at the age of 45 
weeks (alb-myctg n=21; Casp8hepalb-myctg n=13), 55 weeks (alb-myctg n=11; Casp8hepalb-myctg 
n=23) and 65 weeks (alb-myctg n=16; Casp8hepalb-myctg n=22), respectively. The extracted livers 
were analyzed for macroscopically visible tumor nodes. Tumor-positive mice were defined as animals 
with a minimum of 1 tumor node with a diameter ≥1 mm. (B) Maximal tumor size in alb-myctg and 
Casp8hepalb-myctg animals was determined by measuring the largest nodule found in the individual 
liver. (C) The total number of nodules of each alb-myctg and Casp8hepalb-myctg mouse between 45 
and 65 weeks of age was determined and is indicated as individual value and median (purple bar). 
 
The previous data indicated that Casp8hepalb-myctg mice display a strongly 
accelerated tumor growth beginning 55 weeks of age in comparison to slow growing 
alb-myctg tumors. To further support these findings, tumor growth of both groups was 
also monitored by periodical MRI measurements.  
 
Fig. 4.3.2 shows a representative comparison of tumor growth in alb-myctg (left 
panel) versus Casp8f/falb-myctg (right panel) mice in a contrast-enhanced T1 
weighted MRI. Periodical HCC analysis of an alb-myctg mouse between the age of 55 
and 65 weeks depicted only a slight increase in size as shown in Figure 4.3.2 
consistent with earlier reports describing c-myc transgenic mice as a model for slow 
growing tumors (Lee et al., 2004). In sharp contrast, the right panel displays a 
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contrast-enhanced T1-image of a Casp8hepalb-myctg mouse demonstrating a tumor 
nodule with a diameter of approximately 2 mm at the age of 55 weeks which showed 
a 5 fold increase to a diameter of 10 mm ten weeks later. 
 
Figure 4.3.2: Comparison of tumor growth in an alb-myctg versus a Casp8hepalb-myctg mouse 
by MRI. T1-weighted contrast-enhanced MRI sequences of a HCC in an alb-myctg mouse at the age 
of 55 and 65 weeks in comparison to a HCC of a Casp8hep alb-myctg at the same age. On the x-axis 
two different section planes of the same sequence are shown. The MRI scan revealed the slightly 
hyperintense tumor mass compared to the residual liver parenchyma.  
 
A detailed histological analysis of resected, presumed HCC tissue from alb-
myctg and Casp8hepalb-myctg mice was performed by an experienced liver 
pathologist (N. Gassler, Institute of Pathology, UK Aachen). Tumorous tissue of both 
groups was characterized by expansive growth, a higher nuclear to cytoplasmic index 
compared to hepatocytes in non-tumor areas (Fig. 4.3.3) and complete absence of 
portal tracts in both genotypes. Furthermore an increase of cellularity and mitotic 
figures was observed inside the HCC. 
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Figure 4.3.3: Representative HE-stained histological sections of livers from 65-weeks old mice 
displaying healthy tissue next to HCC. Tissues of alb-myctg (left) and Casp8hepalb-myctg (right) 
livers show strong anisokaryosis, increased mitotic bodies (MB) and higher nuclear-to-cytoplasmic 
ratio (N/C) as signs of large-cell dysplasia. Dashed black line indicates cellular border between 
tumorous and non-tumorous liver tissue. PV: Portal vein. 
 
In summary, these data indicate that ablation of Caspase-8 might have a 
protective effect on tumor initiation in c-myc over-expressing livers, but also leads to 
accelerated tumor progression as soon as tumor formation is initiated.   
   
4.3.2 Differential expression of pro-apoptotic genes in Casp8hepalb-myctg 
mice 
To better understand the mechanism leading to a delayed HCC initiation but 
accelerated progression in Casp8hepalb-myctg mice compared to alb-myctg animals, 
the gene expression of some pro-apoptotic genes also involved in tumorigenesis 
were analyzed.  
The most prominent candidate for tumor selective death receptor-activation is 
the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL ligand 
induces selectively apoptosis in tumor cells by binding to two death receptors (DR4 
and DR5) and holds promise as a potential therapeutic agent against cancer. At the 
age of ten weeks animals from both groups did not show any signs of dysplastic 
nodules or HCCs and were used as controls for Real-time PCR experiments. Gene 
expression of DR5 and TRAIL was determined in these controls and compared to 
alb-myctg mice and Casp8hepalb-myctg animals at the age of 65 weeks with high 
tumor incidence (Fig. 4.3.4). Both groups showed an age-dependent increase of DR5 
expression indicating existence of tumors. However, DR5 expression in 65 weeks old 
Casp8hepalb-myctg mice was 2 fold higher compared to single c-myc transgenic 
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animals (Fig. 4.3.4 A). It has to be noted that increased DR5 expression in 
Casp8hepalb-myctg mice can not result in enhanced TRAIL-mediated apoptosis due 
to a block of the Caspase-8 dependent pathway. 
In addition, the expression of TRAIL also increased with age, although no 
significant differences between the two genotypes were found at any time point (Fig. 
4.3.4 B). 
 
 
Fig. 4.3.4: Induced expression of the TRAIL receptor DR5 in 65 weeks old Casp8hepalb-myctg 
mice. Quantitative RT-PCR analysis demonstrates expression of (A) DR5 and (B) TRAIL mRNA in 
livers from alb-myctg and Casp8hepalb-myctg at the age of 10 and 65 weeks. The DR5/ GAPDH 
expression ratio as well as the TRAIL/ GAPDH expression ratio was determined for each time point 
and calculated as fold induction in comparison to untreated controls Results are expressed as mean of 
at least 10 animals per group; error bars indicate SD. Grey bars represent alb-myctg mice, black bars 
represent Casp8hepalb-myctg animals. 
 
The importance of c-myc and E2F1 in carcinogenesis is emphasized by their 
capacity to induce both cell proliferation and cell death. In addition of sharing 
functional properties, increasing evidence suggests that these two proto-oncogenes 
can regulate each others activities. Recently, E2F1 has been suggested to function 
as critical anti-apoptotic factor in liver cancer. This acts in favor of c-myc driven cell 
growth by suppression of c-myc-induced apoptosis (Ladu et al., 2008).  
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E2F1 mRNA expression increased age-depending and Casp8hepalb-myctg 
mice displayed a slightly elevated tendency at 10 and 65 weeks of age compared to 
alb-myctg animals. However, differences were not significant at both time points. 
Earlier reports have suggested that c-myc sensitizes cells to apoptosis by 
promoting the activation of the mitochondrial pathway through a bax-dependent 
mechanism (Nieminen et al., 2007).  
In agreement with these data, bax expression in alb-myctg mice at the age of 
65 weeks was significantly upregulated (3.5 fold induction, Fig. 4.3.5 B) compared to 
10 week old controls. In sharp contrast, aged Casp8hepalb-myctg animals with high 
tumor incidence showed only a moderate bax-induction (2fold increase, Fig. 4.3.5 B).  
 
Figure 4.3.5: E2F1 expression is elevated in Casp8hepalb-myctg mice while pro-apoptotic bax is 
reduced in mice at the age of 65 weeks. Quantitative RT-PCR analysis demonstrates expression of 
(A) E2F1 and (B) bax mRNA in livers from alb-myctg and Casp8hepalb-myctg at the age of 10 and 65 
weeks. The E2F1/ GAPDH expression ratio and the bax/ GAPDH expression ratio was determined for 
each time point and calculated as fold induction in comparison to untreated controls Results are 
expressed as mean of at least 10 animals per group; error bars indicate SD. Grey bars represent alb-
myctg mice, black bars represent Casp8hepalb-myctg animals. 
 
Thus, retarded tumor initiation but enhanced tumor progression in 
Casp8hepalb-myctg mice correlates with increased DR5 expression despite 
decreased apoptosis signaling due to Caspase-8 deletion and bax deregulation. 
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5 Discussion 
The focus of the present study was a detailed analysis concerning the role of 
the pro-apoptotic factor Caspase-8 for cell proliferation, regeneration and 
carcinogenesis in the liver. To address this question, a recently generated, 
hepatocyte-specific knockout mouse strain for Caspase-8 (Casp8hep) was 
characterized in two different models: In a model of liver regeneration following partial 
hepatectomy (PH) the consequences of Caspase-8 ablation for both termination and 
initiation of liver regeneration was investigated. In a c-myc transgenic animal model 
of hepatocarcinogenesis (alb-myctg), it was analyzed if additional Caspase-8 deletion 
might result in accelerated tumor initiation or progression to reassess the idea of 
apoptosis as a tumor suppressive mechanism. For the latter approach a novel 
experimental concept was established allowing the non-invasive, continuous 
monitoring of tumor growth in mice, which will be discussed in the following 
paragraph. 
 
5.1 Establishing of MRI technique in a murine tumor model of HCC 
Rationale for the study 
The incidence of hepatocellular carcinoma (HCC) is increasing worldwide and 
accounts for as many as 1 million deaths annually, representing the third cause of 
cancer-related death after lung and stomach cancer (Varela et al., 2003). In order to 
define new and better therapeutical targets, strong efforts have been made during 
the last years to better understand the molecular mechanisms of 
hepatocarcinogenesis. Appropriate transgenic- or chemical tumor models in mice are 
a powerful tool for our comprehension of in vivo biology including tumor initiation, 
promotion, progression, and metastasis. More important, they can also facilitate more 
clinically relevant applications such as selection, identification, and validation of 
biomarkers for cancer diagnosis and evaluation of newly developed agents or 
methods for cancer therapies. However, state-of-the-art methods to monitor tumor 
development in murine livers are still limited. 
In the present study a protocol for the monitoring of HCC initiation and 
progression was established by using a clinical 1.5 T MRI scanner and c-myc 
transgenic mice as a model system. Alb-myctg animals are a well established animal 
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model for hepatocarcinogenesis (Ladu et al., 2008; Liedtke et al., 2005). Hepatic 
over-expression of c-myc has been shown to result in chronic hepatic proliferation 
and increased incidence of liver cancer. Typically, HCC derived from alb-myctg mice 
have been characterized by long tumor latency coupled with slow progression of 
tumor growth similar to a group of human HCCs with better prognosis and survival 
(Lee et al., 2004). These findings were confirmed in the current analysis of alb-myctg 
mice exhibiting a tumor incidence of ~40 % at the age of 45 weeks and up to 75 % at 
the age of 65 weeks.  
 
Essential considerations for the development of tumor screening protocols in 
mice  
Several arguments benefit the use of MRI compared to other options. One 
advantage of MRI is that it is harmless to the patient because it works with 
magnetism. Computed tomography (CT) can also be used for the detection and 
characterization of focal liver lesions. However, this modality exposes small rodents 
to relatively high doses of radiation. Each CT scan at a resolution of approximately 
100 µm adds a dose of 0.1 Gy (0.3 Gy for a three phase scan) whereas the lethal 
dose for mice is 8 Gy (Wehrl et al., 2009). Even if the lethal dose may not be reached 
with multiple follow up CT examinations, high radiation exposure by itself might alter 
the course of a disease or influence the results of the study. Ultrasound on the other 
hand may not allow objective imaging of all anatomical regions.  
Based on these considerations, MRI should be preferred for longitudinal follow 
up imaging in rodents. MRI is not associated with radiation exposure and can be 
repeatedly used for imaging of small animals without any long term effects or 
alteration of the course of the disease.  
Additionally, MR images provide a superior three-dimensional spatial 
resolution. An entire overview of the architecture of the liver by applying various 
sequences in different orientations as seen in Tab. 4.2.1 and Fig. 4.2.2 was obtained. 
A good homogeneity of the magnetic field facilitated the acquisition of high quality 
images without strong artifacts. The application of a dedicated small coil allowed for 
achievement of images with a high signal to noise-to-ratio, so that spatial resolution 
was accommodated to the small sized animals.  
The most important issue in this study was the development of a stable logistic 
protocol, including anesthesia and positioning of the animals for imaging. 
5 Discussion 
 
102
Standardized placement of the animal and the coil in a stable fashion on the MR 
scanner was of utterly importance for fast acquisition of the imaging protocol and 
facilitated inter- and intraindividual comparison of the datasets. Gross movements 
lead to artifacts and can render image analysis impossible. This was especially 
problematic for T1 weighted images acquired shortly after injection of the contrast 
medium. This sequence can not be repeated in the same imaging session, due to the 
already injected dose.  
Importantly, MRI works with well tolerated contrast enhanced mechanism, 
yielding detailed anatomical and functional information (Cohen et al., 2007). In initial 
experiments two distinct commonly used contrast media were tested revealing that 
Primovist® contrast agent was highly specific for hepatocytes and further improved 
the imaging of murine livers. In T1-weighted scans only few minutes after application 
strong contrast accumulation was seen in hepatocytes of healthy liver tissue. This 
allowed the healthy tissue to be clearly demarcated from various lesions (Fig. 4.2.5). 
On the other hand diagnostics of tumors with Magnevist® contrast-enhancement 
proved to be less reliable for the application in the murine liver. Differences of healthy 
liver parenchyma compared to tumorous tissue were barely visible. Therefore, 
Magnevist® was excluded from further studies.  
Future approaches for better contrast enhancement in the liver could use MRI-
detectable reporter genes under the control tissue- or disease specific gene 
promoters. In this context it was recently shown, that the iron-accumulating protein 
ferritin might be an appropriate reporter gene for MRI studies in the liver (Cohen et 
al., 2005; Cohen et al., 2007). 
 
MRI enables continuous monitoring for tumor initiation and progression 
Analysis of tumor development and progression in distinct transgenic mouse 
strains usually requires the investigation of large numbers of animals in end-point 
experiments in order to create reliable data. MRI provides a superior advantage as it 
allows the non-invasive monitoring of tumor development in one mouse at different 
time points in real-time.  
Within this study, the tumor progression in a number of alb-myctg mice could 
be successfully analyzed in detail by periodical MR imaging in 5 weeks intervals. 
With this approach, which served as a proof of principle, earlier findings were 
confirmed describing the properties of c-myc-driven carcinogenesis in the liver with 
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conventional methods. In this context it could be validated that HCCs derived from c-
myc over-expressing hepatocytes comprise a long latency period and slow tumor 
growth as reported earlier (Ladu et al., 2008), demonstrating that MRI in mice is 
superior to conventional methods for the monitoring of HCC. 
In the second part of this work the MRI technique in mice was further improved 
and applied to concrete scientific questions. Especially, the influence of Caspase-8 
on the c-myc dependent hepatocarcinogenesis was successfully investigated by 
periodical MRI measurement showing differential onset and tumor progression in alb-
myctg – compared to Casp8hepalb-myctg mice. An additional promising application 
which was initiated during this work, involved the cross regulation of Caspase-8 and 
NEMO during hepatocarcinogenesis: Lüdde et al. (2007) demonstrated that ablation 
of NEMO in liver parenchymal cells causes massive spontaneous apoptosis and 
subsequent development of hepatocellular carcinoma. Preliminary, periodical MRI 
analysis of Casp8hepNEMOhep mice however indicated that ablation of Caspase-8 
protects from HCC development in NEMOhep mice (data not shown).  
Future potential applications for the use of MRI in murine livers will be the 
evaluation of novel anti-cancer drugs on tumor regression in animal experiments.  
 
Limitations of MRI for the detection of murine HCC  
Several studies have demonstrated that MRI represents one of the highest 
imaging accuracy of all imaging methods available to date In this study monitoring of 
small single nodules of 2 mm diameter was made possible (compare Fig. 4.2.8). To 
determine the limit of detection concerning tumor size, a big number of animals with 
expected onset of tumor development between 45 and 57 weeks of age was 
screened by MRI and subsequent macroscopic liver analysis. These experiments 
demonstrated that MR imaging is a powerful tool for efficient investigation of tumors ≥ 
4 mm. However, investigation of small nodules (≤ 4 mm) which is important to define 
tumor initiation, seems to be limited and it can not be excluded that nodules ≤ 2 mm 
will be only detected in part. Application of MRI does also not seem to be functional 
on chemically-induced HCC animal models e.g. after application of 
Diethylnitrosamine (DEN, data not shown). These types of tumors are characterized 
by small, multinodular appearance making it difficult to distinguish between single 
lesions. These problems might be enhanced by to the small size of the analyzed 
object (mice versus humans) in combination with the relatively weak magnetic field 
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strength (1.5 T) of the used MRI scanner. Further improvements of MRI application in 
murine HCC models are crucial by optimizing the set-ups for a clinical 3 T MRI with 
higher resolution to also detect very small nodules at early stages. Of notice, recent 
MR scanners optimized for small animals provide a field strength of 7-9 T but are 
unavailable in most research centers. 
On T1-weighted scans the intensity of HCC can be highly variable due to 
hemorrhage and the presence of copper, protein, lipid and glycogen. This can make 
proper diagnostic more difficult. As an estimation in T1- weighted scans, one-third 
appear hypointense, one-third isointense and one-third are hyperintense relative to 
the healthy liver tissue (Digumarthy et al., 2005). Signal intensity on T2-weighted 
images varies from isointense to slight hyperintensity compared to the surrounding 
liver parenchyma. Nonetheless, in this work 91 % of the tumors could clearly be 
identified by MRI. These findings were confirmed by macroscopic and histopathologic 
analysis (Fig. 4.2.6).  
Taken together this study established a non-invasive method to monitor tumor 
growth and allows comparison between different types of knockout mice concerning 
tumor susceptibility. It was demonstrated that a lack of dedicated small rodent MRI 
should not be an obstacle for research in mice. The use of 1.5 T clinical MRI could 
even be advantageous, as it makes direct translation and correlation into human 
clinical studies easier. Nevertheless, limitations in reliable detection and 
characterization of small HCC remain an area of further investigation. This will help to 
gain better insight and to understand the underlying molecular mechanisms of HCC 
initiation and development. 
 
5.2 The impact of Caspase-8 for liver regeneration following PH 
In the adult liver, hepatocytes are long-lived and rarely undergo proliferation, 
yet they retain a remarkable ability to proliferate (Michalopoulos and DeFrances, 
1997). Human or animal livers have an optimal function mass that is proportional to 
the body size of the individual. Imbalance of the equilibrium e.g. after liver 
transplantation is rapidly restored. Surgical resection or “small-for-size” liver 
transplantation triggers proliferative response and restoration of the deficit mass. A 
“large-for-size” transplantation or drug-induced hyperplasia results in cell death until 
optimal ratio is reached (Koniaris et al., 2003).  
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Partial hepatectomy is the model that most clearly demonstrates the 
regenerative capacity of the liver. Within 7 to 10 days after 70 % PH the liver has 
regained its original size and quickly restored its function. Much has been learned in 
the past years about this regenerative response. It is initiated by a series of signaling 
events that allow the hepatocytes to enter the cell cycle and undergo several rounds 
of proliferation (Fausto et al., 2006). But yet, little is known about the mechanisms 
underlying termination of regeneration.  
 
Caspase-8 is dispensable for the termination of liver regeneration 
A constitutive knockout of the pro-apoptotic factor Caspase-8 was shown to be 
lethal due to an abundance of developmental defects (Varfolomeev et al., 1998) 
indicating an important role of Caspase-8 for development and morphogenesis. 
Therefore, a conditional, hepatocyte-specific knockout mouse strain (Casp8hep) was 
generated in the Department of Medicine III (UK Aachen) (C. Liedtke, D. 
Riethmacher and C. Trautwein, unpublished results). Casp8hep mice are viable and 
segregate according to Mendelian rules. Macroscopically no differences were seen 
between WT controls and Casp8hep mice concerning body size, weight and liver 
morphology. Also liver/ body weight ratio of untreated animals in both groups was 
identical.  
The hypothesis of the present work was that conditional ablation of Caspase-8 
might effect apoptosis signaling and thus contribute to a delayed termination of liver 
regeneration after partial hepatectomy potentially resulting in hepatomegaly or even 
development of hepatocellular carcinoma. Moreover, at the starting point of this study 
it was postulated that Caspase-8 deletion might change TNF signaling cascades via 
modulated NF-B and/ or JNK activation.  
To test these hypotheses, Casp8hep mice were subjected to 70 % PH and 
analyzed for molecular and cellular changes during liver regeneration and termination 
compared to appropriate control animals (Casp8f/f). Interestingly, liver/ body weight 
ratio did not differ among the two groups after entire liver restoration two weeks post 
surgery. A subset of Casp8hep mice was even observed for up to 6 months after 
surgery without any signs of hepatomegaly or pre-carcinogenic lesions (data not 
shown) indicating that Caspase-8 is dispensable for proper termination of the 
regeneration process.  To support this idea, Caspase-8 activity was measured in liver 
samples of controls and Casp8hep mice between 72 h and 7 days after surgery 
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revealing no detectable Caspase-8 activity at any time point. Thus, other 
mechanisms must be involved in termination of liver regeneration.  
 
Ablation of Caspase-8 results in an accelerated onset of G0-G1/S-phase 
transition 
Surprisingly, the analysis of hepatocyte proliferation and cell cycle regulation 
in Casp8hep mice revealed an accelerated initiation of G0-G1 phase transition as 
evidenced by early induction of Cyclin D mRNA- and protein expression. Moreover, 
the onset of DNA synthesis identified by maximal Cyclin E expression as well as S-
phase progression monitored by Cyclin A expression profiles and BrdU incorporation, 
was enhanced and accelerated until 40-48 h post surgery. However, at later time 
points (60 - 96 h post PH) the expression levels of Cyclin D, E1 and A as well as 
BrdU incorporation displayed no further differences between the groups.   
These unexpected findings raised the question why the liver/ body weight ratio 
of Casp8hep mice 24 - 96 h post PH was not different from controls assuming that 
excessive DNA synthesis might also lead to more hepatocyte proliferation and 
mitosis. However, concerning the aberrant Cyclin B expression serving as mitotic 
marker, it is very likely that mitosis in these mice is retarded despite amplified DNA 
synthesis during cell cycle initiation. Alternatively, prolonged high Cyclin A expression 
and BrdU incorporation could also indicate decelerated and inefficient DNA synthesis 
thus compensating accelerated cell cycle start. However, this hypothesis needs 
further investigation. 
A recent study investigating another conditional knockout allele of Caspase-8, 
revealed conflicting data (Ben Moshe et al., 2007). In their experimental settings, Ben 
Moshe et al describe high mortality after PH, strongly reduced liver regeneration 
during the initial phase associated with delayed expression of cell cycle markers such 
as Cyclin D, E and A. However, two important issues might contribute to the 
differences between the present work and the study by Ben Moshe et al: First, these 
authors conditionally deleted exons 1 and 2 of Caspase-8 as previously described by 
Kang et al. (2004) leading to a truncated but expressed Caspase-8 protein whereas 
Casp8hep mice of the present study only express AA 1-137 due to a premature stop-
codon. Therefore, it can not be excluded that the Caspase-8 knockout allele 
generated by Ben Moshe et al could mediated different effects. Second, Ben Moshe 
et al reported high mortality in their mice after 2/3 surgery and therefore performed 
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the majority of regeneration experiments in the alternate model of 1/3 liver resection. 
However, strong molecular differences in the experimental model used (1/3 -versus 
2/3 hepatectomy) might explain the differences between both studies. In this context 
it has been shown earlier that the complexity of liver resection (sham operation, 1/3 
PH or 2/3 PH) is directly proportional to the increase in JNK and AP1 activity in the 
liver (Westwick et al., 1995).  
 
Transcriptional Cyclin D regulators control accelerated S-phase in Casp8hep 
mice 
The initial findings clearly demonstrated that Casp8hep mice are more prone to 
an earlier onset of cell cycle. Current studies suggest that induction of Cyclin D1 is 
sufficient to trigger cell replication of adult hepatocytes. Furthermore, these results 
support the concept that Cyclin D1 is the crucial intracellular mediator of mitogenic 
signals that control hepatocyte proliferation in the regenerating liver (Schwabe et al., 
2003). 
Up-regulation of Cyclin D1 mRNA as observed in the present study is a strong 
indication for a regulation on the transcriptional level. To understand the underlying 
mechanisms of the earlier onset of liver regeneration in mice lacking Caspase-8 it is 
important to review the mechanisms involved in the transcriptional regulation of 
Cyclin D1. The Cyclin D1 promoter contains two functional NF-B binding sites for 
the subunits p50 and p65 (Hinz et al., 1999) and a binding element for activating 
protein 1 (AP-1). A link between JNK activation and Cyclin D1 expression via c-Jun 
activation was demonstrated earlier (Herber et al., 1994). Accordingly, ectopic 
expression of either c-fos or c-Jun induces Cyclin D1 mRNA expression (Westwick et 
al., 1995). 
The presence of c-Jun in the AP-1 complex is absolutely required for cell cycle 
progression after PH. Knockout mice for c-Jun (c-jun-/-) suffer from failure of hepatic 
development (Behrens et al., 2002; Hilberg et al., 1993). In line with the previous 
findings, phosphorylation of c-Jun was observed significantly earlier after liver 
resection in Casp8hep animals. Also activity of transcription factor AP-1 was strongly 
enhanced in primary Casp8hep hepatocytes immediately after TNF stimulation.  
AP-1 regulates Cyclin D1 expression by at least two mechanisms: directly by 
activation of the Cyclin D1 promoter and indirectly by increasing E2F1 activity. Thus 
both AP-1 and E2F1 play important roles in regulating Cyclin D1 expression (Shen et 
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al., 2008). In quiescent hepatocytes E2F1 is absent while E2F4 is associated with 
p130. As cells enter the cell cycle these complexes are disrupted, while E2F1 is 
transcriptionally induced in mid- to late G1-phase. During S-phase E2F1 
phosphorylates Cyclin A/ CDK2 complexes evoking their activation (Santoni-Rugiu et 
al., 1998). In line with these data, significant up-regulation of E2F1 was detected 
during G1/ S-phase in Casp8hep mice potentially contributing to accelerated Cyclin D 
induction. Downregulation of antagonistic E2F4 as observed in quiescent Casp8hep 
livers. This may further facilitate initiation and progression of cell cycle in these 
animals. 
Apart from JNK activation TNF- also mediates activation of the transcription 
factor NF-B further driving Cyclin D expression. Consistent with earlier findings 
(Beraza et al., 2009), in primary hepatocytes and livers from Casp8f/f control mice, 
NF-B activation was a fast and transient event in response to TNF stimulation. Also 
phosphorylation and nuclear translocation of the NF-B subunit p65 after PH was 
restricted to only a short period in control animals. In comparison, an already basal 
activation of NF-B activity was observed in primary Casp8hep hepatocytes lasting 
for up to 6 h after TNF stimulation. Furthermore, hepatectomized Casp8hep animals 
displayed immediate and sustained p65 phosphorylation after surgery. In 
contradiction to these results, a significant down-regulation of IB- expression was 
observed in these animals. B- is a subunit of the IB inhibitor complex and has 
been described as one of the first target genes of NF-B transcription. In the current 
scenario in Casp8hep mice, a constitutive down-regulation of B- could further 
contribute to prolonged NF-B activation. However, the precise molecular basis 
leading to B- downregulation in Casp8hep mice is not clarified yet. Taken 
together, these data strongly indicate that mice lacking Caspase-8 are already 
primed for NF-B activation at basal condition and are thus more efficiently triggered 
to immediately respond upon TNF-stimulation compared to WT littermates.  
This is additionally supported by strong constitutive expression levels of FLIPL 
protein in Casp8hep animals. FLIPL plays a key role for Caspase-8- and NF-B 
signaling pathways and is one of the first target genes of NF-B. It has been 
suggested that protection against Caspase-8 mediated apoptosis is augmented by 
an auto-amplification loop of FLIPL. Hence, TNF- stimulation in knockout of 
Caspase-8 acts in favor of the inflammatory pathway of NF-B instead of apoptosis. 
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Ablation of Caspase-8 affects TNF receptor complex formation 
To further characterize the link between Caspase-8 ablation and accelerated 
NF-B and JNK activation after PH– induced TNF-stimulation, protein interactions 
within receptor complex-I and -II were extensively analyzed. In the WT situation, 
binding of TNF- to TNF-R1 rapidly initiates the plasma membrane bound complex-I 
which is composed of TNF-R1, the adapter protein TRADD, the protein kinase RIP1, 
and the TNF receptor-associated factor 2 (TRAF2). This complex-I induces 
immediate activation of the JNK and/ or NF-B signaling pathways, but no apoptosis. 
Investigation of complex-I components and their interaction in Casp8hep 
animals shortly after PH (0-6 h after surgery) revealed significant modifications of the 
normal complex assembly and aberrant expression profiles of complex components 
RIP1 and TRAF2, respectively. These modifications involved accelerated induction of 
RIP1, aberrant basal protein expression and strong up-regulation of TRAF2 and both 
earlier and stronger TRADD expression in Caspase-8 deleted mice. As the presence 
of RIP1 and TRAF2 at complex-I are required for the recruitment and activation of 
IKK and JNK (Devin et al., 2000), these data further indicate that hyper-activation of 
JNK1 and NF-B is already predetermined at the complex-I level.  
Concerning complex-I assembly, Casp8hep animals revealed some further 
remarkable characteristics including strong constitutive complex formation of JNK1 
with TRADD, accelerated association of JNK1 with TRAF2 and immediate interaction 
between TRAF2 and FLIPL, which was not observed in WT controls. The aberrant 
complex-I formation seen in Casp8hep animals strongly supports the hypothesis that 
Caspase-8 does not only mediate pro-apoptotic functions via DISC complex 
association, but is also important for proper composition of complex-I.   
  
A current model explaining the findings of this study is illustrated in Fig. 5.1. 
Genetic ablation of Caspase-8 induces stronger response of NF-B and JNK upon 
TNF-stimulation after PH. This is mediated by a fast recruitment of complex-I 
components TRADD, TRAF2 and RIP1 to the TNF-R1. TRAF2 and RIP1 then recruit 
and activate the IKK complex resulting in subsequent activation and nuclear 
translocation of NF-B. Transcription factor NF-B causes transcription of FLIPL 
protein which in turn binds to the complex-I further enhancing the proliferative 
signaling by recruiting TRAF2 and RIP1 to the complex and additionally activating 
IKK complex. In WT livers, FLIPL is under the control of Caspase-8 preventing further 
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signal enhancement. Furthermore, also JNK is attracted and activated by complex-I 
leading to phosphorylation and nuclear translocates of c-Jun as a part of the AP-1 
transcription factor which in turn stimulates activation of the transcription factor E2F1. 
Eventually, NF-B, AP-1 and E2F1 bind to their respective binding sites within the 
Cyclin D1 promoter inducing a vast initiation of the cell cycle. 
 
Non-parenchymal cells in Casp8hep livers may contribute to accelerated NF-B 
and JNK activation via increased TNF expression  
A striking observation in Casp8hep animals during the priming phase of 
regeneration was a basal elevated TNF expression in combination with small 
inflammatory infiltrates as found in tissue sections of these animals. One of the main 
sources for TNF expression are the resident macrophages in the liver (Kupffer cells), 
which can be further characterized by the surface marker F4/80. In this context, it is 
remarkable, that the expression of F4/80 and CCR5 was significantly upregulated in 
Casp8hep mice after PH compared to Casp8f/f animals. In the liver, the chemokine 
receptor CCR5 is predominantly expressed on T cells and Kupffer cells which further 
hints at excessive infiltration of TNF-expressing cells in Casp8hep livers. Attraction of 
Kupffer cells into the liver may contribute to further increased amounts of excreted 
TNF leading to an enhancement of the signaling pathway. This might be an 
additional aspect explaining accelerated activation of TNF-dependent signals in 
Casp8hep mice. However, the mechanistic link between Caspase-8 ablation in 
hepatocytes and increased infiltration of inflammatory (Caspase-8 expressing) cells 
needs further exploration. 
  
Accelerated onset of liver regeneration in Casp8hep mice is predominantly 
mediated via NF-B 
In the previous experiments accelerated onset of liver regeneration in 
Casp8hep mice was tracked down to up-regulation of Cyclin D and correlated with 
earlier activation of JNK- and NF-B-dependent pathways, suggesting that Cyclin D1 
is an important mediator of pro-proliferative effects of JNK and NF-B. 
In a next step the contributions of NF-B and/or JNK signaling pathways for 
advanced transcription of Cyclin D were dissected by crossing Caspase-8hep mice 
with hepatocyte-specific NEMO knockout animals to create a Caspase-8/ NEMO 
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double knockout line (Casp8hepNEMOhep). NEMOhep mice display a complete 
abrogation of NF-B activation (Luedde et al., 2007) and reveal a complex 
spontaneous phenotype involving apoptosis, steatosis and carcinogenesis. 
Consequently, TNF signaling in Casp8hepNEMOhep mice can only be mediated via 
the remaining JNK signaling pathway. Of notice, the extensive characterization of 
Casp8hepNEMOhep mice was not within the scope of this study and will be 
presented elsewhere.  
Interestingly, the Cyclin D1 expression profile of Casp8hepNEMOhep mice was 
identical to control animals strongly implicating, that enhanced NF-B - and not JNK 
signaling is responsible for the phenotype seen in Casp8hep mice.  However, 
hepatocyte proliferation kinetics as monitored by Cyclin A expression and BrdU 
incorporation was even slightly delayed further demonstrating that JNK signaling 
alone is sufficient to initiate the cell cycle although with slightly reduced efficiency. Of 
even higher importance, Casp8hepNEMOhep animals revealed strong Cyclin A 
expression two weeks after liver resection and hepatomegaly of the remnant livers 
six weeks after PH. This is especially remarkable as hepatomegaly was originally 
expected in Casp8hep mice due to deficient termination of the regeneration process. 
As a conclusion, Caspase-8 and NF-B seem to act in a synergistic manner in 
order to terminate liver restoration via a yet unknown mechanism but potentially 
involving JNK regulation. This further indicates that the JNK signaling pathway in the 
Casp8hepNEMOhep animals rather transmits a persistent continuous stimulus 
instead of a short and strong impulse. 
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Figure 5.1: Proposed model of TNF-signaling pathway in Caspase-8 deficient mice after PH. 
Comparison of Casp8f/f with Casp8hep mice shortly after PH. Left panel: Complex-I formation and TNF 
signaling in WT mice immediately after PH: Binding of TNF to the TNF-R1 initiates the pro-proliferative 
signaling cascade ultimately after PH. TRADD binds with its DED to the TNF-R and recruits TRAF2 
and RIP1 subsequently forming complex-I. TRAF2 and RIP1 recruit and activate IKK and JNK to the 
complex. Active IKK-complex phosphorylates the inhibitor of NF-kB (IkB) causing the release of NF-kB 
and its translocation into the nucleus. In WT cells IB is one of the first targets of NF-B leading to its 
own regulation by a negative feedback-loop. JNK activation leads to phosphorylation of c-Jun and its 
nuclear translocation as part of the transcription factor AP-1. AP-1 activates the transcription factor 
E2F1 leading to phosphorylation of various Cyclin/ CDK complexes during cell cycle progression. 
Ultimately, NF-B, AP-1 and E2F1 occupy a binding site within the Cyclin D1 promoter therefore 
promoting Cyclin D1 transcription and driving quiescent hepatocytes from G0 to G1- phase of the cell 
cycle. 
Right panel: In Casp8hep mice JNK1 and TRADD are constitutively associated to complex-I. 
Furthermore complex formation in Caspase-8 deleted mice was observed earlier between TRAF2 -
JNK. This causes advantageous NF-kB and c-Jun/ AP-1 activation leading to earlier Cyclin D 
transcription. Additionally, in Caspase-8 deleted mice FLIPL transcription is strongly upregulated after 
PH. Association of FLIPL with TRAF2 in the complex-I further enhances the proliferative signaling.  
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5.3 Ablation of Caspase-8 retards tumor initiation but triggers tumor 
progression in a c-myc transgenic model of hepatocarcinogenesis 
Apoptosis is a fundamental process in tissue homeostasis and necessary to 
keep the balance between cell loss and cell gain in normal tissue. Programmed cell 
death is an efficient way of eliminating unwanted senescent, virally infected and 
damaged cells from the organism (Kerr et al., 1972). Concerning cancer 
development, apoptosis is believed to be essential for elimination of malign 
transformed cells. Accordingly, apoptosis resistance caused by silencing or deletion 
of pro-apoptotic genes or over-expression of apoptosis-inhibitory factors seems to 
trigger carcinogenesis (Hanahan and Weinberg, 2000). Caspase-8 is the initiating 
Caspase mediating death receptor dependent apoptotic cascades. Of notice, several 
kinds of human tumors, like childhood neuroblastoma, hepatocellular carcinoma or 
gastric carcinomas are frequently deficient in Caspase-8 (Soung et al., 2005a; Soung 
et al., 2005b; Teitz et al., 2000). However, 12 to 14-months old Casp8hep mice 
investigated in the context of this study, did not provide any signs of carcinogenesis 
(data not shown). This indicates that a deletion of Caspase-8 alone is not sufficient to 
induce HCC development. Thus, at least a second tumorigenic trigger seems to be 
necessary to overcome the threshold to tumorigenesis.  
Deregulation of the c-myc proto-oncogene is implicated in the development of 
numerous rodent and human tumors including HCC. Hepatocyte-specific, c-myc 
transgenic mice (alb-myctg) have been described to trigger proliferation in the 
absence of mitogenic stimuli. Likewise, they are also capable of sensitizing cells to 
apoptosis (Ladu et al., 2008).  
Based on the fact, that hepatic tumors derived from c-myc transgenic mice are 
rarely silenced for Caspase-8 expression, one aim of this study was to evaluate, if in 
turn Caspase-8 deletion in alb-myctg mice might further trigger hepatocarcinogenesis 
or tumor progression. Therefore, Casp8hep mice were crossed with alb-myctg 
animals and subsequently analyzed for tumor development, tumor growth and 
genetic tumor markers compared to alb-myctg controls. Monitoring of tumor 
development and growth was performed by periodical measurement of animals 
between 45 and 65 weeks of age by MRI technique. During this 20 week time frame 
severe differences between both genotypes were observed. Surprisingly, onset of 
tumor development was significantly later in Casp8hepalb-myctg mice. At the age of 
45 weeks only 20 % of the animals exhibited HCCs compared to 40 % in the alb-
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myctg reference group. These results were unexpected but indicate that Caspase-8 
inactivation has a protective function concerning tumor initiation at least in the c-myc 
derived tumor model. This could be explained by the fact that over-expression of c-
myc in the liver does not only trigger proliferation, but can also induce moderate 
apoptosis (Ladu et al., 2008). As a consequence, hepatocyte death in alb-myctg mice 
may trigger a regenerative response in the liver with compensatory proliferation of 
hepatocytes further contributing to the oncogenic phenotype of these animals. This 
side effect of c-myc induced hepatocarcinogenesis might be blocked in Casp8hep 
alb-myctg mice due to blunted apoptosis thereby explaining the delayed onset of HCC 
development in these animals. 
In contrast to these results, Casp8hepalb-myctg mice at the age of 55 - 65 
weeks revealed excessive tumor growth in comparison to the alb-myctg reference 
group as shown by MR imaging. These findings correlated with strongly increased 
DR5 - and slightly stronger E2F – and TRAIL expression as well as significant down-
regulation of the pro-apoptotic factor bax in Casp8hepalb-myctg animals. Especially 
up-regulation of DR5 in combination with decreased bax level might be important for 
excessive tumor progression in Casp8hepalb-myctg mice. 
It has been shown before, that the TRAIL-DR5 axis - in addition to its pro-
apoptotic function, is also able to strongly induce pro-inflammatory and non-apoptotic 
signals (Trauzold et al., 2006). In the absence of Caspase-8, DR5 can not activate 
the canonical pro-apoptotic pathway. Instead, ablation of Caspase-8 could – 
analogous to the findings in the regeneration model, modulate the assembly of the 
DR5 receptor complex and thus induce a pro-inflammatory response resulting into 
elevated proliferation and tumor progression.  
Accelerated tumor progression in Casp8hepalb-myctg mice could be further 
supported by down-regulation of bax as found in this study. As a consequence, both 
death receptor mediated apoptosis (represented by Caspase-8) and intrinsic, 
mitochondria mediated apoptosis (represented by bax) are blunted in these animals 
potentially leading to complete apoptosis resistance. However, the mechanism 
leading to bax down-regulation is not characterized yet and needs further 
investigation. 
The transcription factor E2F1 was also slightly upregulated in both young - and 
65 week old Casp8hepalb-myctg mice. It has been demonstrated before that co-
expression of c-myc and E2F1 transgenes enhances survival of HCC (Ladu et al., 
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2008). Elevated E2F1 expression was also detected in Casp8hep mice during liver 
regeneration. Therefore strong E2F expression seems to be a property of Caspase-8 
ablation and presumably also contributes to stronger tumor progression of HCC.  
In summary the present investigations demonstrate a profoundly altered tumor 
initiation and progression in the alb-myctg - compared to the Casp8hepalb-myctg 
model. These findings clearly indicate that the absence of Caspase-8 has a 
protective effect on the initiation of tumor development but is strongly contributing to 
the progression of tumor growth. However, further studies have to reveal if this is only 
specific for c-myc dependent tumor models or rather displays a general mechanism.  
In addition, this study points to some problems regarding therapeutical interventions 
in apoptosis signaling as discussed e.g. for hepatitis patients. Although transient 
inhibition of Caspase-8 can evoke some benefits (Zender et al., 2003), lack of 
Caspase-8 could be of high risk for patients with elevated tumor susceptibility. 
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6 Summary 
Binding of the cytokine TNF- to TNF-Receptor 1 mediates pleiotropic effects 
via two different signaling complexes. Complex-I triggers activation of NF-B and 
activation of c-Jun N-terminal kinases (JNK) leading to inflammation and/ or cell 
proliferation, whereas complex-II induces apoptosis through Caspase-8. TNF 
signaling is crucial for the priming phase of liver regeneration following partial 
hepatectomy (PH) which directly contributes to gene activation of Cyclin D via NF-B, 
c-Jun/ AP-1 and E2F1.  The aim of the present study was to investigate the 
consequences of Caspase-8 deletion for TNF signaling during liver regeneration and 
termination as well as the role of Caspase-8 for initiation and development of 
hepatocellular carcinoma. Consequently, animals expressing Caspase-8 (f/f) on a 
regular level or mice deleted () in Caspase-8 were generated to define the role of 
Caspase-8 during TNF-mediated signaling and subjected to 2/3 PH.  
Cessation of liver regeneration was observed in the same manner in both 
genotypes at equal time points clearly indicating that the function of Caspase-8 is 
dispensable for the process of termination. Surprisingly, animals with deleted 
Caspase-8 were more prone to TNF-mediated NF-B and c-Jun/ AP-1 activation due 
to advantageous formation of complex-I subsequently leading to earlier onset of cell 
cycle progression.  
For the characterization of Casp8hep mice in genetic models of 
hepatocarcinogenesis, a standardized protocol for the application of magnetic 
resonance imaging (MRI) on genetically modified mice was established. Using this 
technique and conventional methods it was demonstrated that concomitant Caspase-
8 ablation and c-myc over-expression in murine livers (Casp8hepalb-myctg) caused 
delayed tumor development but accelerated progression of HCC when compared to 
alb-myctg mice. These findings provide strong evidence for a protective function of 
Caspase-8 in hepatocellular carcinogenesis. 
In summary, it was demonstrated that Caspase-8 mediates not only pro-
apoptotic, but also non-apoptotic functions as it contributes to the proper assembly of 
TNF- complex-I formation. Thus, ablation of Caspase-8 results in aberrant complex-I 
formation and subsequently accelerated NF-B and JNK activation eventually leading 
to earlier Cyclin D expression and induction of cell cycle activity. 
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7 Zusammenfassung 
Das Zytokin TNF- bewirkt über die Bindung an den TNF-Rezeptor 1 die 
Aktivierung von zwei unterschiedlichen Komplexen. Komplex-I verursacht die 
Aktivierung von NF-B und Jun-Kinasen (JNK), welche pro-inflammatorische 
proliferative Signale vermitteln. Komplex-II induziert Apoptose durch Caspase-8 
Aktivierung. Weiterhin spielt TNF- eine entscheidende Rolle während der frühen 
Leberregeneration nach partieller Hepatektomie (PH), da es an der Gentranskription 
von Cyclin D via NF-B, c-Jun/ AP-1 und E2F1 beteiligt ist. Ziel der Arbeit war die 
Untersuchung der Funktion von Caspase-8 im Rahmen der Leberregeneration und 
Termination. Desweiteren sollte die Rolle von Caspase-8 bei der Initiation und im 
Verlauf des hepatozellulären Karzinoms analysiert werden. Um die Rolle von 
Caspase-8 im Zusammenhang mit TNF-induzierter Leberregeneration zu 
untersuchen, wurden Tiere mit Caspase-8 Expression (f/f) und Caspase-8 deletierte 
Mäuse () generiert und einer 2/3 Hepatektomie unterzogen. 
In beiden Genotypen konnte ein zeitgleiches Ende der Regeneration 
festgestellt werden. Dies lässt das Fazit zu, dass Caspase-8 für den 
Terminationprozess keine Rolle spielt. Interessanterweise konnte jedoch eine 
verstärkte NF-B und c-Jun/ AP-1 Aktivierung in Caspase-8 deletierten Mäusen 
beobachtet werden. Dies war auf eine veränderte Komplex-I Formation 
zurückzuführen und verursachte letztendlich eine Verstärkung der Cyclin D1 
Transkription und einen schnelleren Einstieg in den Zellzyklus. 
Zur Charakterisierung von Casp8hepMäusen im Modell der 
Hepatokarzinogenese, wurde ein Protokol für die Anwendung der 
Magnetresonanztomographie (MRT) etabliert. Hierbei konnte demonstriert werden, 
dass ein Fehlen von Caspase-8 in Zusammenhang mit einer c-myc Überexpression 
(Casp8hepalb-myctg) in murinen Lebern zu einer verzögerten Tumorentstehung, 
gefolgt von einem verstärkten Wachstum der Tumore führt. Diese Daten geben klare 
Anhaltspunkte für die protektive Wirkung von Caspase-8 bei der Manifestation des 
hepatozellulären Karzinoms.  
Zusammenfassend konnte gezeigt werden, dass Caspase-8 nicht nur pro- 
sondern auch anti-apoptotische Funktionen hat. Ein Fehlen von Caspase-8 führt zu 
einem veränderten Komplex-I, einer erhöhten NF-B/JNK-Aktivierung,  gefolgt von 
einer schnelleren Cyclin D-Expression und Zellzyklus-Aktivierung.
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9.1 Abbreviations                                                                                                        
A  
as anti-sense 
AB antibody 
ALT Alanine transaminase 
AP1 activating protein-1 
Apaf-1 apoptotic protease activating factor-1 
APS Ammoniumpersulfate 
AST Aspartate transaminase 
ATP  Adenosintriphosphat  
B  
- scintillation counter beta- scintillation counter 
bax BCL2-associated X Protein  
Bcl B-cell lymphoma protein  
Bid BH3 interacting domain death agonist  
BrdU Bromodesoxyuridine 
BSA Bovines Serumalbumin  
C  
CARD Caspase recruitment domain 
Caspase cysteinyl aspertate-specific proteinases  
CDK cyclin dependent kinase 
c-IAP cellular inhibitor of apoptosis 
cm centimeter 
cpm counts per minute 
cre causes recombination 
Ctrl Control 
D  
DAB 3,3´-Diaminobenzidine 
DAPI 4´,6- Diamidino- 2- phenylindole Dihydrochlorid  
DED death effector domain  
DD death domain  
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VII
dH2O destilled water 
DISC death inducing signaling complex 
DNA desoxy-ribonucleic acid  
dNTP Desoxyribonukleosidtriphosphat  
DMEM Dulbeccos minimum essential medium  
DR3 death receptor 3 
DR5 death receptor 5 
DTT Dithiothreitol  
E  
EBSS Earles basic salt solution 
EDTA ethylene-diamine-tetraascorbate  
EMSA Electrophoretic Mobility Shift Assay 
EtOH Ethanol 
F  
FADD Fas-associating death domain protein  
FCS fetal calf serum 
FFE fast field echo 
FISP Fast Imaging with Steady state Precession 
FLIP FLICE-inhibitory protein 
FOV field of view 
G  
g gramm 
GAPDH Glyceraldehyd-3-Phosphate Dehydrogenase 
H  
h hour 
HCC hepatocellular carcinoma 
HRP Horseradish Peroxidase  
I  
IB Inhibitor of kappaB 
IKK IB kinase 
i.p. intraperitoneal 
i.v. intravenous 
J  
JNK/ SAPK c-Jun N-terminal kinases/stress-activated protein kinases  
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VIII
K  
kb kilobase 
kDa kilo Dalton  
KO knockout 
L  
l liter  
M  
MAPK Mitogen-activated protein (MAP) kinases 
MAP3K1 Mitogen-activated protein kinase kinase kinase 1 
MRI Magnetic Resonance Imaging 
µ mikro  
mRNA messenger Ribonucleic Acid  
N  
NEMO NF-kappaB essential modulator 
NF-B Nuclear Factor kappa B 
O  
ORF open reading frame 
P  
PBS Phosphat-buffert saline  
PCNA Proliferating Cell Nuclear Antigen 
PCR Polymerase Chain Reaction 
PFA Paraformaldehyde 
PH partial hepatectomy 
PMSF Phenylmethylsulfonylfluorid 
R  
RIP1 receptor-interacting protein 1 
RNA Ribonucleic acid 
rpm rounds per minute 
RT PCR Reverse Transkriptions 
S  
s sense 
SDS  Sodiumdodecylsulphat 
T  
T Tesla 
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IX
TAE  Tris-Acetat-EDTA 
TBE  Tris-Borat-EDTA-Puffer 
TBS  Tris-buffered saline 
TEMED  N, N, N´, N´-Tetramethylethylendiamin 
TSE turbo-spin echo 
  
TNF-α tumor necrosis factor-alpha 
TNF-R1/ 2 TNF-receptor1/ 2 
TRADD  TNF-R1-associated death domain protein 
TRAF2 TNF-receptor-associated protein 2 
TRAIL TNF-related apoptosis-inducing ligand 
TUNEL  terminal deoxynucleotidyltransferase-mediated dUTP-biotin 
nick end labelling 
U  
UV  Ultraviolett 
W  
WT Wildtype 
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